Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3013742	s-prealb	mg/l (g/l)	14416	33614	0.00%
3013742	s-prealb	g/l (g/l)	11243	27869	0.00%
3013742	p-prealb	g/l (g/l)	8815	15481	0.29%
3013742	s-prealb	— (—)	3630	6119	100.00%	Distribution not available
3013742	p-prealb	— (—)	1415	1985	100.00%	Distribution not available
3013742	prealb	g/l (g/l)	1276	1471	0.00%
3013742	s-prealbumiini	g/l (g/l)	137	167	0.00%
3013742	p-prealb	mg/l (g/l)	103	116	0.00%
3013742	prealb	— (—)	85	87	100.00%	Distribution not available
3013742	p-prealbumiini	g/l (g/l)	67	103	0.00%
3013742	prealbumiini,plasma	g/l (g/l)	37	58	0.00%
3013742	prealbumiini	g/l (g/l)	7	9	0.00%	Distribution not available	Distribution not available
3013742	s-prealbl	mg/l (g/l)	7	9	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Insulin, intermediate and long-acting

4062

21245

2.00

320.21

2.7

2.2

0.20

0.21

g/l

37.03

3734

19701

Covid-19 confirmed case

2853

13638

2.29

319.25

2.5

2.2

0.21

g/l

1.41

2650

12640

Exposure to unspecified factor

6851

30263

1.71

318.80

2.4

2.3

0.21

0.22

g/l

0.55

6275

28224

Mucosal proctocolitis

1188

3760

3.70

314.32

3.5

2.3

0.23

0.22

g/l

7.38

1130

3511

Asthma, excluding more controls

4804

13639

1.93

313.94

2.3

0.22

g/l

1.92

4507

12762

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1868

7400

2.72

313.79

2.4

2.3

0.22

g/l

1.89

1706

7012

Crohn disease

1213

3903

3.64

312.59

3.9

2.3

0.23

0.22

g/l

6.88

1151

3654

Intestinal infectious diseases

7841

28228

1.65

312.50

2.5

2.3

0.22

0.21

g/l

0.26

7277

26233

Type 2 diabetes, definitions combined, including avohilmo

6441

22554

1.74

310.76

2.3

2.2

0.22

g/l

1.31

5970

21023

Insulin, combination of fast acting with intermediate-acting or long-acting

4456

22673

1.91

310.48

2.8

2.2

0.20

0.21

g/l

38.93

4102

21021

All kidney diseases

8243

26243

2.32

307.65

2.7

2.2

0.21

0.22

g/l

26.81

7654

24477

Any reimbursement code in KELA

3958

6717

3.16

307.65

2.7

1.9

0.22

0.23

g/l

3.52

3734

6179

Viral Sepsis

1793

6352

3.23

307.65

3.2

2.1

0.21

g/l

3.12

1639

5917

Alcohol dependence

2293

9073

2.85

307.65

2.6

2.3

0.20

0.22

g/l

17.07

2038

8512

Malignant neoplasm of stomach, including Hilmo

763

1340

7.70

307.65

3.2

1.9

0.20

g/l

0.79

736

1198

Malignant neoplasm of pancreas, including Hilmo

1114

1979

7.72

307.65

3.5

2.0

0.19

0.20

g/l

2.39

1057

1780

Colorectal adenocarcinoma

2356

5046

5.97

307.65

2.4

2.0

0.21

0.20

g/l

3.32

2280

4543

Heart failure,strict

4392

13776

2.49

307.65

2.3

2.2

0.19

0.21

g/l

83.12

4003

12835

Insulin medication

4454

19650

2.04

307.65

2.8

2.3

0.20

0.21

g/l

36.31

4100

18260

Other disorders of fluid, electrolyte and acid-base balance

3200

10519

3.38

307.65

2.8

2.2

0.19

0.21

g/l

14.66

2904

9777

Alcohol use disorder, ICD-based

3662

14964

2.74

307.65

2.5

2.4

0.20

0.22

g/l

24.61

3259

13989

Hepatocellular carcinoma, including Hilmo

528

626

15.18

307.65

5.8

1.9

0.17

0.19

g/l

7.17

500

552

Malignant neoplasm of rectum, including Hilmo

1551

2971

6.98

307.65

2.2

2.0

0.22

0.20

g/l

6.78

1507

2672

Asthma, unspecified (mode)

3679

14043

2.09

307.65

2.3

2.2

0.21

0.22

g/l

5.42

3435

13097

Erysipelas

5484

20325

2.22

307.65

2.3

2.1

0.20

0.22

g/l

60.01

5011

18947

Adenocarcinoma and papilloma adenocarcinoma of rectum

1164

2253

6.92

307.65

2.3

2.0

0.21

0.20

g/l

4.88

1135

2028

Malignant neoplasm of breast, including Hilmo

3057

7917

2.74

307.65

1.7

2.1

0.23

0.22

g/l

15.00

2944

7239

Primary biliary cholangitis (PBC)

508

585

20.84

307.65

5.1

1.9

0.21

0.22

g/l

3.02

485

558

Nonalcoholic fatty liver disease

1545

3032

7.57

307.65

2.7

2.3

0.24

0.22

g/l

14.39

1450

2853

Bacterial infection, other or unspecified

5784

17576

3.18

307.65

2.8

2.1

0.19

0.22

g/l

77.79

5307

16337

Mental and behavioural disorders due to alcohol

4389

17967

2.59

307.65

2.5

2.4

0.20

0.22

g/l

29.32

3914

16822

Condition for Implicit Sepsis (Organ dysfunction codes)

7320

22884

2.46

307.65

2.8

2.1

0.20

0.22

g/l

67.77

6704

21397

Other bacterial diseases

9391

24091

2.73

307.65

2.7

2.2

0.20

0.22

g/l

111.25

8698

22500

Other diseases of pancreas

1125

2385

6.63

307.65

3.4

1.9

0.22

0.21

g/l

2.20

1086

2206

Colectomy operation

1921

5904

4.05

307.65

2.8

2.2

0.21

g/l

2.95

1844

5465

Type 2 diabetes

6912

23135

1.84

307.65

2.3

2.2

0.22

g/l

0.41

6389

21557

Chronic hepatitis, not elsewhere classified

700

862

16.08

307.65

5.7

1.9

0.21

0.22

g/l

2.73

662

815

Diabetes mellitus

7185

24272

1.82

307.65

2.4

2.3

0.21

0.22

g/l

2.16

6639

22636

Other antidepressants

7333

21330

1.85

307.65

2.3

0.22

0.21

g/l

8.74

6674

19999

Any gastric operation

7152

7699

5.17

307.65

2.7

1.6

0.21

0.23

g/l

47.51

6739

6918

Complications of surgical and medical care, not elsewhere classified

8536

26825

2.37

307.65

2.6

2.2

0.21

0.22

g/l

8.42

7993

24847

Other diseases of intestines

8067

23427

2.08

307.65

2.7

2.3

0.22

g/l

0.75

7543

21780

Diabetes, varying definitions

7172

24233

1.82

307.65

2.4

2.3

0.21

0.22

g/l

2.01

6627

22600

Hepatic failure, not elsewhere classified

705

1015

12.66

307.65

5.8

1.9

0.16

0.22

g/l

42.00

637

946

Type 2 diabetes, wide definition

6009

19730

2.09

307.65

2.3

2.1

0.21

g/l

2.77

5523

18320

Non-invasive ventilation

1672

5465

2.98

307.65

2.6

2.3

0.20

0.22

g/l

25.94

1580

5194

Type 2 diabetes, definitions combined

6480

22517

1.77

307.65

2.3

2.2

0.22

g/l

0.79

6011

20977

Autoimmune diseases excluding thyroid diseases

7849

22911

1.98

307.65

2.9

2.1

0.22

g/l

0.33

7351

21283

Other diseases of liver

2893

5420

7.71

307.65

3.4

2.0

0.22

g/l

0.50

2678

5093

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2409

4783

6.74

307.65

2.7

2.1

0.19

0.21

g/l

10.81

2308

4335

Eating disorder

833

1885

5.25

307.65

3.0

2.6

0.23

g/l

0.67

761

1767

7163

21011

2.22

307.65

2.5

2.2

0.21

0.22

g/l

36.34

6622

19605

Ulcer of lower limb, not elsewhere classified

1537

4808

3.92

307.65

2.2

0.19

0.20

g/l

6.70

1403

4457

Obesity and other hyperalimentation

4735

22856

2.15

307.65

2.3

0.22

g/l

0.05

4411

21392

Acute pancreatitis

1976

6051

3.88

307.65

3.6

2.0

0.20

0.21

g/l

12.65

1881

5549

KRA_PSY_EATING, excluding more controls

828

1364

7.27

307.65

3.0

2.6

0.23

g/l

0.48

756

1299

Implicit Sepsis

7212

22563

2.57

307.65

2.8

2.1

0.20

0.22

g/l

65.46

6580

21101

Fibrosis and cirrhosis of liver

1854

2256

19.37

307.65

5.0

1.9

0.17

0.21

g/l

70.05

1709

2116

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3125

8353

2.54

307.65

3.3

2.2

0.20

0.23

g/l

48.95

2914

7874

Liquid cancers, helper endpoint

2772

9474

2.81

307.65

2.4

2.1

0.20

0.21

g/l

8.66

2557

8569

Complications of medical and surgical care

6296

26671

2.38

307.65

2.8

2.2

0.21

g/l

7.13

5914

24697

Influenza and pneumonia

8210

26680

2.09

307.65

2.5

2.3

0.21

0.22

g/l

43.14

7601

24930

Any death

5895

17574

2.73

307.65

2.6

2.2

0.18

0.22

g/l

263.67

5347

16479

Diabetes medication

7055

25423

1.72

307.65

2.4

2.3

0.21

0.22

g/l

2.08

6521

23704

Other diseases of the digestive system

2914

11677

2.83

307.65

3.2

2.1

0.19

0.21

g/l

22.78

2670

10779

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

9597

25651

2.88

307.65

2.8

2.2

0.20

0.22

g/l

58.93

8896

23892

Solid cancers, helper endpoint

7576

16033

3.10

307.65

2.4

2.2

0.22

g/l

1.54

7256

14641

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

5047

23944

2.03

307.65

2.5

2.2

0.21

g/l

2.18

4692

22173

Other nutritional deficiencies

5096

23516

2.20

307.65

2.4

2.3

0.22

g/l

0.48

4739

22002

Nephropathy related operations

1336

4004

4.17

307.65

4.7

2.4

0.21

g/l

0.72

1271

3730

L04AD Calcineurin inhibitors

1310

3443

4.94

307.65

6.4

2.4

0.23

0.22

g/l

2.88

1273

3225

Autoimmune diseases

7793

23043

1.80

307.65

2.8

2.2

0.22

g/l

0.23

7267

21406

Cardiovascular diseases (excluding rheumatic etc)

4272

11088

2.35

307.65

2.8

2.4

0.22

0.23

g/l

8.62

4019

10451

Other septicaemia

4007

12403

3.65

307.65

3.1

2.1

0.19

0.21

g/l

68.25

3667

11516

Abnormal findings on examination of blood, without diagnosis

3721

17074

2.19

307.65

2.7

2.3

0.21

g/l

0.40

3460

15810

Condition for Implicit Sepsis (Organ dysfunction codes)

7442

23335

2.38

307.65

2.8

2.1

0.20

0.22

g/l

63.90

6849

21843

General symptoms and signs

8362

19972

2.24

307.65

2.6

2.2

0.21

0.22

g/l

17.10

7751

18660

Implicit bacterial Sepsis

4505

13731

3.27

307.65

2.9

2.1

0.19

0.21

g/l

53.30

4091

12765

Heart failure, strict

4702

16411

2.21

307.65

2.2

0.19

0.21

g/l

75.76

4262

15246

Autoimmune diseases related-to ILD

6347

29229

1.98

307.65

2.9

2.2

0.22

0.21

g/l

8.33

5955

27110

Hypertensive diseases (excluding secondary)

3742

9042

2.59

307.65

2.5

2.2

0.23

g/l

2.83

3508

8541

Endocrine, nutritional and metabolic diseases

5444

13850

2.09

307.65

2.6

2.3

0.22

g/l

0.25

5068

12990

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

7807

26938

2.12

307.65

2.5

2.3

0.20

0.22

g/l

48.48

7209

25172

Depression

6576

26620

1.76

307.65

2.5

2.3

0.22

g/l

6.27

5993

24957

Malignant neoplasm, wide definition for exclusion

7928

16685

3.09

307.65

2.5

2.2

0.22

g/l

1.15

7586

15242

Other heart diseases

3355

9289

2.53

307.65

2.6

2.3

0.21

0.23

g/l

25.08

3131

8759

5694

19606

2.86

307.65

2.9

2.2

0.20

0.22

g/l

64.41

5114

18333

Aplastic and other anaemias

4317

16242

2.81

307.65

2.8

2.1

0.19

0.21

g/l

20.20

3940

15008

Dialysis, with operation codes

1417

4018

4.43

307.65

4.6

2.3

0.21

g/l

0.20

1348

3743

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

7163

21011

2.22

307.65

2.5

2.2

0.21

0.22

g/l

36.34

6622

19605

Certain infectious and parasitic diseases

7275

17951

2.15

307.65

2.6

2.1

0.21

0.22

g/l

36.81

6753

16772

Chronic viral hepatitis

727

1313

7.73

307.65

2.7

2.4

0.20

0.23

g/l

23.05

655

1240

Hypothyroidism, levothyroxine purchases

1465

1903

4.66

307.65

2.6

2.2

0.22

0.24

g/l

4.49

1367

1798

Metabolic disorders

7475

23033

2.12

307.65

2.5

2.3

0.21

0.22

g/l

0.43

6905

21490

Symptoms and signs involving the digestive system and abdomen

7687

18709

2.19

307.65

2.7

2.1

0.21

0.22

g/l

14.74

7197

17317

Diarrhoea and gastroenteritis of presumed infectious origin

4978

25011

1.90

307.65

2.8

2.3

0.21

0.22

g/l

2.71

4620

23255

Neoplasms

5314

11625

2.58

307.65

2.6

2.3

0.22

g/l

2.74

5051

10599

Implicit viral Sepsis

1792

6343

3.24

307.65

3.2

2.1

0.21

g/l

3.15

1638

5908

Nutritional anaemias

4612

17974

2.78

307.65

2.9

2.1

0.20

0.21

g/l

26.13

4244

16641

Cholelithiasis, broad definition with cholecystitis

6739

22058

2.21

307.65

2.6

2.0

0.21

0.22

g/l

13.58

6376

20318

Malignant neoplasm

7790

16316

3.15

307.65

2.5

2.2

0.22

g/l

0.95

7462

14904

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

7444

25381

2.03

307.65

2.9

2.2

0.21

0.22

g/l

0.69

6986

23569

Inflammatory bowel disease

2676

10943

2.73

307.65

3.6

2.3

0.23

0.22

g/l

12.93

2530

10210

Pneumonias (Asthma/COPD co-morbidities)

7962

26893

2.13

307.65

2.5

2.3

0.21

0.22

g/l

47.30

7363

25121

Other anaemias

3989

15374

2.79

307.65

2.8

2.1

0.19

0.21

g/l

18.68

3641

14206

Implicit bacterial Sepsis

4219

12758

3.40

307.65

2.9

2.0

0.19

0.21

g/l

50.42

3826

11843

Malignant neoplasm of colon, including Hilmo

2040

4840

5.22

307.65

2.5

2.0

0.20

g/l

0.40

1961

4346

Colorectal cancer

2816

6025

5.82

307.65

2.4

2.0

0.21

0.20

g/l

1.82

2721

5417

Inflammatory bowel disease, strict (require KELA)

1996

7532

2.99

307.65

3.7

2.3

0.23

0.22

g/l

14.62

1901

7023

Hypothyroidism (congenital or acquired)

1479

1921

4.65

307.65

2.6

2.3

0.23

0.24

g/l

4.38

1380

1816

Fall on same level

7770

26293

1.68

307.65

2.4

2.3

0.21

0.22

g/l

11.71

7121

24630

Complications of procedures, not elsewhere classified

6954

26029

2.42

307.65

2.7

2.2

0.21

0.22

g/l

4.94

6530

24110

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

1215

2320

7.03

307.65

2.3

2.0

0.21

0.20

g/l

3.96

1184

2088

Cholecystectomy

5195

24690

1.94

307.65

2.6

2.1

0.21

g/l

0.21

4923

22824

Hypertension

5407

16487

1.96

307.65

2.4

2.3

0.22

g/l

0.85

5044

15468

Septicaemia

4439

13699

3.54

307.65

3.0

2.1

0.19

0.21

g/l

76.44

4059

12715

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5129

23472

2.37

307.65

2.8

2.1

0.21

g/l

3.51

4824

21733

Colon adenocarcinoma

1219

2822

5.37

307.65

2.6

1.9

0.20

g/l

0.96

1172

2532

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

6611

23238

1.80

307.65

2.5

2.3

0.21

0.22

g/l

3.99

6110

21675

Anaemias

2680

1882

11.23

307.65

3.5

2.4

0.21

0.23

g/l

26.28

2509

1781

Atrial fibrillation and flutter

2280

5995

2.68

307.65

2.4

2.2

0.21

0.23

g/l

28.44

2127

5647

ILD medications

8825

24487

2.08

307.65

3.0

2.1

0.22

0.21

g/l

4.14

8318

22657

Inflammatory bowel disease treatment related agents

8919

25827

2.06

307.65

2.8

2.2

0.22

g/l

2.36

8379

23936

Noninfective enteritis and colitis

3904

17265

2.48

307.65

3.3

2.2

0.22

0.21

g/l

8.31

3673

16057

Depression medications

1814

2056

4.75

307.65

2.5

2.4

0.23

0.24

g/l

2.57

1683

1946

ILD medications: azathioprine

1496

4374

4.06

307.65

4.5

2.1

0.23

0.22

g/l

12.99

1434

4073

Heart failure and antihypertensive medication

2329

4847

3.61

307.65

2.5

2.2

0.19

0.22

g/l

30.05

2144

4538

Constipation

6619

25832

1.88

307.65

2.7

2.2

0.21

g/l

8.27

6099

24038

Hypertension, essential

5421

16070

2.03

307.65

2.4

2.3

0.22

g/l

0.19

5038

15067

Viral hepatitis, IBD co-morbidity

832

1089

10.51

307.65

2.8

2.4

0.20

0.22

g/l

14.92

754

1040

Infections, IBD-co-morbidities

1447

3073

3.80

307.65

3.4

2.3

0.21

0.22

g/l

2.15

1341

2910

Iron deficiency anaemia

3999

15451

2.89

307.65

2.9

2.1

0.20

0.21

g/l

22.37

3680

14314

Ascites

1325

2084

10.28

307.65

4.4

2.0

0.15

0.21

g/l

102.54

1186

1934

Malaise and fatigue

4447

14175

2.79

307.65

2.4

2.1

0.20

0.22

g/l

29.80

4034

13204

Implicit viral Sepsis

2465

9630

2.88

307.65

3.0

2.1

0.21

g/l

3.77

2267

8963

Examination and observation for other reasons

4710

12187

2.40

307.65

2.9

2.0

0.22

g/l

0.89

4420

11316

Certain infectious and parasitic diseases

4939

13370

1.94

307.65

2.5

2.1

0.21

0.22

g/l

17.07

4592

12509

Medical observation and evaluation for suspected diseases and conditions

4760

12258

2.10

307.65

2.7

2.0

0.22

g/l

0.05

4394

11373

Persons encountering health services for other counselling and medical advice, not elsewhere classified

8326

24571

1.95

307.65

2.5

2.3

0.22

0.21

g/l

0.83

7812

22816

Disorders of gallbladder, biliary tract and pancreas

9516

23664

2.82

307.65

3.1

2.0

0.21

0.22

g/l

25.97

9018

21815

Other medical care

4968

14735

3.55

307.65

2.6

2.2

0.19

0.21

g/l

92.83

4655

13601

Gastrointestinal diseases

4161

7082

3.15

307.65

2.7

1.6

0.22

0.23

g/l

8.49

3919

6523

Viral hepatitis

906

1989

6.00

307.65

2.9

2.3

0.20

0.23

g/l

21.32

824

1866

Cholangitis (primary sclerosing, PSC)

1135

1726

10.92

307.65

6.0

2.0

0.20

0.21

g/l

7.60

1104

1585

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2280

4374

2.75

307.65

2.5

2.0

0.22

0.23

g/l

6.99

2142

4090

Heart failure, not strict

6861

19409

2.68

307.65

2.8

2.2

0.20

0.22

g/l

90.69

6331

18143

Cardiovascular diseases

3738

9716

2.17

307.65

2.7

2.4

0.22

0.23

g/l

3.99

3518

9166

ILD medications: prednisolone, methylprednisolone, prednisone

8597

24184

2.12

307.65

3.0

2.1

0.22

0.21

g/l

2.37

8085

22382

GASTRO-related operations

7152

7699

5.17

307.65

2.7

1.6

0.21

0.23

g/l

47.51

6739

6918

Bleeding

6351

24300

1.99

307.65

2.8

2.2

0.20

0.22

g/l

44.95

5844

22592

Hypo-osmolality and hyponatraemia

1648

5837

3.27

307.65

2.7

2.1

0.19

0.20

g/l

11.51

1503

5407

Bacterial Sepsis

4745

14283

3.27

307.65

2.9

2.1

0.19

0.21

g/l

59.41

4317

13284

Pneumonia, organism unspecified

7334

25282

2.19

307.65

2.5

2.3

0.20

0.22

g/l

51.22

6768

23615

Other diseases of biliary tract

1301

2547

7.37

307.65

5.3

1.8

0.19

0.21

g/l

15.93

1244

2341

Unspecified jaundice

710

1312

7.60

307.65

4.7

1.8

0.17

0.21

g/l

23.89

649

1211

Nausea and vomiting

2441

8164

3.31

307.65

3.0

2.0

0.21

g/l

3.99

2255

7519

Obesity

4715

22775

2.15

307.65

2.3

0.22

g/l

0.00

4395

21314

Persons encountering health services for specific procedures and health care

9242

24691

2.43

307.65

2.6

2.3

0.21

0.22

g/l

38.59

8629

22939

Alcoholic liver disease

1772

2865

10.02

307.65

4.4

2.0

0.16

0.22

g/l

103.99

1574

2675

ILD medications: immunosuppressive drugs

5177

22073

2.37

307.65

3.7

2.1

0.22

g/l

9.17

4927

20517

Diseases of liver

6417

11480

8.39

307.65

3.9

2.0

0.20

0.22

g/l

61.39

5878

10723

Malignant neoplasm of breast, HER2-negative, including Hilmo

3056

7917

2.73

307.65

1.7

2.1

0.23

0.22

g/l

14.96

2943

7239

Other or unspecified ileus, impaction or obstruction

1798

5954

3.52

307.65

3.0

2.1

0.20

0.21

g/l

1.82

1680

5472

Explicit Sepsis

4551

14397

3.42

307.65

3.0

2.1

0.19

0.21

g/l

77.28

4164

13389

Persons encountering health services in other circumstances, wide

8819

24666

1.95

307.65

2.5

2.2

0.22

0.21

g/l

0.24

8213

22888

Diseases of the digestive system

4105

17413

2.62

307.65

3.3

2.2

0.20

0.21

g/l

22.01

3790

16100

Caries of dentine

2377

7131

3.81

307.65

3.8

2.2

0.21

g/l

0.88

2242

6650

Transplanted organ and tissue status

1184

2963

5.20

307.65

6.7

2.4

0.22

g/l

2.05

1155

2773

Acute renal failure

2409

7428

3.96

307.65

3.1

2.1

0.19

0.21

g/l

10.33

2200

6835

Mental and behavioural disorders due to alcohol, excluding acute intoxication

3957

16088

2.74

307.65

2.5

2.4

0.20

0.22

g/l

29.73

3515

15058

Malignant neoplasm of breast, HER2-negative

3019

7744

2.80

307.65

1.7

2.1

0.23

0.22

g/l

16.04

2905

7074

Any mental disorder

7791

22309

1.84

307.65

2.4

2.3

0.21

0.22

g/l

1.47

7107

21004

Oesophageal varices

950

1256

17.49

307.65

6.3

2.1

0.15

0.22

g/l

80.42

868

1182

Abnormalities of breathing

6206

20694

1.83

307.65

2.3

2.4

0.22

g/l

1.21

5738

19320

Cholelithiasis

6378

21722

2.17

307.65

2.6

1.9

0.21

0.22

g/l

7.72

6037

20003

Oedema, not elsewhere classified

2746

10315

2.94

307.65

2.5

2.1

0.20

0.22

g/l

18.61

2508

9628

Asthma, unspecified (mode), excluding more controls

3572

12908

2.20

307.65

2.3

2.2

0.21

0.22

g/l

8.57

3342

12074

Malignant neoplasm of breast, HER-positive

2292

6896

2.86

307.65

1.7

2.1

0.23

0.22

g/l

15.48

2205

6288

Renal tubulo-interstitial diseases

7586

25303

2.44

307.65

2.7

2.2

0.20

0.22

g/l

39.00

7000

23579

Acute tubulo-interstitial nephritis

4542

20402

2.05

307.65

2.4

2.2

0.20

0.21

g/l

26.22

4174

18990

Diabetes, insulin treatment (Kela reimbursement)

6962

25591

1.72

307.65

2.4

2.3

0.21

0.22

g/l

4.51

6434

23839

Oxycodone

4513

11757

4.17

307.65

2.8

2.1

0.20

0.21

g/l

25.25

4247

10847

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2940

4730

10.85

307.65

4.7

2.1

0.16

0.21

g/l

147.21

2645

4416

Intestinal stricture

2998

11367

3.05

307.65

3.0

2.1

0.20

0.21

g/l

3.85

2816

10494

Mental and behavioural disorders due to psychoactive substance use

5151

20644

2.54

307.65

2.5

2.3

0.20

0.22

g/l

27.97

4610

19334

Mood disorders, excluding more controls

6595

21713

1.91

307.65

2.4

2.3

0.22

g/l

3.31

5989

20457

Dyspnoea

6427

27583

1.82

307.65

2.3

0.21

g/l

5.57

5950

25649

Tramadol

6749

16847

2.69

307.65

2.7

2.1

0.22

g/l

1.08

6279

15625

Substance abuse

5018

20254

2.56

307.65

2.5

2.3

0.20

0.22

g/l

27.83

4490

18967

Azathioprine

1496

4457

3.98

307.65

4.5

2.2

0.23

0.22

g/l

12.68

1434

4153

Mood disorders

7050

27702

1.72

307.65

2.4

2.3

0.22

g/l

8.40

6415

25931

Renal failure

4376

15306

2.88

307.65

2.8

2.2

0.20

0.21

g/l

1.67

4008

14120

Parasetamol

4960

13399

1.96

307.65

2.3

2.6

0.22

g/l

1.00

4631

12421

Malignant neoplasm of head and neck

1073

1868

7.97

307.65

2.4

2.0

0.23

0.20

g/l

17.07

1040

1695

Malignant neoplasm of liver and intrahepatic bile ducts

458

607

12.10

307.65

5.9

2.0

0.17

0.19

g/l

6.00

434

539

5508

19127

2.92

307.65

2.9

2.2

0.20

0.22

g/l

67.68

4940

17879

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4682

22505

2.27

307.65

2.7

2.2

0.21

g/l

3.03

4388

20851

Obesity due to excess calories

3621

16900

2.33

307.65

2.3

2.4

0.22

g/l

0.42

3366

15807

Malignant neoplasm of breast

3035

7814

2.78

307.65

1.7

2.1

0.23

0.22

g/l

15.55

2919

7142

5-aminosalicylic acid

1808

6613

3.07

307.65

3.6

2.2

0.23

0.22

g/l

10.93

1714

6154

Autoimmune diseases excluding thyroid diseases, strict definition

7631

22265

1.99

307.65

2.9

2.2

0.21

0.22

g/l

0.38

7145

20665

Chronic kidney disease

2558

10544

2.67

307.65

2.8

2.1

0.21

0.20

g/l

6.72

2340

9706

Malignant neoplasm of colon

1568

3661

5.31

307.65

2.5

1.9

0.20

g/l

0.02

1507

3282

Fever of other and unknown origin

5359

16999

3.15

307.65

3.0

2.2

0.20

0.22

g/l

45.94

5016

15861

Other and unspecified iron deficiency

3105

11950

2.95

307.65

2.8

2.1

0.20

0.21

g/l

10.28

2843

11070

GI-bleeding

2858

11648

2.76

307.65

3.2

2.1

0.19

0.21

g/l

25.78

2614

10747

Benzodiazepine use

7271

28730

1.84

307.65

2.4

2.2

0.22

g/l

0.06

6663

26784

Opioids

7186

18083

2.19

307.65

2.5

2.1

0.22

g/l

2.32

6723

16769

Malignant neoplasm of rectum

1169

2262

6.90

307.65

2.3

2.0

0.21

0.20

g/l

4.96

1137

2038

Dental caries

2665

8075

3.71

307.65

3.9

2.2

0.21

g/l

0.38

2512

7546

Hypothyroidism and >3 levothyroxin purchases

1465

1903

4.66

307.65

2.6

2.2

0.22

0.24

g/l

4.49

1367

1798

Obesity, other/unspecified

2628

11304

2.55

307.65

2.4

2.3

0.22

g/l

2.11

2470

10576

Abdominal and pelvic pain

7235

18703

2.05

307.65

2.6

2.1

0.21

0.22

g/l

3.63

6798

17311

Alcohol use disorder, Swedish definition

5355

18211

3.06

307.65

2.9

2.2

0.20

0.22

g/l

65.85

4801

17022

Other and unspecified anaemias

3965

15261

2.80

307.65

2.8

2.1

0.19

0.21

g/l

18.25

3618

14103

IBD patients in KELA-register

1996

7318

3.09

307.65

3.7

2.3

0.23

0.22

g/l

14.60

1901

6826

Cholangitis (primary sclerosing, PSC), with reimbursement 202

474

501

27.05

307.65

7.1

2.4

0.21

0.22

g/l

2.40

467

471

Colitis, primary sclerosing

375

353

33.46

307.65

6.6

2.2

0.21

0.23

g/l

3.15

370

330

Hypertensive diseases

5414

16494

1.96

307.65

2.4

2.3

0.22

g/l

0.80

5051

15475

Ulcerative colitis

2028

8173

2.77

307.65

3.6

2.2

0.23

0.22

g/l

9.76

1915

7614

Diseases of arteries, arterioles and capillaries (FINNGEN)

2003

4836

3.21

307.65

2.4

2.2

0.21

0.23

g/l

16.40

1849

4553

Malignant neoplasm of digestive organs

5496

8754

6.53

307.65

3.1

2.1

0.20

0.21

g/l

11.74

5267

7891

Erysipelas

4254

17909

2.28

307.65

2.4

2.1

0.20

0.22

g/l

46.64

3883

16649

Oral corticosteroids

8139

25278

2.03

307.65

2.6

2.2

0.22

0.21

g/l

0.35

7625

23422

Intestinal infectious diseases

6612

29745

1.77

307.65

2.7

2.2

0.21

0.22

g/l

3.05

6127

27642

Codeine

6320

17799

2.03

307.65

2.2

2.1

0.22

g/l

1.33

5858

16508

Malignant neoplasm of oral cavity

572

746

13.11

307.65

2.3

1.9

0.23

0.20

g/l

9.16

552

672

Type 2 diabetes, strict (exclude DM1)

6504

22779

1.76

307.65

2.3

2.2

0.22

g/l

0.93

6033

21224

Budesonide

1363

4185

3.84

307.65

4.3

2.1

0.23

0.22

g/l

10.67

1289

3899

Any event in cancer register

8034

18026

2.89

307.65

2.4

2.3

0.22

g/l

3.45

7666

16531

Used for control exclusion in common control thyroid runs

7389

21473

1.82

307.65

2.8

2.2

0.22

g/l

0.29

6901

19909

Mood [affective] disorders

7048

27665

1.73

307.65

2.4

2.3

0.22

g/l

8.32

6414

25894

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

753

1091

10.54

307.65

5.4

1.9

0.17

0.20

g/l

12.98

711

971

Other viral hepatitis

853

1631

7.19

307.65

2.9

2.4

0.20

0.23

g/l

25.49

777

1532

Anxiety disorders, excluding more controls

5486

20182

1.86

307.65

2.6

2.3

0.22

g/l

5.31

5049

19055

Malignant neoplasm of pancreas

839

1574

7.18

307.65

3.4

1.9

0.19

0.20

g/l

3.03

793

1407

Paralytic ileus and intestinal obstruction

2454

8807

3.20

307.65

2.9

2.1

0.20

0.21

g/l

2.61

2295

8121

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

1020

1468

10.65

307.65

5.2

2.0

0.17

0.20

g/l

16.00

965

1320

Other bacterial diseases

9180

24098

2.86

307.65

2.8

2.2

0.20

0.22

g/l

127.00

8471

22486

Diseases of oesophagus, stomach and duodenum

8540

25301

2.16

307.65

2.7

2.2

0.21

0.22

g/l

6.67

7946

23525

Implicit Sepsis

6852

21323

2.69

307.65

2.8

2.1

0.20

0.22

g/l

66.59

6235

19898

Malignant neoplasm of oral cavity, including Hilmo

693

1028

10.46

307.65

2.3

1.9

0.23

0.20

g/l

10.59

672

919

All pneumoniae

7994

26965

2.12

307.65

2.5

2.3

0.21

0.22

g/l

46.54

7391

25192

Bacterial infection, other or unspecified

5421

16616

3.25

307.65

2.8

2.1

0.19

0.22

g/l

72.10

4972

15437

All-cause Heart Failure

4591

16152

2.19

307.65

2.2

0.19

0.21

g/l

74.03

4158

15009

Acute pancreatitis (for exclusion)

1976

7022

3.31

307.65

3.6

2.2

0.20

0.21

g/l

9.66

1881

6497

Cirrhosis of liver, NAS

1292

1635

20.08

307.65

5.1

2.0

0.16

0.21

g/l

84.17

1173

1526

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2234

6420

4.07

307.65

2.5

2.1

0.19

0.21

g/l

9.46

2139

5816

Substance abuse, excluding more controls

5018

16648

2.85

307.65

2.5

2.3

0.20

0.22

g/l

22.69

4490

15681

First line medication for Crohn's disease

9123

22781

2.33

307.65

2.9

2.1

0.22

g/l

1.94

8611

21036

Benign neoplasm of colon, rectum, anus and anal canal

4715

22726

1.93

307.65

2.6

2.2

0.22

0.21

g/l

9.69

4419

20989

All chronic kidney diseases

4567

16463

2.50

307.65

2.7

2.2

0.21

g/l

2.59

4210

15294

Other inflammatory liver diseases

965

1834

7.65

307.65

4.9

1.9

0.20

0.22

g/l

14.43

915

1724

Hernia of abdominal wall, postoperative

1882

2801

8.16

307.65

3.3

1.4

0.21

0.23

g/l

9.17

1801

2510

Malignant neoplasm of breast, ER-positive, including Hilmo

2328

6968

2.84

307.65

1.7

2.1

0.23

0.22

g/l

15.48

2239

6352

Chronic pancreatitis

1769

3612

6.86

307.65

3.8

2.0

0.20

0.21

g/l

15.16

1672

3330

Malignant neoplasm of stomach

659

1130

7.96

307.65

3.2

1.9

0.20

g/l

1.15

636

1013

Other disorders of skin and subcutaneous tissue

5176

25027

1.97

307.65

2.5

2.2

0.20

0.21

g/l

12.40

4762

23222

Gastro-oesophageal reflux disease

4683

22809

1.88

306.84

2.4

2.1

0.22

g/l

2.78

4362

21206

Psychiatric diseases

6675

20147

1.73

306.77

2.4

2.3

0.21

0.22

g/l

1.31

6122

18975

Other heart diseases, wide

6089

22202

1.76

305.51

2.4

0.21

0.22

g/l

27.77

5664

20819

General examination and investigation of persons without complaint and reported diagnosis

4389

12242

1.97

304.02

2.7

2.0

0.21

0.22

g/l

1.31

4124

11362

Benign neoplasm of other and ill-defined parts of digestive system

1633

6323

3.00

302.78

2.8

2.1

0.22

0.21

g/l

12.14

1545

5876

Hepatocellular carcinoma

368

458

13.83

301.25

6.1

1.8

0.17

0.19

g/l

5.63

353

403

Other functional intestinal disorders

3261

15373

2.11

300.54

2.5

2.2

0.21

g/l

0.21

3015

14234

Substance use, excluding alcohol

1561

5866

2.98

299.47

2.4

0.21

0.22

g/l

4.80

1400

5528

Gastroduodenal ulcer

2075

8934

2.56

297.34

3.1

2.0

0.19

0.21

g/l

12.87

1896

8224

Infections of the skin and subcutaneous tissue

4094

22377

1.93

296.41

2.7

2.4

0.21

0.22

g/l

12.29

3795

20873

Codeine or tramadol medication

7546

26086

1.65

294.54

2.1

2.3

0.22

0.21

g/l

8.61

6992

24241

Artificial opening status

695

1636

5.80

292.88

3.4

2.2

0.21

g/l

0.28

661

1532

Depression or dysthymia

4595

14029

1.90

291.31

2.4

2.3

0.22

0.21

g/l

2.27

4191

13232

Adenocarcinoma and ductal carcinoma of pancreas

461

756

8.95

290.83

4.0

1.9

0.19

0.20

g/l

2.27

442

685

Use of hypnotics and sedatives

7185

25925

1.66

290.51

2.4

2.3

0.22

0.21

g/l

1.72

6636

24162

Hypokalaemia

1149

3752

3.62

290.45

3.1

2.2

0.20

0.21

g/l

4.17

1044

3509

Malignant neoplasm of tongue, including Hilmo

405

585

11.03

290.45

2.3

1.9

0.23

0.20

g/l

7.45

392

526

L04AA Selective immunosuppressants

1859

7773

2.69

289.20

4.6

2.2

0.22

g/l

4.08

1789

7278

Cerebrovascular diseases (FINNGEN)

2133

6416

2.54

288.63

2.4

2.2

0.21

0.23

g/l

12.99

1989

6051

COPD/asthma related infections

6807

21014

1.69

286.80

2.5

2.2

0.21

0.22

g/l

15.11

6313

19607

COPD/asthma/ILD related infections

6807

21014

1.69

286.80

2.5

2.2

0.21

0.22

g/l

15.11

6313

19607

Personality disorders, excluding more controls

1704

6775

2.72

286.76

2.3

0.22

0.23

g/l

0.10

1536

6423

Hypothyroidism, drug reimbursement

773

1219

4.83

286.69

2.2

0.22

0.23

g/l

5.59

727

1160

Other eating disorders

538

1012

6.60

285.11

3.1

2.8

0.23

g/l

0.29

488

945

Asthma

4981

14858

1.84

283.00

2.3

2.2

0.22

g/l

0.36

4666

13866

Osteopathies and chondropathies

4008

20767

1.92

281.83

2.6

2.2

0.21

g/l

10.20

3690

19318

malignant neoplasm of female genital organs

1146

3746

3.49

281.80

1.8

2.0

0.21

g/l

1.14

1085

3390

Eating disorders

899

2553

4.05

278.21

3.0

2.5

0.23

0.22

g/l

0.88

822

2391

Atrial fibrillation and flutter with reimbursement

1884

4845

2.70

278.07

2.3

2.2

0.20

0.22

g/l

22.49

1753

4566

Convulsions, not elsewhere classified

1704

6822

2.69

275.95

2.7

2.3

0.21

0.22

g/l

6.65

1532

6373

Diseases of arteries, arterioles and capillaries

4712

20278

1.82

271.88

2.3

2.2

0.20

0.21

g/l

7.47

4311

18793

Other (not insulin) diabetes medications

6449

23891

1.67

269.63

2.3

2.2

0.22

g/l

0.70

5970

22251

Other pulmonary diagnosis

5150

14982

1.80

269.62

2.4

2.2

0.21

0.22

g/l

8.57

4791

13981

Persons encountering health services in other circumstances

2763

13734

2.14

269.59

2.6

2.2

0.21

g/l

2.04

2529

12805

Benign neoplasm: Colon

3936

21228

1.90

266.05

2.6

2.1

0.22

0.21

g/l

9.58

3692

19601

Other diseases of pleura

3323

15550

2.02

265.55

2.6

2.2

0.19

0.21

g/l

28.84

3053

14357

Iron deficiency anaemia secondary to blood loss (chronic)

1399

5326

3.00

265.46

3.1

2.1

0.19

0.21

g/l

14.91

1295

4932

Anxiety (asthma-related co-morbidities)

3784

16039

1.92

265.41

2.5

2.4

0.23

0.22

g/l

1.91

3469

15168

Cardiac arrhythmias

3717

13009

1.95

265.00

2.3

0.21

0.23

g/l

17.09

3465

12279

Polyarthropathies

4705

17843

1.81

264.96

2.4

2.3

0.21

g/l

0.89

4368

16656

Malignant neoplasm of tongue

332

429

13.64

264.83

2.4

2.0

0.23

0.20

g/l

6.70

319

384

Excluding asthma or asthma-COPD overlap

5128

14982

1.79

264.45

2.4

2.2

0.21

0.22

g/l

7.94

4777

13981

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

6443

26024

1.66

263.04

2.8

2.1

0.20

0.22

g/l

46.83

5949

24223

Other soft tissue disorders, not elsewhere classified

6268

22902

1.67

262.73

2.3

2.4

0.22

0.21

g/l

3.50

5794

21306

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1130

3836

3.35

262.69

2.4

2.1

0.20

0.21

g/l

2.25

1070

3475

Diseases of the skin and subcutaneous tissue

6632

20823

1.66

262.46

2.5

2.3

0.21

0.22

g/l

3.29

6152

19362

Codes for special purposes

3659

20250

1.92

261.96

2.5

2.3

0.21

g/l

0.54

3401

18814

Provisional assignment of new diseases of uncertain etiology

3652

20225

1.92

260.87

2.5

2.3

0.21

g/l

0.53

3395

18791

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3962

17917

1.90

259.61

2.4

2.2

0.21

g/l

0.37

3633

16601

Continuous positive airway pressure

1391

4366

2.96

258.93

2.4

0.21

0.22

g/l

4.22

1288

4142

Injuries to the head

7335

29327

1.60

258.90

2.4

2.3

0.21

0.22

g/l

7.50

6667

27414

Other gastritis (incl. Duodenitis)

1777

7632

2.59

258.81

3.0

2.1

0.20

0.21

g/l

2.64

1651

7066

Antihypertensive medication - note that there are other indications

3596

10045

1.98

258.70

2.7

2.4

0.22

g/l

0.18

3377

9440

Autoimmune hepatitis

233

206

37.71

254.81

6.7

1.9

0.20

0.22

g/l

1.86

227

197

Ulcerative colitis, NAS

1200

4302

3.19

254.64

4.2

2.3

0.23

0.22

g/l

3.37

1138

4018

Diverticular disease of intestine

4785

18010

1.79

254.48

2.4

2.1

0.22

0.21

g/l

2.70

4425

16696

Intracranial trauma

3890

15242

1.88

253.77

2.4

0.21

0.22

g/l

4.56

3544

14267

Heart failure and bmi 25plus

2655

8864

2.22

253.12

2.2

2.3

0.19

0.21

g/l

43.17

2428

8255

Total colectomy operation

552

1223

6.28

251.41

3.5

2.3

0.23

0.22

g/l

1.98

532

1144

Total colectomy

552

1223

6.28

251.41

3.5

2.3

0.23

0.22

g/l

1.98

532

1144

Pain in limb

5458

22412

1.70

250.51

2.3

2.4

0.22

0.21

g/l

2.14

5028

20852

COPD differential diagnosis

5072

15032

1.76

248.56

2.4

2.2

0.21

0.22

g/l

8.58

4721

14028

ILD differential diagnosis

5070

15030

1.76

248.20

2.4

2.2

0.21

0.22

g/l

8.64

4719

14026

Diarrhoea and gastroenteritis of presumed infectious origin

6653

28268

1.61

247.72

2.6

2.3

0.22

0.21

g/l

1.33

6192

26268

Poisoning by drugs, medicaments and biological substances

1747

7562

2.53

247.50

2.5

2.4

0.22

g/l

2.10

1583

7081

Care involving use of rehabilitation procedures

4113

21924

1.81

247.23

2.4

2.2

0.22

g/l

0.05

3829

20356

Other Crohn's disease

697

1835

4.64

245.94

4.0

2.2

0.24

0.22

g/l

4.06

662

1717

Asthma (mode)

4776

15030

1.77

243.69

2.3

2.2

0.22

g/l

0.02

4479

14026

Second line medication for Crohn's disease

3941

22814

1.83

243.43

3.1

2.3

0.22

g/l

9.91

3733

21286

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1321

5090

2.93

242.97

3.6

2.4

0.23

0.22

g/l

7.71

1255

4762

Alcohol abuse, main dg, excluding more controls

1152

4119

3.14

242.89

2.4

0.21

0.22

g/l

5.61

1041

3887

Non-ischemic cardiomyopathy

2373

9353

2.24

240.76

2.3

2.2

0.19

0.21

g/l

42.46

2146

8696

Malignant neoplasm of oesophagus, including Hilmo

434

800

7.42

240.63

2.9

2.0

0.19

0.20

g/l

0.47

418

715

Ulcerative colitis (strict definition, require KELA)

1348

5279

2.87

239.72

3.6

2.3

0.23

0.22

g/l

8.21

1275

4937

Pain, not elsewhere classified

1889

8541

2.39

239.30

2.6

2.1

0.22

g/l

0.69

1755

8000

Symptoms and signs concerning food and fluid intake

937

3023

3.59

238.98

2.5

2.2

0.21

g/l

1.72

857

2843

Volume depletion

902

2870

3.71

237.64

2.9

2.2

0.19

0.20

g/l

1.88

815

2658

Gastric ulcer

1439

5842

2.76

237.57

3.1

2.0

0.19

0.21

g/l

10.17

1320

5374

Asthma (only as main-diagnosis), excluding more controls

4172

13639

1.82

237.46

2.3

0.22

g/l

1.35

3915

12762

Benign neoplasms

6246

21933

1.63

234.74

2.5

2.3

0.22

0.21

g/l

10.45

5863

20262

Dysphagia

1755

7792

2.46

234.27

2.3

1.9

0.21

g/l

0.82

1624

7201

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1419

5761

2.75

233.80

3.5

2.3

0.23

0.22

g/l

10.05

1344

5387

COPD (mode)

2209

8326

2.26

232.21

2.1

2.2

0.20

0.21

g/l

11.76

2013

7753

Neurotic, stress-related and somatoform disorders

5743

25499

1.64

231.60

2.6

2.3

0.22

g/l

9.96

5286

23871

Anxiety disorders

5802

25716

1.64

231.58

2.6

2.3

0.22

g/l

10.26

5338

24071

Decubitus ulcer and pressure area

679

1860

4.63

229.88

2.4

2.0

0.18

0.20

g/l

12.74

618

1719

Recurrent or chronic depression

2585

9144

2.10

229.44

2.4

0.23

0.22

g/l

4.24

2359

8699

Syncope and collapse

2906

13240

1.99

228.77

2.4

2.1

0.21

0.22

g/l

6.51

2631

12320

Selective serotonin reuptake inhibitors

6393

21499

1.61

226.45

2.3

0.22

0.21

g/l

8.23

5838

20168

Heart failure and coronary heart disease

3134

12112

1.98

226.07

2.2

2.3

0.19

0.21

g/l

26.70

2847

11167

Biguanides

6211

24462

1.61

226.06

2.2

0.22

0.21

g/l

1.49

5726

22761

Osteoporosis

2017

8999

2.31

225.78

2.8

2.1

0.20

0.21

g/l

4.79

1846

8337

Poisoning by medicine

1579

6816

2.54

225.35

2.4

0.22

g/l

1.90

1434

6391

Other noninfective gastroenteritis and colitis

1851

8556

2.37

224.86

3.2

2.2

0.21

g/l

1.29

1732

7939

Fentanyl

898

2932

3.51

223.53

3.1

2.0

0.19

0.20

g/l

3.10

839

2690

Disorders of lipoprotein metabolism and other lipidaemias

5308

20551

1.67

223.32

2.1

2.3

0.22

0.21

g/l

5.01

4906

19137

Other reaction to severe stress, and adjustment disorders

2358

11922

2.11

222.17

2.8

2.3

0.22

g/l

0.06

2191

11219

Other disorders of urethra and urinary system

4564

19998

1.72

222.01

2.3

2.2

0.21

g/l

1.44

4195

18647

Other diseases of intestine

1184

4580

2.94

217.26

3.2

2.1

0.21

g/l

0.34

1113

4254

Pain in throat and chest

5355

20219

1.65

216.85

2.3

0.22

g/l

0.54

4964

18873

Crohn's disease NAS

644

1761

4.46

215.67

4.6

2.3

0.23

0.22

g/l

2.85

610

1644

Other anxiety disorders

2870

13451

1.95

214.75

2.5

2.3

0.23

0.22

g/l

3.16

2639

12622

Other symptoms and signs involving the digestive system and abdomen

1253

5005

2.77

212.27

2.6

1.9

0.21

0.22

g/l

1.63

1172

4648

Falls/tendency to fall

6868

22812

1.56

211.12

2.4

2.3

0.21

0.22

g/l

6.22

6325

21385

Exclusions for E4_PCOS_CONSORTIUM

4529

17286

1.72

211.04

2.4

2.3

0.22

g/l

1.09

4223

16132

All anxiety disorders

3840

17889

1.78

211.03

2.5

2.3

0.23

0.22

g/l

3.84

3523

16788

Pain (limb, back, neck, head abdominally)

4642

14051

1.72

210.17

2.5

2.2

0.21

g/l

0.47

4318

13047

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

311

479

10.06

210.01

2.1

2.0

0.23

0.20

g/l

6.33

302

434

Gout

2081

9029

2.21

209.74

2.4

2.3

0.21

0.20

g/l

1.24

1910

8341

Headache

3853

18173

1.76

209.46

2.4

2.2

0.22

g/l

1.51

3567

17005

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

298

438

10.42

209.32

5.2

1.8

0.17

0.20

g/l

5.14

284

397

Insulin, fast-acting

2500

13221

2.03

208.60

2.9

2.3

0.19

0.21

g/l

43.29

2295

12324

Factors influencing health status and contact with health services

1875

4163

2.37

207.60

2.3

1.9

0.21

0.22

g/l

2.44

1747

3844

Asthma (only as main-diagnosis)

4285

14858

1.74

207.36

2.3

2.2

0.22

g/l

0.15

4017

13866

Other special examinations and investigations of persons without complaint or reported diagnosis

4119

12259

1.77

206.71

2.6

2.0

0.21

0.22

g/l

0.62

3853

11374

Cutaneous abscess, furuncle and carbuncle

1841

8784

2.28

205.94

2.7

2.3

0.21

0.22

g/l

6.38

1700

8196

L04AX Other immunosuppressants

3733

22301

1.77

205.45

3.1

2.3

0.22

g/l

7.70

3534

20806

Symptoms and signs involving cognition, perception, emotional state and behaviour

6217

28101

1.57

205.28

2.3

0.21

0.22

g/l

4.49

5684

26230

Personal history of malignant neoplasm

673

1970

4.18

204.65

1.6

2.1

0.24

0.21

g/l

24.59

662

1842

Chronic apical periodontitis

7109

27417

1.53

204.41

2.3

2.2

0.22

g/l

0.07

6584

25517

Other CVD (FINNGEN)

917

2403

3.35

201.76

2.3

2.2

0.20

0.22

g/l

9.92

837

2265

Pure hypercholesterolaemia

4735

19331

1.67

201.35

2.1

2.2

0.22

0.21

g/l

5.23

4396

17990

Missing teeth due to accident, extraction or parodontitis

4014

23162

1.73

200.51

2.5

2.2

0.21

g/l

0.37

3703

21520

Ventral hernia

1802

8646

2.29

200.50

3.0

2.1

0.21

g/l

1.37

1721

8016

Acute alcohol intoxication, ICD10

1492

6633

2.48

200.04

2.5

2.4

0.21

0.22

g/l

8.07

1341

6217

Hernia

5992

26562

1.57

199.70

2.5

2.2

0.21

0.22

g/l

0.50

5608

24654

Secondary uncertain malignant neoplasm

903

3157

3.20

198.20

2.2

2.1

0.18

0.20

g/l

13.47

844

2843

Care involving dialysis

715

2211

3.86

198.15

3.0

2.3

0.22

0.21

g/l

1.79

673

2070

Persons encountering health services for specific procedures, not carried out

726

2255

3.74

197.65

2.8

2.3

0.21

0.22

g/l

1.92

655

2117

Peripheral artery disease

3011

13541

1.89

196.78

2.1

2.2

0.20

g/l

4.55

2739

12479

Other diseases of blood and blood-forming organs, wide

1682

7933

2.35

196.68

2.7

2.3

0.20

0.21

g/l

4.07

1559

7388

Other bacterial intestinal infections

1392

6068

2.54

196.08

3.0

2.1

0.21

g/l

0.60

1275

5635

Chronic gastritis

1945

9662

2.19

195.91

2.8

2.0

0.21

g/l

0.36

1760

8930

Explicit bacterial Sepsis

868

3008

3.30

195.65

3.0

2.1

0.19

0.21

g/l

16.10

804

2813

Abnormal findings on diagnostic imaging of lung

3277

18399

1.82

194.26

2.4

2.2

0.21

g/l

1.24

3053

17019

Symptoms and signs involving the urinary system

5001

24528

1.62

193.94

2.4

2.3

0.21

g/l

4.31

4566

22806

Other diseases of urinary system

6365

23936

1.55

193.54

2.3

0.21

g/l

1.24

5863

22328

Cholecystitis

1076

4193

2.87

192.99

3.0

1.8

0.18

0.21

g/l

19.44

1010

3822

Hernia of abdominal wall

3090

17936

1.83

190.48

2.9

2.2

0.21

g/l

0.22

2915

16652

Malignant neoplasm of other and unspecified parts of tongue

238

306

13.56

190.43

2.2

1.9

0.23

0.20

g/l

4.26

229

276

Intestinal adhesions without obstruction

773

2567

3.55

190.20

3.1

2.0

0.20

0.21

g/l

2.38

730

2381

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1205

4979

2.67

190.16

2.5

2.4

0.22

0.23

g/l

3.12

1097

4672

Adenocarcinoma and papillary adenocarcinoma of stomach

328

580

7.53

188.70

3.3

1.9

0.20

0.19

g/l

0.54

319

515

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1868

9229

2.17

188.40

2.4

0.22

g/l

1.69

1706

8644

Asthma, hospital admission 2, infections

3811

22869

1.71

188.35

2.4

2.3

0.21

g/l

0.48

3548

21194

Asthma-related infections

3811

22869

1.71

188.35

2.4

2.3

0.21

g/l

0.48

3548

21194

Suicide or other Intentional self-harm

1676

7974

2.28

188.34

2.4

0.22

g/l

1.94

1522

7454

Concussion

3190

15071

1.81

187.93

2.4

0.21

0.22

g/l

2.89

2916

14108

Acute alcohol intoxication

1769

8605

2.22

187.63

2.4

0.20

0.22

g/l

6.53

1592

8063

Medicines for HER+ breast cancer

2457

12672

1.98

187.43

1.7

2.2

0.23

0.21

g/l

26.43

2361

11755

Haemorrhage from respiratory passages

2429

11814

1.98

187.34

2.5

2.3

0.20

0.21

g/l

4.64

2210

10962

Other bacterial intestinal infections

1652

7859

2.29

186.73

2.8

2.1

0.21

g/l

0.70

1515

7302

Gout, FINNGEN

2081

10765

2.09

186.03

2.4

2.2

0.21

0.20

g/l

1.32

1910

9911

Pulmonary heart disease, diseases of pulmonary circulation

2255

12006

2.03

185.83

2.5

2.1

0.20

0.21

g/l

4.79

2087

11075

Early onset COPD, excluding more controls

1408

6283

2.44

185.37

2.3

2.2

0.21

0.22

g/l

1.70

1295

5863

Coagulation defects, purpura and other haemorrhagic conditions

1456

6638

2.42

184.62

3.0

2.3

0.20

0.21

g/l

7.98

1362

6187

Streptococcal septicaemia

752

2493

3.51

184.51

3.0

2.2

0.19

0.21

g/l

16.25

694

2329

Insulin, fast-acting or short human

2512

13841

1.94

184.19

2.9

2.3

0.19

0.21

g/l

40.18

2305

12896

Implicit fungal Sepsis

640

1949

3.97

182.77

3.1

2.0

0.21

0.22

g/l

1.27

580

1823

Malignant neoplasm of oesophagus

320

579

7.70

181.73

3.0

2.0

0.19

0.20

g/l

0.96

306

518

Abnormal results of function studies

793

2747

3.39

181.43

3.0

2.3

0.21

0.22

g/l

0.35

714

2559

Sequelae of external causes of morbidity and mortality

1855

9363

2.16

179.76

2.5

2.2

0.21

g/l

0.50

1744

8713

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

878

2162

3.22

178.75

2.3

0.21

g/l

0.24

826

2045

Symptoms and signs involving the circulatory and respiratory systems

6163

20734

1.54

178.39

2.4

0.22

g/l

0.21

5720

19358

Low back pain

4784

22239

1.61

177.57

2.3

0.22

0.21

g/l

1.91

4420

20719

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1141

4777

2.69

177.42

2.7

2.2

0.20

0.21

g/l

4.20

1062

4452

Reimbursement for rheumatic diseases

3703

22832

1.70

177.02

3.3

2.2

0.21

g/l

1.01

3493

21217

Problems related to lifestyle

801

2795

3.22

176.94

2.4

2.2

0.21

0.22

g/l

3.22

710

2620

Asthma-related pneumonia or sepsis

2471

13692

1.92

176.82

2.4

2.2

0.21

g/l

0.29

2290

12626

Asthma, hospital admissions 3, pneumonia

2471

13692

1.92

176.82

2.4

2.2

0.21

g/l

0.29

2290

12626

Asthma-related pneumonia

2466

13661

1.92

176.63

2.4

2.2

0.21

g/l

0.31

2287

12596

Anorexia (incl.atypical)

517

1378

4.38

176.61

3.6

2.6

0.23

0.22

g/l

1.33

474

1283

Crohn's disease of small intestine

618

1878

3.89

175.43

3.8

2.2

0.23

0.22

g/l

3.79

598

1754

External causes of morbidity and mortality

4036

12348

1.70

175.33

2.4

2.3

0.21

0.22

g/l

3.57

3742

11566

Alcohol-induced chronic pancreatitis

634

1983

3.93

174.93

3.1

2.4

0.19

0.22

g/l

9.77

584

1852

Disorders of adult personality and behaviour

1793

8973

2.13

174.51

2.4

0.22

g/l

0.10

1615

8414

Venous thromboembolism

3567

21215

1.71

174.21

2.4

2.2

0.20

0.21

g/l

4.60

3300

19611

Alcohol withdrawal state with delirium

667

2154

3.76

174.17

2.8

2.4

0.19

0.22

g/l

14.46

580

2013

Amputation

866

3209

3.12

174.16

2.3

2.2

0.18

0.20

g/l

8.21

778

2955

973

3784

2.85

174.10

2.8

2.2

0.22

g/l

0.29

896

3537

Adenocarcinoma of pancreas

324

618

7.18

173.63

3.8

1.9

0.18

0.20

g/l

2.39

308

558

Invasive ventilation

689

2280

3.64

172.24

2.9

2.3

0.20

0.21

g/l

2.51

622

2132

Disorders of mineral metabolism

747

2577

3.40

171.98

3.2

2.3

0.21

g/l

0.63

697

2420

Chronic ulcer of skin, not elsewhere classified

664

2153

3.73

171.78

2.6

2.1

0.19

0.21

g/l

4.83

619

2001

Fungal Sepsis

445

1112

5.17

171.59

3.5

2.1

0.21

g/l

0.92

415

1049

Gout, idiopatic and unspecified

1787

9069

2.16

171.33

2.3

2.2

0.21

0.20

g/l

1.93

1639

8375

Persons encountering health services for examination and investigation

3991

12260

1.69

171.20

2.5

2.0

0.21

0.22

g/l

0.32

3738

11375

Personality disorders

1704

8451

2.16

170.23

2.3

2.4

0.22

g/l

0.24

1536

7920

Unspecified kidney failure

856

3190

3.09

170.03

2.7

2.0

0.20

g/l

0.14

787

2922

Malignant cancer of tonsil and base of tongue, including Hilmo

301

550

7.76

169.92

2.8

2.0

0.24

0.21

g/l

9.67

293

496

L02BG Aromatase inhibitors

2044

10869

2.04

169.31

1.7

2.1

0.23

0.21

g/l

28.27

1967

10079

Abnormal serum enzyme levels

2135

11274

2.00

167.16

2.7

2.4

0.22

0.21

g/l

7.94

2009

10431

Bacterial intestinal infections, IBD co-morbidities

1375

6388

2.37

166.45

3.0

2.2

0.20

0.21

g/l

0.73

1259

5931

Cellulitis

1562

7617

2.23

165.76

2.5

2.3

0.20

0.21

g/l

4.99

1434

7095

Mental and behavioural disorders due to opioids

378

846

5.54

165.02

2.4

0.20

0.24

g/l

12.73

331

787

Pain in joint

3488

13496

1.71

164.57

2.5

2.2

0.23

0.21

g/l

13.11

3228

12576

Hard cardiovascular diseases

5292

21142

1.55

163.28

2.4

2.3

0.21

0.22

g/l

6.34

4912

19757

Gout, unspecified

1506

7319

2.27

163.26

2.4

2.2

0.21

0.20

g/l

1.46

1376

6755

Hyperkalaemia

554

1656

4.05

162.92

3.0

2.2

0.19

0.20

g/l

0.84

499

1538

Malignant neoplasm of other and unspecified parts of biliary tract

216

295

11.56

162.36

5.2

1.8

0.17

0.20

g/l

6.43

206

261

Intracranial injury

3671

21835

1.66

162.20

2.4

2.3

0.21

g/l

3.81

3336

20344

Purpura and other haemorrhagic conditions

1057

4460

2.67

161.78

3.2

2.3

0.19

0.21

g/l

12.68

988

4151

Alcohol abuse, main dg

1152

5031

2.53

161.57

2.4

0.21

0.22

g/l

6.41

1041

4708

Open wound of head

3450

20713

1.68

159.54

2.4

2.3

0.20

0.21

g/l

9.56

3114

19284

DVT of lower extremities and pulmonary embolism

2762

16251

1.80

159.44

2.4

2.2

0.20

0.21

g/l

3.00

2552

15038

Chronic hepatitis NAS

230

353

11.53

159.23

5.1

2.3

0.20

0.22

g/l

1.53

210

335

Crohn disease (strict definition, require KELA)

568

1745

3.84

158.54

4.0

2.3

0.24

0.22

g/l

3.00

550

1637

Atherosclerosis, excluding cerebral and coronary sclerosis

2733

12656

1.82

158.14

2.1

2.2

0.20

g/l

2.67

2482

11650

7046

25739

1.46

158.00

2.4

2.2

0.21

g/l

0.86

6523

23901

Crohn disease (strict definition, require KELA, min 2 HDR)

561

1716

3.86

157.69

4.0

2.3

0.24

0.22

g/l

2.80

543

1611

Malignant neoplasm of breast, HER-negative

1152

4953

2.48

157.61

1.7

2.0

0.23

0.21

g/l

8.83

1105

4496

Finngen Rheumatological endpoints

5874

22936

1.50

157.10

2.4

2.3

0.22

g/l

0.22

5461

21377

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

561

1707

3.78

157.10

2.1

2.5

0.21

0.23

g/l

6.83

496

1597

Malignant neoplasm of small intestine, including Hilmo

319

652

6.41

157.04

3.2

2.0

0.21

0.20

g/l

1.80

308

592

Pulmonary embolism

2015

10928

1.98

156.77

2.4

2.1

0.20

0.21

g/l

2.75

1864

10090

Obesity related asthma

2282

12856

1.89

156.18

2.2

2.3

0.22

0.21

g/l

4.04

2138

12005

Cystitis

5232

20966

1.54

155.39

2.3

0.21

g/l

0.14

4820

19553

Valvular heart disease excluding rheumatic fever

3007

13013

1.76

155.10

2.3

0.20

0.22

g/l

38.87

2766

12164

Pulmonary heart disease

2015

10969

1.97

154.94

2.4

2.1

0.20

0.21

g/l

2.61

1864

10124

Malignant neoplasm of breast, ER-negative, including Hilmo

1246

5396

2.37

154.79

1.8

2.0

0.23

0.21

g/l

8.30

1193

4891

Noninfectious colitis NAS

1026

4349

2.62

154.26

3.3

2.2

0.21

g/l

0.17

955

4038

Other external causes of accidental injury

5010

16637

1.56

154.11

2.4

2.3

0.21

0.22

g/l

3.97

4610

15625

Immunodeficiencies

487

1398

4.35

153.82

3.9

2.5

0.23

0.22

g/l

4.72

463

1313

Periodontitis

5985

27900

1.48

153.73

2.4

2.2

0.22

0.21

g/l

0.45

5556

25949

Malignant neoplasm of corpus uteri, including Hilmo

660

2246

3.35

153.50

1.6

2.0

0.22

0.21

g/l

7.00

635

2030

Chronic periodontitis, including avohilmo

5967

27891

1.48

152.92

2.4

2.2

0.22

0.21

g/l

0.38

5543

25939

Benign neoplasm: Pancreas

359

851

6.11

152.74

2.9

2.1

0.23

0.21

g/l

6.18

350

796

Implicit fungal Sepsis

401

1011

5.10

152.68

3.3

2.1

0.21

g/l

0.44

373

953

Asthma (diagnoses ohter than nonallergic)

5368

30625

1.50

152.67

2.3

0.22

0.21

g/l

1.60

5027

28410

Injuries to the abdomen, lower back, lumbar spine and pelvis

2552

14751

1.81

152.41

2.4

2.2

0.21

g/l

2.96

2314

13649

Immunodeficiency with predominantly antibody defects

329

719

6.33

152.27

4.0

2.6

0.24

0.22

g/l

3.22

317

681

Toxic liver disease

231

366

9.76

152.13

3.6

2.0

0.19

0.22

g/l

4.32

213

347

Neurological diseases, wide definition

1800

4471

2.11

152.11

2.4

2.6

0.22

g/l

0.33

1682

4230

Polyneuropathies and other disorders of the peripheral nervous system

1554

7837

2.17

151.70

2.7

2.2

0.21

g/l

0.23

1443

7266

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

588

1894

3.63

151.68

4.0

2.3

0.24

0.22

g/l

2.83

570

1774

Diaphragmatic hernia

2399

13850

1.85

151.35

2.4

2.1

0.21

g/l

3.17

2226

12842

Malignant cancer of tonsil and base of tongue

255

446

8.24

150.96

2.8

2.1

0.24

0.21

g/l

7.50

247

400

Vocal cord dysfunction

858

2962

2.81

150.90

2.4

2.2

0.22

g/l

1.84

812

2822

Chronic lower respiratory diseases

7393

28337

1.43

150.67

2.3

2.4

0.21

0.22

g/l

0.46

6889

26350

Crohn's disease of large intestine

478

1363

4.22

150.33

4.4

2.3

0.23

0.22

g/l

3.00

448

1275

STROKE

3438

14561

1.68

149.93

2.3

0.21

0.22

g/l

7.97

3210

13613

Non-rheumatic valve diseases

2970

12919

1.75

149.80

2.3

0.20

0.22

g/l

38.95

2731

12071

Sequelae with surgical and medical care as external cause

1460

7249

2.21

148.87

2.5

2.2

0.21

g/l

0.18

1367

6730

Specific personality disorders

1464

7233

2.17

147.96

2.4

0.22

g/l

0.03

1323

6788

Portal vein thrombosis

244

424

9.08

147.90

5.0

2.2

0.18

0.22

g/l

9.86

228

397

Enterocolitis due to Clostridium difficile

871

3507

2.82

147.78

3.1

2.1

0.20

0.21

g/l

2.14

785

3241

Attention to artificial openings

419

1114

4.73

147.71

2.9

2.3

0.20

0.21

g/l

0.46

397

1033

Dorsalgia

6091

22770

1.48

147.64

2.3

0.22

0.21

g/l

4.06

5635

21205

Malignant neoplasm of ovary, including Hilmo

489

1424

4.02

147.49

1.8

2.1

0.20

0.21

g/l

2.44

462

1300

Disorders of other endocrine glands

2763

16412

1.74

145.56

2.7

2.3

0.22

0.21

g/l

5.41

2582

15265

Accidents

4958

16637

1.54

145.16

2.4

2.3

0.21

0.22

g/l

4.11

4560

15625

Gout, strict definition

1320

6388

2.29

145.01

2.3

2.2

0.21

0.20

g/l

1.87

1204

5899

Other diseases of anus and rectum

1919

10457

1.95

144.44

2.4

2.1

0.21

g/l

1.94

1768

9668

Lower back pain or/and sciatica

6394

29769

1.45

143.56

2.3

0.22

0.21

g/l

2.06

5900

27690

Misadventures to patients during surgical and medical care

1033

4542

2.52

142.99

3.0

2.1

0.21

g/l

0.91

969

4221

Ulcerative ileocolitis

400

1051

4.70

142.40

3.6

2.2

0.23

0.22

g/l

0.38

386

978

Malnutrition

296

634

6.87

142.30

3.4

2.8

0.18

0.21

g/l

10.13

280

595

COPD

2952

14850

1.72

141.77

2.2

0.20

0.21

g/l

2.72

2691

13734

Peripheral artery operations in Hilmo

963

4128

2.59

141.22

2.2

0.19

0.20

g/l

6.47

873

3808

Ulcerative colitis (strict definition, all Crohn cases excluded)

1009

4416

2.51

140.29

3.4

2.3

0.23

0.22

g/l

7.04

956

4134

Bronchitis

6508

29385

1.44

140.28

2.5

2.2

0.21

0.22

g/l

0.48

6023

27299

Other diseases of the respiratory system

1427

7179

2.16

139.48

2.8

2.2

0.20

g/l

2.80

1331

6592

Other respiratory disorders and diseases

1427

7179

2.16

139.48

2.8

2.2

0.20

g/l

2.80

1331

6592

Thrombocytopenia, unspecified

632

2255

3.30

137.78

3.4

2.3

0.19

0.21

g/l

10.82

585

2103

Intestinal malabsorption

453

1333

4.17

137.20

3.9

2.1

0.21

0.22

g/l

2.10

420

1248

Malignant neoplasm of skin

2565

10378

1.77

136.57

2.2

2.1

0.21

g/l

0.05

2379

9383

Dermatitis

3779

24842

1.58

136.51

2.5

2.3

0.21

g/l

0.13

3501

23129

Pleural effusion

1124

5231

2.37

135.98

2.5

2.1

0.18

0.20

g/l

22.29

1031

4819

Emotionally unstable personality disorder

795

3156

2.75

135.62

2.4

0.23

g/l

0.22

723

2968

Laparoscopic right hemicolectomy

564

1929

3.63

135.48

2.1

0.22

0.21

g/l

2.80

550

1794

Unspecified fall

3159

19796

1.65

134.75

2.3

0.21

g/l

3.54

2863

18394

2711

16470

1.71

134.68

2.5

2.4

0.22

g/l

1.26

2533

15317

Postprocedural disorders of digestive system, not elsewhere classified

367

967

4.94

132.48

4.5

2.1

0.22

0.21

g/l

0.46

358

905

Acute peritonitis

569

1959

3.44

132.24

3.6

2.2

0.19

0.21

g/l

8.73

540

1818

Diseases of the respiratory system

3865

12551

1.59

131.83

2.4

2.2

0.21

0.22

g/l

6.30

3612

11713

Other acute lower respiratory infections

3244

19845

1.62

131.48

2.6

2.3

0.21

g/l

1.23

3003

18377

Follow-up examination after treatment for conditions other than malignant neoplasms

2593

10247

1.74

131.19

2.4

2.0

0.22

g/l

0.58

2428

9534

Ischemic heart diseases

5157

21574

1.49

131.03

2.4

2.3

0.21

0.22

g/l

6.50

4774

20124

Nonalcoholic steatohepatitis

168

229

14.78

130.78

3.7

2.3

0.22

0.23

g/l

0.14

158

213

6-mercaptopurine

322

762

5.15

130.72

3.4

2.3

0.24

0.22

g/l

4.34

308

710

Other chronic obstructive pulmonary disease

2809

14364

1.70

130.67

2.1

2.2

0.20

0.21

g/l

2.59

2557

13282

Other and unspecified polyneuropathies, also in other diseases

1338

6768

2.16

129.69

2.7

2.2

0.21

g/l

0.75

1242

6275

Bipolar affective disorders

1139

5380

2.27

129.50

2.4

2.3

0.23

0.22

g/l

2.80

1047

5083

Other CVD

1365

6951

2.14

129.08

2.3

2.1

0.20

g/l

1.06

1230

6391

Injuries to the thorax

2832

17759

1.67

128.61

2.5

2.3

0.20

0.21

g/l

5.89

2561

16479

Adjustment and management of implanted device

1177

5681

2.24

127.89

2.2

2.1

0.20

g/l

1.79

1075

5234

Hypothyroidism, strict autoimmune

4208

18638

1.53

127.47

2.3

2.1

0.22

0.21

g/l

0.43

3885

17284

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2467

9962

1.75

127.22

2.3

2.1

0.21

g/l

0.01

2282

9006

Glomerular diseases

1256

6248

2.20

127.13

2.5

2.4

0.22

0.21

g/l

1.60

1176

5817

Other chronic obstructive pulmonary disease, including avohilmo

3388

18263

1.61

126.95

2.1

2.2

0.20

0.21

g/l

2.93

3097

16913

Right hemicolectomy

545

1883

3.48

126.95

2.7

2.1

0.20

g/l

0.89

521

1749

Peripheral arterial reconstruction

1199

5877

2.24

126.69

1.9

2.1

0.20

g/l

0.47

1094

5405

Diseases of peritoneum

790

3269

2.73

126.59

3.4

2.2

0.19

0.21

g/l

6.76

745

3048

Dermatitis and eczema

6643

30162

1.40

125.58

2.4

2.3

0.22

0.21

g/l

2.27

6143

28052

Any operation in hilmo

196

11.56

125.11

2.7

1.4

0.23

0.25

g/l

1.66

181

All influenza

1579

8489

1.98

124.91

2.7

2.3

0.21

g/l

2.25

1457

7906

Secondary hypertension

557

1899

3.24

124.83

2.9

2.3

0.23

0.22

g/l

2.26

528

1780

Malignant neoplasm of oropharynx, including Hilmo

235

454

7.05

124.26

2.7

2.0

0.23

0.21

g/l

4.78

229

410

Cardiomyopathy

1168

5702

2.22

123.46

2.2

2.3

0.20

0.22

g/l

10.41

1076

5336

Genitourinary diseases

3476

11193

1.61

123.29

2.7

2.4

0.22

g/l

0.08

3251

10440

Bacterial pneumoniae

2466

13240

1.72

123.25

2.4

2.2

0.21

g/l

4.59

2257

12308

Neurological diseases

5158

18101

1.47

122.45

2.3

2.4

0.22

g/l

1.25

4813

16898

Candidiasis

1781

10016

1.89

122.31

2.6

2.2

0.21

g/l

0.35

1642

9332

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2314

9398

1.76

121.90

2.2

2.1

0.21

g/l

0.15

2132

8483

Retention of urine

2172

10536

1.79

121.28

2.2

0.20

g/l

3.37

1963

9739

Malignant neoplasm of corpus uteri

553

1949

3.22

120.91

1.6

2.0

0.22

0.21

g/l

4.71

530

1760

Injuries to the hip and thigh

2941

17048

1.63

120.63

2.2

0.20

0.21

g/l

15.25

2676

15751

Chronic periodontitis, complicated

3372

22161

1.58

120.00

2.4

2.3

0.21

g/l

0.06

3126

20651

Extracorporeal dialysis

540

1919

3.36

119.38

3.2

2.3

0.22

0.21

g/l

1.19

509

1792

Percutaneous Coronary Intervention

4864

20930

1.48

119.13

2.4

2.3

0.21

0.22

g/l

5.23

4509

19506

Mycoses

1710

9609

1.90

118.41

2.7

2.3

0.21

g/l

2.28

1579

8949

Weight loss

782

3333

2.66

117.93

2.3

0.21

g/l

0.21

706

3114

Malignant neoplasm of small intestine

234

472

6.61

117.55

3.3

1.9

0.21

0.20

g/l

1.34

224

422

Schizophrenia or delusion, excluding more controls

1646

9013

1.90

117.23

2.2

2.3

0.22

g/l

0.21

1481

8519

Injury, poisoning and certain other consequences of external causes

3177

10135

1.62

116.87

2.4

2.3

0.21

0.22

g/l

2.40

2964

9479

Sleep disorders (combined)

6672

25835

1.39

116.60

2.1

2.3

0.22

0.21

g/l

22.46

6213

24025

Agranulocytosis

842

3728

2.54

116.04

2.9

2.3

0.20

0.21

g/l

6.09

786

3493

Mental and behavioural disorders due to sedatives or hypnotics

528

1860

3.24

115.97

2.4

2.3

0.21

0.22

g/l

3.48

456

1741

Sleep apnoea

5624

26389

1.42

115.09

2.1

2.3

0.22

0.21

g/l

12.74

5234

24572

Other and unspecified dermatitis

3097

20326

1.59

114.92

2.5

2.3

0.21

g/l

0.00

2882

18951

Abnormal findings on diagnostic imaging of other body structures

976

4598

2.34

114.66

2.5

2.2

0.21

g/l

0.17

931

4268

Bacterial pneumonia, not elsewhere classified

2324

12514

1.71

114.37

2.3

2.2

0.21

g/l

3.81

2127

11637

Other ulcerative colitis

473

1586

3.46

113.99

4.2

2.2

0.23

0.22

g/l

1.79

448

1473

Paroxysmal tachycardia

1265

5377

2.08

113.73

2.3

0.21

0.22

g/l

7.79

1190

5071

Enlarged lymph nodes

983

4620

2.29

113.67

2.5

2.1

0.21

0.22

g/l

2.40

923

4327

Delirium, not induced by alcohol and other psychoactive substances

876

3961

2.45

113.38

2.3

2.1

0.19

0.20

g/l

4.50

769

3671

Hypotension

1169

5908

2.15

113.16

2.2

2.1

0.19

0.20

g/l

1.45

1051

5429

Collagenous colitis

694

2857

2.75

112.61

3.0

2.1

0.21

g/l

0.22

658

2669

Fracture of rib(s), sternum and thoracic spine

1908

11222

1.80

112.44

2.4

2.3

0.20

0.21

g/l

2.92

1723

10419

Coronary revascularization (ANGIO or CABG)

4827

20935

1.46

112.40

2.4

2.3

0.21

0.22

g/l

4.82

4484

19511

Amputation of toe

595

2289

3.02

112.27

2.2

2.1

0.19

0.20

g/l

6.80

541

2118

Emergency coronary revascularization (for ACS)

5236

22868

1.44

112.17

2.3

0.21

g/l

4.77

4851

21236

Non-Hodgkin lymphoma, all, including Hilmo

765

3262

2.55

112.11

2.2

2.1

0.19

0.20

g/l

3.16

709

2945

COPD, early/later onset

2829

15378

1.63

112.04

2.1

2.2

0.20

0.21

g/l

2.64

2575

14223

ILD, hospital admission 2, with pulmonary infections

720

3016

2.67

111.77

2.4

2.1

0.21

g/l

0.13

674

2791

Major coronary heart disease event

5137

22248

1.44

110.72

2.4

2.3

0.21

g/l

5.43

4750

20717

Certain disorders involving the immune mechanism

1272

6666

2.07

110.70

3.1

2.3

0.22

0.21

g/l

5.39

1204

6227

Fracture of femur

1721

8911

1.86

110.61

2.2

2.1

0.19

0.20

g/l

15.43

1542

8155

Presence of cardiac and vascular implants and grafts

2718

12889

1.64

109.97

2.1

0.20

0.21

g/l

7.85

2492

11859

Alcohol-induced acute pancreatitis

366

1091

4.21

109.81

3.7

2.3

0.19

0.22

g/l

6.09

343

1011

In situ neoplasms

2311

14362

1.69

109.71

2.1

0.22

0.21

g/l

15.02

2174

13292

Acute bronchitis

2450

15099

1.66

109.50

2.4

2.2

0.21

g/l

0.52

2263

13947

COPD, hospital admissions

2792

15271

1.62

109.11

2.1

2.2

0.20

0.21

g/l

2.24

2542

14121

Respiratory insufficiency

592

2276

2.89

108.54

2.4

2.1

0.19

0.21

g/l

3.20

546

2110

Hyperkinetic disorders, excluding more controls

543

1881

2.93

107.95

2.7

3.0

0.23

g/l

0.49

497

1792

Other symptoms and signs involving cognitive functions and awareness

2822

16737

1.61

107.51

2.2

0.20

0.21

g/l

2.70

2548

15541

Use of disulfiram, acamprosate or naltrexone

653

2676

2.75

106.61

2.4

0.22

g/l

0.31

588

2506

Abnormal weight loss

714

3066

2.64

106.13

2.2

2.3

0.21

g/l

0.12

651

2859

COPD related to multimorbidity

2457

13132

1.67

105.92

2.1

2.2

0.20

g/l

2.67

2224

12121

Disorders of lens

4089

17749

1.49

105.83

2.5

2.3

0.21

g/l

10.76

3788

16523

Later onset COPD, excluding more controls

1319

5397

2.02

105.45

2.0

0.19

0.20

g/l

8.31

1199

5001

Crohn disease (strict definition, all UC cases excluded)

413

1342

3.58

105.02

3.6

2.3

0.23

0.22

g/l

2.23

399

1258

Mental and behavioural disorders due to use of other stimulants, including caffeine

257

605

5.14

104.94

2.3

2.5

0.20

0.24

g/l

8.92

224

562

Glomerular disorders in diseases classified elsewhere

822

3749

2.43

104.89

2.4

2.3

0.21

g/l

0.28

767

3487

Systemic connective tissue disorders

2156

13322

1.71

104.89

2.4

2.1

0.21

g/l

1.21

2002

12396

Exposure to other specified factors

4369

28539

1.45

104.85

2.4

0.22

g/l

1.40

4002

26680

Hydronephrosis

789

3532

2.46

104.57

2.4

2.2

0.20

0.21

g/l

4.11

735

3281

Other diseases of stomach and duodenum

519

1924

3.10

104.45

3.4

1.9

0.20

0.21

g/l

0.86

486

1786

Episodal and paroxysmal disorders

6495

24681

1.37

104.17

2.2

2.4

0.22

0.21

g/l

7.46

6045

22936

Candidiasis

923

4418

2.29

103.57

2.9

2.2

0.21

g/l

2.21

859

4131

Fibrosis of liver

141

208

14.05

103.28

6.2

2.4

0.19

0.23

g/l

6.61

136

196

Sleep apnoea, including avohilmo

5836

26775

1.39

103.22

2.1

2.3

0.22

0.21

g/l

14.92

5432

24925

Unspecified haematuria

2572

13700

1.63

102.78

2.4

2.3

0.20

0.21

g/l

1.23

2338

12692

Other dorsopathies, not elsewhere classified

5911

22853

1.39

102.23

2.3

0.22

0.21

g/l

6.04

5490

21282

Other complications of surgical and medical care, not elsewhere classified

678

2893

2.59

100.49

2.9

2.1

0.21

g/l

0.50

631

2702

Cerebrovascular diseases

4453

22394

1.45

100.47

2.2

2.3

0.20

0.21

g/l

7.18

4079

20783

Mycoses

4930

31316

1.41

100.43

2.4

2.3

0.22

g/l

1.05

4532

29173

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

730

3249

2.52

99.39

3.2

2.2

0.21

g/l

0.00

701

3026

Soft tissue disorders

6024

23125

1.37

97.77

2.4

0.22

0.21

g/l

2.74

5589

21511

Malignant neoplasm of rectosigmoid junction, including Hilmo

258

648

4.90

97.58

2.4

1.8

0.21

0.20

g/l

1.32

249

580

Other diseases of lip and oral mucosa

2391

15398

1.63

97.49

2.5

2.3

0.22

0.21

g/l

1.40

2247

14361

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1731

10306

1.78

97.43

2.3

0.23

0.22

g/l

3.96

1617

9665

Glucagon-like peptide-1 (GLP-1) analogues

1731

10306

1.78

97.43

2.3

0.23

0.22

g/l

3.96

1617

9665

Malignant neoplasm of bladder, including Hilmo

668

2831

2.54

97.32

2.4

1.9

0.21

0.20

g/l

3.81

611

2541

Bulimia nervosa (incl. atypical)

250

605

4.76

97.03

2.7

2.5

0.23

g/l

1.12

230

572

Malignant neoplasm of oropharynx

184

359

7.01

96.49

2.8

2.0

0.24

0.21

g/l

5.12

178

321

Irritable bowel syndrome

1539

8864

1.82

96.40

2.3

2.1

0.23

0.22

g/l

11.47

1426

8251

Basal cell carcinoma

2128

9085

1.68

96.15

2.2

2.0

0.21

g/l

0.16

1958

8196

Spondylopathies

4695

20275

1.42

96.12

2.2

2.3

0.22

0.21

g/l

2.18

4329

18878

Non-selective monoamine reuptake inhibitors

2208

13464

1.65

95.96

2.2

0.21

g/l

0.48

2042

12651

Bacterial pneumonia (organism specified)

2647

15796

1.58

95.77

2.4

2.2

0.21

g/l

0.84

2425

14602

Disorders of thyroid, IBD co-morbidities

989

3392

2.15

95.05

2.3

2.2

0.22

g/l

0.53

934

3216

Emotional disorders starting during childhood or adolecense, excluding more controls

273

688

4.28

95.03

3.1

3.8

0.22

0.23

g/l

0.89

253

650

Basal cell carcinoma, including avohilmo

2200

9467

1.66

94.45

2.2

2.1

0.21

g/l

0.18

2027

8543

Fracture of lumbar spine and pelvis

1389

7842

1.89

94.31

2.4

2.1

0.20

0.21

g/l

5.56

1257

7244

Diseases of the myoneural junction and muscle

851

4104

2.28

94.27

2.3

0.20

0.21

g/l

4.39

760

3824

Other pleural conditions

735

3350

2.43

94.07

2.5

2.1

0.18

0.20

g/l

16.54

672

3084

Cardiomyopathy (excluding other)

826

3929

2.29

93.87

2.2

2.3

0.19

0.22

g/l

11.00

752

3674

COPD, hospital admission 2, with asthma infections

1957

10373

1.71

92.98

2.2

0.20

g/l

2.65

1788

9580

Vascular disorders of the intestines

513

2000

2.90

92.88

2.8

1.9

0.19

0.20

g/l

1.59

474

1843

Acute upper respiratory infections of multiple and unspecified sites

4293

22924

1.43

92.56

2.6

2.3

0.22

g/l

0.53

4000

21326

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

625

2671

2.60

92.53

2.7

2.1

0.21

g/l

0.98

582

2490

Dizziness and giddiness

4346

24947

1.42

92.33

2.2

2.3

0.21

g/l

0.54

4002

23243

Benign neoplasm: Colon, unspecified

1597

9471

1.80

92.25

2.7

2.2

0.21

g/l

4.68

1481

8784

Superficial injury of head

1435

8224

1.85

92.18

2.2

2.3

0.21

g/l

0.86

1296

7685

Viral pneumonia

831

3989

2.26

91.93

2.7

2.3

0.21

g/l

0.32

765

3720

Other specific joint derangements/joint disorders

4146

19139

1.44

91.77

2.5

2.4

0.23

0.22

g/l

12.05

3846

17893

Osteomyelitis

508

1993

2.92

91.69

2.6

2.3

0.19

0.21

g/l

6.52

468

1860

Hypertensive heart and/or renal disease

1558

6737

1.82

91.68

2.1

2.2

0.20

g/l

0.67

1404

6251

Early onset COPD

1408

8076

1.86

91.49

2.3

0.21

g/l

0.04

1295

7537

Symptoms and signs involving the skin and subcutaneous tissue

4057

28615

1.43

91.47

2.4

2.3

0.22

0.21

g/l

11.85

3806

26564

Nonorganic sleeping disorders, excluding more controls

1015

5213

2.05

91.32

2.4

2.3

0.23

0.22

g/l

3.67

933

4930

Cardiomyopathies, Primary/intrinsic

798

3789

2.29

91.15

2.2

2.3

0.19

0.21

g/l

10.21

728

3547

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1021

4637

2.06

91.12

3.0

2.9

0.23

g/l

0.54

935

4360

Diseases of pulp and periapical tissues, including avohilmo

6159

24130

1.35

91.06

2.3

0.22

0.21

g/l

0.35

5720

22408

Kidney transplant status

436

1601

3.19

90.26

4.2

2.6

0.24

0.22

g/l

5.92

417

1501

Gingivitis and periodontal diseases

6047

23599

1.35

89.58

2.4

2.2

0.22

0.21

g/l

1.90

5600

21920

Other disorders of glucose regulation and pancreatic internal secretion

610

2621

2.59

89.49

2.7

2.4

0.19

0.21

g/l

10.78

549

2442

Other and unspecified myopathies

641

2829

2.54

89.08

2.3

2.1

0.19

0.21

g/l

6.36

565

2635

Other respiratory diseases principally affecting the interstitium

1169

6404

1.97

88.91

2.3

2.1

0.21

0.20

g/l

1.31

1090

5909

Malignant neoplasm of ovary

328

1032

3.65

87.50

1.8

2.1

0.20

0.21

g/l

2.11

306

943

Other systemic involvement of connective tissue (FG)

1555

9127

1.77

87.41

2.3

2.1

0.21

g/l

0.49

1433

8483

Injuries to the knee and lower leg

6876

29531

1.32

87.39

2.3

0.22

g/l

0.17

6364

27475

ILD, hospital admissions 3, with pneumonia sepsis

604

2616

2.58

87.26

2.3

2.1

0.20

0.21

g/l

0.22

562

2431

Nonhereditary hypogammaglobulinemia

153

282

8.24

87.06

4.8

2.2

0.23

0.22

g/l

0.45

147

265

Elevated blood glucose level

607

2640

2.57

87.02

2.8

2.3

0.20

0.21

g/l

2.86

559

2456

Presence of other functional implants

3395

16471

1.48

86.73

2.2

2.1

0.20

0.21

g/l

3.79

3096

15211

622

2739

2.54

86.69

3.6

2.3

0.14

0.21

g/l

61.98

522

2538

COPD-related respiratory insufficiency

806

3931

2.25

86.67

2.3

2.2

0.20

g/l

0.96

745

3626

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

662

2961

2.40

85.99

2.2

1.8

0.21

0.19

g/l

3.28

616

2634

Gastrointestinal stromal tumor and sarcoma

144

252

8.46

85.85

2.1

1.8

0.23

0.20

g/l

3.35

138

226

Diseases of oral cavity, salivary glands and jaws

3536

12686

1.48

85.52

2.3

2.1

0.21

g/l

0.85

3275

11729

Panic disorder

806

3922

2.18

84.55

2.3

0.23

g/l

0.24

722

3686

Diagnoses used for exclusion with ILD

1540

9251

1.76

83.85

2.6

2.2

0.20

0.21

g/l

1.05

1411

8561

Hypoglycaemia, other or unspecified

505

2054

2.76

83.83

2.8

2.4

0.19

0.21

g/l

10.64

454

1913

Viral and other specified intestinal infections

1457

8261

1.77

83.68

2.8

2.4

0.22

g/l

0.34

1371

7700

Vitamin B12 deficiency anaemia

706

3316

2.33

83.17

3.0

2.0

0.20

0.21

g/l

2.63

658

3055

Fracture of shoulder and upper arm

2151

13998

1.60

83.14

2.3

0.20

0.21

g/l

6.22

1948

12999

Assault

781

3793

2.21

83.11

2.5

2.4

0.22

0.23

g/l

4.71

715

3552

Osteoporosis with pathological fracture (FG)

544

2312

2.67

82.85

2.5

2.0

0.19

0.20

g/l

1.97

489

2130

Conduction disorders

1728

8606

1.71

82.82

2.2

2.3

0.20

0.21

g/l

9.55

1582

8025

Biological medication for rheuma

1015

5424

2.00

82.39

3.3

2.4

0.23

0.22

g/l

4.17

971

5096

Abnormalities of heart beat

2025

12764

1.62

82.00

2.3

2.2

0.22

0.21

g/l

0.52

1857

11889

Acidosis

223

582

4.96

81.67

2.7

2.3

0.20

0.21

g/l

1.08

200

544

Senile cataract

3675

16105

1.45

81.34

2.5

2.2

0.20

0.21

g/l

10.78

3402

15002

Hypothyroidism, other/unspecified

5031

24877

1.36

81.32

2.3

0.22

0.21

g/l

2.08

4669

23107

Disorders of the thyroid gland

5369

26547

1.35

80.83

2.3

0.22

0.21

g/l

2.84

4988

24645

Pneumonitis due to solids and liquids

579

2542

2.52

80.76

2.9

2.1

0.18

0.20

g/l

8.44

512

2346

Hypertensive Heart Disease

1383

6312

1.81

80.51

2.1

2.2

0.20

g/l

1.05

1247

5848

Nerve, nerve root and plexus disorders

6065

28660

1.33

80.46

2.2

2.3

0.22

0.21

g/l

0.42

5629

26613

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1818

11489

1.66

80.31

2.6

2.3

0.20

0.21

g/l

7.31

1662

10680

Other disorders of veins

2307

15318

1.56

79.31

2.3

2.1

0.21

0.22

g/l

5.49

2104

14306

Dorsopathies

5912

23024

1.33

79.27

2.3

2.4

0.22

0.21

g/l

5.32

5506

21448

Other/unspecified dorsalgia

2155

14043

1.58

79.24

2.4

2.2

0.22

0.21

g/l

3.33

1974

13085

Hypothyreosis and Thyroxine purchase for inclusion criteria

5192

25830

1.35

79.05

2.3

2.2

0.22

0.21

g/l

1.77

4816

24004

Duodenal ulcer

704

3366

2.27

78.93

3.1

2.0

0.19

0.20

g/l

4.66

630

3098

Hypertension, portal

29.02

78.56

7.6

2.2

0.17

0.22

g/l

4.30

Other arthritis (FG)

1807

11465

1.65

78.37

2.4

2.3

0.22

0.21

g/l

0.24

1694

10692

Other interstitial pulmonary diseases

990

5363

2.00

78.37

2.3

2.2

0.21

0.20

g/l

1.63

924

4967

Neuroendocrine tumor and carcinoma of small intestine

145

275

7.14

78.24

2.6

1.9

0.22

0.20

g/l

2.13

137

249

ILD, hospital admissions

979

5289

2.00

78.23

2.3

2.2

0.21

0.20

g/l

1.70

914

4901

Pacemaker

1938

11996

1.63

78.01

2.1

0.19

0.20

g/l

6.14

1757

11027

Interstitial lung disease

990

5371

1.99

78.01

2.3

2.2

0.21

0.20

g/l

1.66

924

4974

Interstitial lung disease endpoints

990

5371

1.99

78.01

2.3

2.2

0.21

0.20

g/l

1.66

924

4974

Disorders of calcium metabolism

468

1904

2.77

77.92

3.1

2.2

0.20

0.21

g/l

2.53

433

1792

Amenorrhoea

409

1539

2.89

77.70

3.6

2.4

0.22

g/l

0.00

377

1448

Undetermined asthma, excluding more controls

744

3634

2.18

77.61

2.3

2.2

0.22

g/l

0.01

687

3395

Diseases of the musculoskeletal system and connective tissue

3088

10701

1.48

77.40

2.5

0.22

g/l

1.21

2868

10038

Benign neoplasm: Sigmoid colon

1210

7000

1.86

76.91

2.5

2.2

0.22

0.21

g/l

8.20

1147

6499

Other embolism and thrombosis

820

4198

2.11

76.40

2.7

2.1

0.21

g/l

1.45

753

3908

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

557

2449

2.46

76.25

2.0

0.21

0.20

g/l

3.64

520

2206

COPD, hospital admissions 3, with asthma pneumonia sepsis

1615

8553

1.70

75.97

2.2

2.1

0.20

g/l

1.96

1467

7864

Ulcerative enterocolitis

266

811

3.89

75.65

4.2

2.3

0.24

0.22

g/l

3.28

251

753

Functional dyspepsia

1480

9030

1.72

75.28

2.4

2.0

0.22

g/l

2.51

1378

8407

Drug-induced neutropenia

528

2313

2.58

75.24

2.4

2.2

0.20

0.21

g/l

5.51

505

2179

Malignant neoplasm of larynx, including Hilmo

181

424

5.26

74.96

2.7

1.9

0.21

0.20

g/l

1.54

176

373

Secondary and unspecified malignant neoplasm of lymph nodes

475

1967

2.64

74.70

2.3

2.1

0.19

0.21

g/l

3.05

444

1787

Type 1 diabetes

1369

8179

1.75

74.68

2.5

2.4

0.19

0.22

g/l

30.52

1239

7649

Unspecified privation

707

3469

2.22

74.50

2.5

2.2

0.22

0.21

g/l

1.49

652

3237

Carcinoma in situ of other and unspecified digestive organs

317

1100

3.55

74.45

2.4

2.2

0.23

0.21

g/l

5.59

300

1024

Generalized anxiety disorder

818

4188

2.06

74.35

2.7

2.4

0.23

0.22

g/l

1.61

753

3938

Asthma, including avohilmo

6748

29881

1.29

74.15

2.3

2.4

0.22

0.21

g/l

3.94

6298

27738

Behavioural syndromes associated with physiological disturbances and physical factors

5124

27809

1.34

73.93

2.3

0.23

0.22

g/l

18.66

4739

25946

Complications of internal orthopaedic prosthetic devices, implants and grafts

1313

7825

1.78

73.93

2.1

2.0

0.20

0.21

g/l

2.43

1207

7230

Diseases of pulp and periapical tissues and dental caries

3935

14702

1.41

73.86

2.3

2.2

0.21

g/l

0.65

3638

13620

Exclusions for E4_PCOS_BROAD

1044

5836

1.91

73.59

2.7

2.5

0.22

g/l

0.92

978

5475

Serous carcinoma of ovary, including Hilmo

246

724

3.99

73.54

1.8

2.1

0.19

0.21

g/l

2.92

234

666

Protein-energy malnutrition of moderate and mild degree

137

270

8.06

73.48

3.1

2.8

0.17

0.21

g/l

6.47

130

252

Other acute viral hepatitis

151

316

6.47

73.28

3.3

2.7

0.18

0.23

g/l

7.67

140

295

Other arrhythmias

3424

18659

1.42

73.10

2.2

2.3

0.21

0.22

g/l

8.36

3163

17475

Other specified/unspecified arthritis

1589

9952

1.67

72.94

2.4

2.3

0.22

0.21

g/l

0.35

1494

9314

Other and unspecified drugs and medicaments

586

2709

2.39

72.55

2.7

2.2

0.21

g/l

1.01

549

2530

Acute upper respiratory infections

5920

28437

1.31

72.37

2.5

2.2

0.22

0.21

g/l

0.88

5516

26366

Benign neoplasm: Rectum

1143

6625

1.85

72.27

2.4

2.2

0.22

0.21

g/l

6.66

1071

6157

Malignant neoplasm of urinary organs

528

2326

2.46

72.03

2.0

0.21

0.20

g/l

3.36

491

2088

Hepatomegaly and splenomegaly, not elsewhere classified

127

233

7.77

71.74

3.1

1.9

0.21

0.22

g/l

1.02

121

218

Injuries to the shoulder and upper arm

4791

29489

1.34

71.69

2.3

0.21

0.22

g/l

4.78

4377

27438

Asthma/COPD (KELA code 203)

5339

28265

1.32

71.57

2.2

2.4

0.22

g/l

0.06

4965

26282

Benign neoplasm: Liver

224

640

4.33

71.37

2.5

2.2

0.23

0.22

g/l

0.95

217

605

Caries of dentine, including avohilmo

4635

17811

1.36

71.35

2.3

2.2

0.21

g/l

0.58

4276

16525

Phobic anxiety disorders

694

3398

2.16

71.25

2.7

2.5

0.22

0.23

g/l

0.73

634

3189

Dental caries, including avohilmo

4350

16583

1.37

71.24

2.3

2.2

0.21

g/l

0.47

4008

15374

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1412

8515

1.71

70.99

3.0

2.5

0.22

g/l

0.54

1326

7996

Benign neoplasm: Rectum, anus and anal canal

1252

7471

1.79

70.91

2.4

2.2

0.22

0.21

g/l

6.53

1168

6936

Other systemic involvement of connective tissue

1599

10126

1.66

70.47

2.4

2.1

0.21

g/l

1.25

1477

9414

Other problems related to primary support group, including family circumstances

669

3174

2.20

70.30

3.9

2.7

0.22

g/l

0.67

631

3000

Undetermined asthma

744

3771

2.10

70.18

2.3

2.1

0.22

g/l

0.35

687

3536

Ischaemic heart disease, wide definition

4463

20884

1.36

70.07

2.2

2.3

0.21

g/l

2.72

4106

19438

Post-traumatic stress disorder

446

1840

2.60

69.76

2.6

2.4

0.23

g/l

0.09

410

1733

Endocarditis

290

979

3.46

69.61

2.9

2.4

0.18

0.21

g/l

8.16

257

919

Cough

2307

14928

1.51

69.44

2.5

2.4

0.22

0.21

g/l

3.42

2165

13948

Persistent mood disorders

1090

6266

1.83

69.35

2.4

2.2

0.22

0.21

g/l

2.67

990

5867

Traumatic subdural haemorrhage

816

4119

2.03

69.23

2.4

2.2

0.20

g/l

1.52

732

3804

Mental and behavioural disorders due to tobacco

581

2728

2.35

69.08

2.6

2.3

0.21

0.22

g/l

0.35

538

2558

Benign neoplasm: Liver/bile ducts

237

718

4.01

68.83

2.5

2.2

0.23

0.22

g/l

1.59

230

678

Other viral diseases

1573

9922

1.65

68.69

3.4

2.5

0.22

g/l

0.42

1482

9271

Fracture of skull and facial bones

1209

7180

1.77

68.36

2.4

2.3

0.21

0.22

g/l

0.63

1105

6723

Open wound of lower leg

913

5018

1.94

68.22

2.6

2.3

0.21

g/l

1.30

843

4668

Lung diseases due to external agents

859

4642

1.98

67.89

2.7

2.1

0.19

0.20

g/l

4.14

774

4281

Malignant neoplasm of bladder

390

1536

2.76

67.77

2.4

1.9

0.21

0.19

g/l

2.96

363

1368

Other cataract

2527

13313

1.49

67.59

2.4

2.2

0.20

0.21

g/l

5.53

2324

12372

Squamous cell neoplasms and carcinomas of the skin

450

1904

2.56

67.13

2.1

1.8

0.21

0.19

g/l

3.88

420

1688

Extreme obesity with alveolar hypoventilation

328

1213

3.16

67.11

2.5

2.2

0.19

0.22

g/l

5.06

300

1144

Hypothyroidism, strict autoimmune, 3 medication purchases required

4631

23904

1.34

67.09

2.3

2.2

0.22

0.21

g/l

0.97

4269

22223

Asthma, hospital admissions , main diagnosis only

4541

30694

1.34

67.07

2.3

0.22

0.21

g/l

2.72

4257

28500

Other diseases of oesophagus

605

2910

2.26

66.98

2.6

2.0

0.20

0.21

g/l

0.72

558

2693

Disorders of iron metabolism

165

398

5.37

66.98

2.8

2.3

0.23

0.22

g/l

2.05

155

373

Smoking dependency

581

2762

2.31

66.97

2.6

2.3

0.21

0.22

g/l

0.32

538

2587

Unspecified misadventure during surgical and medical care

415

1722

2.75

66.90

3.3

2.2

0.20

0.21

g/l

1.21

396

1614

Fracture of lower leg, including ankle

3095

22264

1.42

66.77

2.3

0.21

0.22

g/l

3.50

2858

20759

Amputation of foot

241

759

3.93

66.47

2.4

2.3

0.18

0.21

g/l

5.08

218

699

Secondary malignant neoplasm of respiratory and digestive organs

158

369

5.44

66.37

2.3

1.9

0.16

0.20

g/l

7.51

151

330

Coronary atherosclerosis

3715

17448

1.39

65.99

2.2

2.3

0.21

g/l

5.08

3408

16209

Other specified and unspecified personality disorders

545

2527

2.34

65.98

2.5

2.3

0.22

g/l

0.74

506

2389

Dental operations

3626

13680

1.40

65.33

2.3

2.1

0.21

g/l

0.14

3367

12588

Phlebitis and thrombophlebitis (not including DVT)

1298

7964

1.72

65.21

2.4

2.1

0.21

g/l

1.77

1204

7425

Type of accident

1639

10620

1.61

65.04

2.6

2.3

0.20

0.21

g/l

7.75

1501

9877

ILD, hospital admissions 1, main diag only

863

4755

1.96

64.96

2.2

0.21

0.20

g/l

1.76

805

4406

Disorders of eyelid, lacrimal system and orbit

4799

28195

1.32

64.88

2.3

0.22

0.21

g/l

4.43

4429

26200

Other metabolic disorders

767

4049

2.02

64.76

2.6

2.2

0.22

g/l

1.40

728

3826

Viral and other specified intestinal infections

1075

6103

1.79

64.47

3.1

2.5

0.22

g/l

1.34

1004

5663

AV-block

1027

5173

1.84

64.11

2.1

2.2

0.20

0.21

g/l

7.23

937

4807

Other and unspecified local infections of skin and subcutaneous tissue

612

3010

2.21

64.06

2.9

2.3

0.21

0.22

g/l

2.15

566

2813

Anaemia in chronic diseases classified elsewhere

219

663

4.06

63.97

3.3

2.4

0.21

g/l

0.10

198

621

Other diseases of pericardium

338

1297

2.97

63.77

2.5

2.3

0.19

0.22

g/l

8.19

306

1224

Tumor necrosis factor alpha inhibitors

872

4818

1.92

63.72

3.1

2.4

0.24

0.22

g/l

5.40

832

4530

Papulosquamous disorders

2204

15246

1.50

63.70

2.4

2.3

0.22

0.21

g/l

0.82

2060

14219

Malignant neoplasm of kidney, except renal pelvis

477

2123

2.43

63.61

2.0

0.22

0.20

g/l

3.49

446

1916

Other and unspecified nonorganic psychotic disorders

1019

5883

1.82

63.57

2.3

2.4

0.22

0.23

g/l

0.79

918

5521

Vitamin deficiency

347

1349

2.91

63.48

3.2

2.2

0.19

0.21

g/l

5.85

322

1248

Vitamin deficiency, wide

347

1349

2.91

63.48

3.2

2.2

0.19

0.21

g/l

5.85

322

1248

Stroke, excluding SAH

3457

18717

1.39

63.40

2.2

0.20

0.21

g/l

5.34

3162

17308

L01XE Protein kinase inhibitors

419

1803

2.67

62.97

2.7

2.2

0.20

0.21

g/l

2.23

392

1694

Viral infections characterized by skin and mucous membrane lesions

2323

16238

1.48

62.85

2.8

2.3

0.21

g/l

0.01

2171

15109

Malignant neoplasm of rectosigmoid junction

147

338

5.46

62.72

2.3

1.9

0.20

g/l

0.03

140

301

Stroke, including SAH

3631

19708

1.38

62.70

2.2

0.20

0.21

g/l

6.07

3327

18241

Symptoms and signs involving the nervous and musculoskeletal systems

3210

23727

1.39

62.31

2.2

2.3

0.22

0.21

g/l

2.74

2983

22030

Transport accidents

2372

14254

1.47

62.29

2.3

2.4

0.22

g/l

0.20

2195

13411

Suppurative and necrotic conditions of lower respiratory tract

404

1715

2.66

61.74

2.6

2.3

0.19

0.21

g/l

5.43

367

1594

Diseases of spleen

184

512

4.58

61.61

3.5

2.3

0.20

0.21

g/l

1.42

172

481

Mixed and other personality disorders

477

2155

2.40

61.59

2.2

2.3

0.22

0.23

g/l

0.37

430

2045

Disorders of skin appendages

2528

17981

1.45

61.51

2.4

0.22

g/l

3.06

2374

16779

severe traumatic brain injury, does not include concussion

1277

7926

1.70

61.29

2.4

2.2

0.20

g/l

1.77

1158

7281

Acute posthaemorrhagic anaemia

271

945

3.31

61.27

3.2

2.2

0.18

0.20

g/l

5.43

242

882

Other local infections of skin and subcutaneous tissue

634

3211

2.14

61.10

2.8

2.3

0.21

0.22

g/l

2.09

586

3003

Primary_lymphoid and hematopoietic malignant neoplasms

1404

8936

1.65

61.00

2.3

0.20

0.21

g/l

4.26

1291

8268

Other diseases of hard tissues of teeth

3320

12588

1.40

60.71

2.3

2.1

0.21

g/l

3.80

3063

11653

Epilepsy

1737

11525

1.56

60.54

2.5

2.4

0.21

g/l

0.28

1608

10696

Other retinal disorders

3597

21077

1.37

60.39

2.3

2.2

0.20

0.21

g/l

10.77

3282

19510

Congenital malformations, deformations and chromosomal abnormalities

3026

21164

1.40

60.29

2.6

2.4

0.22

g/l

0.28

2861

19767

Cardiomyopathy, other and unspecified

499

2327

2.35

60.13

2.2

2.3

0.20

0.22

g/l

3.36

467

2187

Other disorders starting during childhood or adolecense, excluding more controls

257

822

3.24

59.97

3.6

3.9

0.22

g/l

0.26

241

784

Malignant neoplasm, without specification of site, including Hilmo

286

1029

3.07

59.73

2.0

1.9

0.18

0.19

g/l

3.12

254

919

Urticaria and erythema

1938

13239

1.52

59.35

2.5

2.4

0.22

g/l

0.86

1797

12355

Other disorders of adrenal gland

338

1347

2.86

59.19

2.8

2.4

0.22

g/l

0.31

309

1275

Adrenocortical insufficiency

285

1045

3.17

59.17

2.9

2.2

0.22

g/l

0.30

262

992

Paralytic ileus

287

1052

3.12

59.10

3.1

1.9

0.21

g/l

0.14

273

971

Malignant neoplasm of respiratory system and intrathoracic organs

961

4592

1.82

59.06

2.1

2.0

0.20

g/l

0.29

902

4122

Other disorders of kidney and ureter

803

4453

1.94

59.05

2.5

2.3

0.22

0.21

g/l

5.31

741

4142

Unspecified mental disorder

2108

14655

1.48

58.58

2.2

2.3

0.22

g/l

1.57

1906

13666

Abnormalities of gait and mobility

766

4202

1.97

58.56

2.2

2.3

0.21

0.20

g/l

1.28

716

3909

Psoriasis vulgaris

1076

6481

1.76

58.37

2.6

2.3

0.22

0.21

g/l

0.51

1009

6044

Other endocrine disorders

384

1560

2.65

58.08

3.4

3.3

0.21

g/l

0.09

368

1487

Cytomegalovirus infection, IBD co-morbidity

206

639

3.95

58.01

5.0

2.3

0.22

g/l

0.05

192

599

Disorders of choroid and retina

4524

25035

1.31

57.91

2.3

2.2

0.20

0.21

g/l

13.49

4159

23222

Psoriasis

1587

10484

1.58

57.88

2.5

2.3

0.22

0.21

g/l

1.09

1485

9781

Preparatory care for dialysis

334

1346

2.87

57.76

2.7

2.3

0.23

0.21

g/l

4.03

322

1256

Umbilical hernia

1498

9786

1.60

57.49

2.8

2.3

0.21

g/l

0.19

1393

9125

Hyperlipidaemia, other/unspecified

2116

13600

1.48

57.42

2.1

2.2

0.21

g/l

4.40

1933

12615

Schizophrenia or delusion

1646

10951

1.56

57.40

2.2

2.3

0.22

g/l

0.05

1481

10212

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

422

1870

2.47

57.36

2.3

2.4

0.22

g/l

0.02

380

1750

Myalgia

1290

8139

1.65

57.32

2.5

2.2

0.22

g/l

5.37

1202

7602

Other joint disorders

4781

19636

1.31

57.23

2.4

0.22

g/l

4.18

4420

18329

Schizophrenia, schizotypal and delusional disorders

1651

11012

1.55

56.89

2.2

2.3

0.22

g/l

0.04

1486

10270

Polycystic ovarian syndrome, consortium definition

3618

16150

1.36

56.74

2.4

2.1

0.22

g/l

0.31

3374

15086

Acute sinusitis

2694

18158

1.41

56.59

2.6

2.3

0.22

g/l

0.02

2525

16944

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

196

594

3.87

56.18

1.7

2.0

0.20

0.21

g/l

1.15

175

552

Other congenital malformations of the digestive system

336

1360

2.79

56.12

6.5

2.9

0.21

g/l

0.53

324

1285

Fissure and fistula of anal and rectal regions

1254

7894

1.66

56.12

2.5

2.2

0.22

0.21

g/l

1.11

1174

7334

Benign neoplasm: Stomach

638

3352

2.08

56.10

2.7

2.1

0.22

0.21

g/l

1.29

591

3128

Other intervertebral disc disorders

4541

21292

1.31

56.00

2.2

2.3

0.22

0.21

g/l

9.64

4177

19829

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

293

1111

2.94

55.91

2.3

1.9

0.19

0.20

g/l

1.13

260

1000

Abscess of anal and rectal regions

500

2391

2.25

55.88

3.0

2.2

0.22

g/l

0.16

467

2232

Major coronary heart disease event excluding revascularizations

3419

17155

1.37

55.81

2.1

2.3

0.20

0.21

g/l

6.06

3124

15907

Family history of malignant neoplasm

618

3194

2.07

55.65

2.4

2.1

0.23

0.22

g/l

3.03

593

2997

Other viral diseases

1894

12926

1.50

55.62

3.1

2.5

0.22

g/l

0.34

1785

12090

Adalimumab

569

2864

2.14

55.62

3.2

2.3

0.23

0.22

g/l

3.04

544

2698

Need for other prophylactic measures

407

1813

2.51

55.57

2.9

2.4

0.22

g/l

0.04

386

1702

Ulcerative rectosigmoiditis

501

2409

2.25

55.54

2.7

2.2

0.23

0.22

g/l

4.06

468

2255

Psychotic depression

358

1491

2.60

55.48

2.5

2.4

0.22

0.21

g/l

0.43

327

1418

Cytomegaloviral disease

208

667

3.78

55.38

5.0

2.3

0.22

g/l

0.04

194

624

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

520

2552

2.23

55.26

2.4

2.1

0.19

0.21

g/l

2.70

475

2363

Assault by bodily force

447

2060

2.34

54.84

2.4

0.22

0.23

g/l

1.43

406

1923

Benign neoplasm: Duodenum

233

808

3.52

54.74

3.0

2.2

0.21

g/l

0.51

220

756

Viral infections characterized by skin and mucous membrane lesions

4684

31617

1.29

54.65

2.5

2.3

0.22

g/l

1.26

4381

29384

Pruritus

643

3400

2.03

54.40

2.7

2.2

0.21

g/l

0.09

591

3183

Benign neoplasm: Small intestine

318

1294

2.86

54.20

2.8

2.2

0.22

0.21

g/l

1.15

296

1205

Special screening examination for infectious and parasitic diseases

1108

4944

1.70

53.91

2.5

2.1

0.24

0.23

g/l

3.01

1022

4624

Dialysis

293

1143

2.93

53.74

3.2

2.5

0.23

0.22

g/l

2.26

288

1067

Heartburn

583

2985

2.07

53.66

2.4

2.0

0.22

g/l

0.51

544

2767

Other and unspecified mood [affective] disorders

382

1658

2.47

53.65

2.2

2.4

0.23

g/l

0.37

348

1571

Other diseases of arteries and capillaries

553

2802

2.14

53.41

2.4

2.2

0.20

0.21

g/l

0.74

502

2608

Other general symptoms and signs

321

1286

2.71

53.22

2.2

2.4

0.22

g/l

0.48

304

1222

Aortic aneurysm

1262

7916

1.64

53.19

2.1

2.2

0.20

g/l

0.45

1159

7290

Arthropathies

4931

19704

1.29

52.94

2.5

2.4

0.22

g/l

0.61

4578

18394

Calcific aortic valvular stenosis, operated

1639

10773

1.54

52.66

2.2

2.1

0.19

0.20

g/l

4.91

1503

9879

Calcific aortic valvular stenosis

1639

10773

1.54

52.66

2.2

2.1

0.19

0.20

g/l

4.91

1503

9879

Benign neoplasm: Transverse colon

678

3710

1.99

52.59

2.8

2.2

0.21

g/l

1.27

642

3454

Stomatitis and related lesions

1080

6691

1.70

52.27

2.6

2.4

0.22

0.21

g/l

0.60

993

6247

Cerebral palsy and other paralytic syndromes

671

3647

1.97

52.27

2.7

2.3

0.21

g/l

0.41

620

3405

Calcific aortic valvular stenosis, diagnosis (helper)

1634

10752

1.54

52.20

2.2

2.1

0.19

0.20

g/l

4.68

1498

9858

Operations 2 for CAVS

1634

10752

1.54

52.20

2.2

2.1

0.19

0.20

g/l

4.68

1498

9858

Congenital malformations, deformations and chromosomal abnormalities

3292

23039

1.35

52.18

2.6

2.4

0.22

g/l

0.67

3105

21516

Haemorrhage, not elsewhere classified

269

1015

2.99

52.17

2.7

2.1

0.20

0.21

g/l

1.54

242

946

Myocardial infarction

2759

14320

1.40

52.13

2.1

2.3

0.20

0.21

g/l

8.33

2512

13278

Disorders of magnesium metabolism

107

229

7.07

52.13

2.8

2.5

0.19

0.21

g/l

1.68

213

Type 1 diabetes, wide definition, subgroup 1

1029

6282

1.70

51.79

2.3

2.4

0.19

0.22

g/l

33.40

931

5869

Calcific aortic valvular stenosis, including rheumatic fever

1638

10792

1.53

51.74

2.2

2.1

0.19

0.20

g/l

4.58

1502

9894

Arthrosis

3964

16798

1.32

51.44

2.2

2.3

0.22

0.21

g/l

0.61

3682

15681

Amputation of thigh

229

804

3.29

51.31

2.2

2.1

0.17

0.19

g/l

5.00

202

735

Injuries to the ankle and foot

3659

25108

1.32

51.26

2.5

2.4

0.22

g/l

0.82

3366

23519

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

139

357

4.73

51.13

2.0

1.9

0.19

0.20

g/l

0.56

123

326

Fibromyalgia

524

2638

2.13

51.01

2.1

2.2

0.23

0.22

g/l

2.70

481

2485

Speech and linguistic disorders, excluding more controls

391

1638

2.38

50.75

3.6

3.1

0.22

g/l

0.46

363

1546

L04AC Interleukin inhibitors

374

1664

2.47

50.71

3.7

2.3

0.23

0.22

g/l

0.49

360

1565

Idiopathic gout

577

3037

2.06

50.29

2.2

0.21

0.20

g/l

0.89

535

2815

Follow-up examination after treatment for malignant neoplasms

607

3231

2.01

50.28

2.9

1.9

0.21

0.20

g/l

0.03

582

2990

Other/unspecified cytomegaloviral diseases

175

537

4.01

50.26

4.8

2.4

0.22

g/l

0.09

166

504

Diseases of the eye and adnexa

4362

17078

1.30

50.23

2.5

2.4

0.22

g/l

0.39

4051

15991

Cardiodefibrillation

2001

14201

1.46

50.21

2.1

2.3

0.20

g/l

3.77

1824

13128

Other congenital malformations of the digestive system

366

1618

2.51

49.98

6.1

2.8

0.21

g/l

0.24

349

1528

Ischaemic Stroke, excluding all haemorrhages

3159

17839

1.36

49.91

2.1

2.2

0.20

0.21

g/l

4.38

2872

16493

Intentional self-harm by sharp object

185

582

3.64

49.55

2.7

2.5

0.22

0.23

g/l

1.27

175

546

Spinal stenosis

2875

16361

1.37

49.51

2.0

2.2

0.21

g/l

0.90

2645

15176

Other and unspecified effects of external causes

1417

9448

1.56

49.08

2.3

2.4

0.22

g/l

0.15

1306

8839

Injuries to the elbow and forearm

3787

25973

1.31

49.07

2.4

2.3

0.21

0.22

g/l

6.30

3472

24209

COPD, hospital admissions 1, only main diagnosis

1901

11461

1.47

49.06

2.1

2.2

0.20

g/l

0.03

1740

10572

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

914

5347

1.75

48.84

3.1

2.7

0.21

0.22

g/l

0.57

874

5015

Vascular diseases of the intestine

278

1109

2.83

48.48

2.9

2.2

0.20

g/l

0.45

253

1027

All influenza (not pneumonia)

791

4599

1.81

48.44

2.7

2.4

0.22

g/l

0.01

745

4303

Nonischemic cardiomyopathy

602

3243

2.00

48.41

2.2

2.4

0.20

0.21

g/l

3.93

548

3027

Dilated cardiomyopathy

709

4029

1.89

48.21

2.2

2.3

0.20

0.21

g/l

3.13

648

3738

Pyothorax

308

1296

2.69

48.21

2.6

2.2

0.19

0.21

g/l

5.40

281

1205

Kela-code for severe mental illness

1854

13072

1.46

47.94

2.2

2.3

0.22

g/l

1.01

1670

12186

Diabetic maculopathy, excluding more controls

596

3205

1.98

47.72

2.2

0.20

0.21

g/l

6.09

543

2983

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

959

5724

1.71

47.65

3.0

2.7

0.21

0.22

g/l

0.58

915

5368

Neuromuscular dysfunction of bladder

547

2874

2.05

47.55

2.4

2.3

0.21

g/l

0.23

503

2692

Emotional disorders and disorders of social functioning with onset specific to childhood

299

1209

2.63

47.51

3.3

3.7

0.22

0.23

g/l

0.55

278

1138

Other viral diseases, not elsewhere classified

994

6175

1.68

46.87

3.4

2.5

0.21

0.22

g/l

0.77

945

5776

Benign neoplasm: Caecum

663

3736

1.92

46.78

2.5

2.2

0.22

0.21

g/l

3.85

623

3479

Paracetamol or NSAID medication

913

2689

1.76

46.78

2.4

3.0

0.22

0.21

g/l

2.67

852

2489

Amputation of ankle bones

186

616

3.60

46.76

2.6

2.3

0.19

0.21

g/l

2.19

171

559

DVT of lower extremities

1032

6502

1.66

46.67

2.3

2.1

0.21

g/l

1.32

953

6054

Arthropathies in other diseases classified elsewhere

263

1042

2.86

46.63

2.6

2.2

0.21

g/l

1.04

239

985

Sciatica+with lumbago

2724

18855

1.36

46.54

2.2

2.3

0.22

0.21

g/l

6.32

2520

17613

Glomerulonephritis

598

3261

1.97

46.49

2.5

2.4

0.22

0.21

g/l

2.39

562

3046

Clear cell adenocarcinoma of kidney

262

1032

2.82

46.42

1.8

2.0

0.21

0.20

g/l

0.88

249

934

Malignant neoplasm of other connective and soft tissue, including Hilmo

244

929

2.91

46.16

2.2

2.1

0.21

0.20

g/l

0.20

237

840

Sequelae of injuries, of poisoning and of other consequences of external causes

1250

8237

1.58

46.15

2.4

2.3

0.22

g/l

0.18

1161

7701

Other abnormalities of plasma proteins

151

448

4.22

45.98

2.7

2.1

0.19

0.21

g/l

3.09

136

419

Somatoform disorder

855

5156

1.74

45.88

2.3

2.2

0.23

0.22

g/l

3.75

771

4835

Malignant neoplasm of palate, including Hilmo

127

8.33

45.85

2.6

2.0

0.22

0.21

g/l

0.28

116

Other postsurgical states

410

1975

2.27

45.74

2.7

2.2

0.20

0.21

g/l

2.16

390

1849

Disorders resulting from impaired renal tubular function

269

1097

2.81

45.36

2.9

2.4

0.24

0.21

g/l

4.48

249

1025

Disorders of parathyroid gland

1163

7493

1.61

45.33

2.6

2.0

0.22

0.21

g/l

4.80

1086

6924

Barrett oesophagus

334

1497

2.49

45.14

2.6

2.0

0.21

g/l

0.27

312

1403

Visual disturbances and blindness

2759

20930

1.35

45.12

2.3

0.22

0.21

g/l

1.27

2554

19471

Procreative management

1710

9974

1.47

45.10

2.6

2.5

0.23

0.22

g/l

0.94

1630

9350

Other pulmonary heart/vessel disease

320

1411

2.54

44.97

2.6

2.2

0.19

0.20

g/l

4.14

300

1309

Other noninfective disorders of lymphatic vessels and lymph nodes

250

983

2.87

44.87

2.9

2.0

0.21

0.22

g/l

1.13

232

933

Non-allergic asthma (mode), excluding more controls

918

5594

1.69

44.86

2.4

2.2

0.22

g/l

0.50

864

5239

Agoraphobia

193

656

3.25

44.77

2.8

2.4

0.22

0.23

g/l

0.89

173

624

Valvular operations

775

4592

1.78

44.67

2.2

2.4

0.19

0.21

g/l

11.57

714

4305

Allergic asthma (mode), excluding more controls

1038

6427

1.63

44.66

2.2

2.3

0.23

g/l

2.38

975

6021

Malignant neoplasm of bronchus and lung, including Hilmo

925

4749

1.69

44.62

2.0

0.20

g/l

0.05

858

4261

Malignant melanoma, including Hilmo

758

4450

1.78

44.59

2.1

2.0

0.22

0.21

g/l

3.02

710

4020

Postmenopausal osteoporosis with pathological fracture

423

2096

2.24

44.44

2.2

1.9

0.19

0.20

g/l

2.99

377

1936

ILD-related respiratory insufficiency

254

1023

2.88

44.25

2.2

2.1

0.20

g/l

0.29

238

954

Alcohol abuse counselling and surveillance

148

441

4.07

44.24

3.9

2.4

0.19

0.23

g/l

6.33

140

411

Gonarthrosis [arthrosis of knee](FG)

4115

18970

1.29

43.95

2.1

2.3

0.21

g/l

0.44

3811

17644

Volvulus

201

717

3.21

43.70

2.9

2.0

0.20

0.21

g/l

1.19

188

663

Hypersplenism

10.33

43.60

4.3

2.5

0.19

0.22

g/l

1.58

Charcot foot

154

475

3.90

43.59

2.4

2.3

0.20

0.22

g/l

3.17

143

449

Diabetic nephropathy, excluding more controls

923

4731

1.71

43.56

2.3

2.4

0.21

0.22

g/l

2.37

848

4357

UC patients in KELA-register (code 208), prior to 1994

303

1326

2.57

43.43

3.8

2.1

0.23

0.22

g/l

3.13

282

1241

Polyuria

1191

7880

1.58

43.36

2.5

2.2

0.22

0.21

g/l

4.71

1095

7336

Abdominal aortic aneurysm (AAA)

554

2975

1.96

43.27

1.9

2.1

0.20

0.19

g/l

1.71

506

2698

Faecal incontinence

509

2690

2.02

43.24

2.2

1.8

0.21

g/l

0.25

455

2483

Superficial injury of lower leg

1294

8700

1.54

43.21

2.3

0.21

g/l

0.03

1187

8111

Secondary right heart disease

290

1249

2.61

43.07

2.5

2.1

0.19

0.20

g/l

3.66

271

1155

Mental and behavioural disorders due to cannabinoids

186

634

3.25

43.07

2.3

2.6

0.21

0.24

g/l

5.79

159

589

Irregular menses

2211

12832

1.39

42.94

2.6

2.2

0.23

0.22

g/l

2.44

2064

12038

Organic, including symptomatic, mental disorders

2760

14957

1.35

42.43

2.1

2.2

0.20

g/l

3.93

2447

13858

Chronic laryngitis and laryngotracheitis

800

4856

1.74

42.40

2.4

2.3

0.22

0.21

g/l

3.05

739

4530

Zoster [herpes zoster]

1017

6544

1.63

42.29

2.4

2.1

0.21

g/l

0.92

951

6080

Non-Hodgkin lymphoma, all

241

953

2.78

42.15

2.0

1.9

0.18

0.19

g/l

1.38

216

855

Enteropathic arthropathies

173

579

3.44

42.14

3.0

2.3

0.23

0.22

g/l

1.06

159

550

Sequelae of cerebrovascular disease

1922

12014

1.43

42.03

2.1

2.2

0.20

g/l

1.14

1724

11090

Non-small cell lung cancer, including Hilmo

665

3595

1.82

41.97

2.0

1.9

0.20

g/l

0.83

617

3233

Other diseases of upper respiratory tract

6137

26543

1.22

41.75

2.3

0.22

0.21

g/l

8.70

5701

24605

Leisure time condition

975

6225

1.64

41.72

2.5

2.3

0.20

0.21

g/l

4.01

883

5799

Myocardial infarction, without ST-elevation

2170

14650

1.39

41.68

2.0

2.2

0.20

g/l

2.83

1944

13487

Spondyloarthritis

906

5672

1.66

41.66

2.5

2.2

0.21

g/l

0.05

831

5253

Other headache syndromes

2147

15863

1.39

41.61

2.2

2.3

0.22

g/l

6.33

2007

14802

Nonorganic sleeping disorders

1015

6532

1.62

41.57

2.4

0.23

0.22

g/l

4.00

933

6101

Sequelae of other external causes

354

1673

2.32

41.57

2.5

2.2

0.21

g/l

1.38

336

1556

Vasculitis limited to skin, not elsewhere classified

203

752

3.13

41.56

2.6

2.2

0.20

0.21

g/l

0.41

191

705

Obsessive-compulsive disorder

324

1462

2.35

41.48

3.2

2.6

0.23

g/l

0.30

303

1380

Benign neoplasm: Ascending colon

809

4968

1.73

41.47

2.6

2.2

0.22

0.20

g/l

5.53

765

4606

Poisoning by narcotics and psychodysleptics [hallucinogens]

129

363

4.18

41.45

2.3

2.5

0.22

0.24

g/l

1.48

112

338

Disturbance of activity and attention

530

2797

1.94

41.41

2.8

3.1

0.23

g/l

0.08

487

2630

Malignant melanoma

630

3596

1.84

41.08

2.1

2.0

0.22

0.21

g/l

2.82

588

3253

Haemolytic anaemias

246

1005

2.77

41.05

3.3

2.4

0.21

g/l

0.32

230

938

Inflammatory diseases of female pelvic organs

2946

16692

1.33

40.94

2.4

2.1

0.22

g/l

1.31

2741

15618

Disorder of lipoprotein metabolism, unspecified

732

4396

1.76

40.38

2.1

2.2

0.21

0.20

g/l

3.26

666

4092

Other infectious diseases

526

2878

1.96

40.35

3.0

2.2

0.20

0.21

g/l

0.49

486

2672

Idiopathic pulmonary fibrosis

477

2540

2.04

40.32

2.0

2.1

0.21

0.20

g/l

2.69

449

2337

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2732

20412

1.33

40.29

2.3

0.22

0.21

g/l

6.96

2554

19038

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1760

12702

1.43

40.24

2.3

0.22

0.21

g/l

1.99

1668

11848

Postprocedural endocrine and metabolic disorders, not elsewhere classified

638

3688

1.82

40.14

2.4

2.2

0.22

g/l

1.34

608

3478

Social phobias

400

1983

2.13

40.10

2.4

2.5

0.23

g/l

0.46

362

1862

Disorders of psychological development

588

3060

1.87

40.09

3.4

3.1

0.22

g/l

0.73

544

2866

Intentional self-harm by unspecified means

108

275

4.70

40.08

3.4

2.7

0.22

0.24

g/l

0.77

256

Left hemicolectomy

190

697

3.22

40.01

2.7

2.2

0.20

g/l

0.54

174

649

Disorders of lacrimal system

2233

16708

1.37

39.78

2.3

2.2

0.22

0.21

g/l

2.85

2041

15580

Other disorders of lacrimal gland

1828

13303

1.42

39.77

2.4

2.2

0.22

0.21

g/l

3.19

1672

12425

Urticaria

1492

10473

1.47

39.75

2.5

2.4

0.22

g/l

1.12

1388

9794

Other disorders of bladder

659

3869

1.81

39.65

2.3

2.2

0.20

0.21

g/l

0.15

601

3610

Unspecified acute lower respiratory infection

803

4966

1.70

39.25

2.7

2.3

0.21

g/l

0.69

745

4619

Fitting and adjustment of other devices

1750

11395

1.43

39.23

2.3

2.1

0.20

0.21

g/l

7.27

1619

10484

Other immunodeficiencies

108

284

4.80

39.11

4.5

3.1

0.23

0.22

g/l

0.57

102

271

Allergic asthma (mode)

1038

6637

1.57

38.90

2.2

2.3

0.23

0.22

g/l

3.46

975

6221

Open wound of ankle and foot

572

3243

1.87

38.80

2.3

2.4

0.20

0.22

g/l

2.68

532

3038

Other arthrosis

2849

15254

1.32

38.67

2.2

2.3

0.22

0.21

g/l

3.40

2633

14230

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

539

3022

1.92

38.58

2.3

2.2

0.22

0.21

g/l

0.43

509

2839

Infections with a predominantly sexual mode of transmission

1358

9391

1.49

38.56

2.6

2.3

0.22

0.23

g/l

0.10

1261

8800

Osteonecrosis

393

1994

2.16

38.47

2.2

0.21

g/l

0.20

371

1868

Oesophageal obstruction

243

1017

2.69

38.44

2.4

1.9

0.20

0.21

g/l

1.64

229

938

Disturbances of skin sensation

1364

9482

1.49

38.38

2.3

0.23

0.22

g/l

13.43

1268

8844

Malignant neoplasm of gallbladder, including Hilmo

142

6.83

38.37

3.5

1.8

0.19

0.20

g/l

0.57

126

Statin medication

3572

15909

1.29

38.09

2.2

2.4

0.23

0.21

g/l

23.99

3323

14856

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

464

2494

2.01

37.96

2.9

2.2

0.21

g/l

0.01

434

2329

Cardiac arrest

352

1442

2.22

37.92

2.5

2.3

0.20

0.22

g/l

4.05

318

1354

Carcinoid syndrome

107

291

4.94

37.84

2.3

0.22

0.21

g/l

0.90

102

273

Degeneration of nervous system due to alcohol

185

691

3.18

37.82

3.0

2.3

0.18

0.21

g/l

5.38

158

637

Other infectious diseases

451

2402

2.02

37.78

3.1

2.2

0.20

0.21

g/l

0.39

414

2234

Emotional disorders starting during childhood or adolescence

275

1200

2.45

37.75

3.2

3.7

0.22

0.23

g/l

0.22

255

1126

Superficial injury of abdomen, lower back and pelvis

779

4827

1.69

37.66

2.3

0.22

g/l

0.47

699

4505

Malignant neoplasm, without specification of site

179

644

3.06

37.60

2.0

1.9

0.18

0.19

g/l

1.65

158

576

Other degenerative diseases of the nervous system

1462

7655

1.47

37.59

2.0

2.2

0.20

0.21

g/l

2.45

1288

7114

Superficial injury of hip and thigh

783

4867

1.69

37.44

2.2

0.20

0.21

g/l

4.66

705

4507

malignant neoplasm of male genital organs

1242

5102

1.53

37.41

2.1

0.21

g/l

0.58

1144

4608

Degeneration of the brain due to alcohol

185

696

3.15

37.31

3.0

2.3

0.18

0.21

g/l

5.13

158

642

Type 1 diabetes, wide definition

1052

6973

1.56

37.25

2.3

2.5

0.19

0.22

g/l

27.99

952

6520

Diffuse large B-cell lymphoma, helper endpoint

248

1057

2.57

37.11

2.3

2.0

0.19

0.20

g/l

1.56

227

955

Diffuse large B-cell lymphoma, including Hilmo

248

1057

2.57

37.11

2.3

2.0

0.19

0.20

g/l

1.56

227

955

Diffuse large B-cell lymphoma

248

1057

2.57

37.11

2.3

2.0

0.19

0.20

g/l

1.56

227

955

Fall on and from stairs and steps

1354

9475

1.48

37.08

2.5

2.3

0.21

g/l

0.44

1247

8800

Non-allergic asthma (mode)

919

5868

1.61

37.05

2.4

2.2

0.22

g/l

0.99

865

5478

Combinations of oral blood glucose lowering drugs

1473

10474

1.46

37.03

2.3

0.22

0.21

g/l

3.03

1380

9766

Injuries to unspecified part of trunk, limb or body region

576

3326

1.84

36.87

2.4

2.3

0.21

g/l

0.21

530

3098

Ulcerative proctitis

343

1673

2.21

36.71

3.0

2.2

0.24

0.22

g/l

5.34

320

1563

Oesophagitis

332

1607

2.25

36.64

2.4

2.0

0.20

0.21

g/l

1.40

305

1495

Colonic or urogenital fistula

1397

9861

1.47

36.47

2.6

2.3

0.22

0.21

g/l

0.58

1311

9192

Visual disturbances

2503

19310

1.33

36.47

2.3

0.22

0.21

g/l

1.57

2320

17983

Encephalopathy

105

287

4.71

36.38

5.1

2.2

0.16

0.21

g/l

9.46

267

Other and unspecified disorders of skin and subcutaneous tissue

381

1945

2.12

36.34

2.8

2.2

0.21

g/l

0.41

349

1815

Familial hypercholesterolemia

810

5121

1.66

36.32

2.2

0.20

g/l

0.27

755

4756

Follow-up care involving plastic surgery

243

1040

2.58

36.27

2.3

2.1

0.21

0.22

g/l

2.17

229

983

Rheumatism, unspecified

761

4745

1.69

36.26

2.1

0.22

0.21

g/l

2.17

713

4438

Spondylosis

2895

18497

1.30

36.21

2.1

2.3

0.22

0.21

g/l

4.88

2656

17225

Other and unspecified vasculitis limited to skin

179

668

3.10

36.15

2.6

2.3

0.20

0.21

g/l

0.59

169

622

Hyperkinetic disorders

558

3118

1.83

36.13

2.8

3.2

0.23

g/l

0.03

512

2929

Gonarthrosis

3480

15772

1.28

36.11

2.1

2.3

0.21

g/l

1.17

3223

14705

Other viral diseases, not elsewhere classified

1284

8879

1.48

35.97

3.1

2.5

0.22

g/l

0.34

1223

8309

Disorders of oesophagus in diseases classified elsewhere

166

599

3.25

35.90

3.3

1.9

0.19

0.21

g/l

2.49

152

557

Anosmia

237

4.33

35.87

2.3

1.9

0.22

g/l

0.14

226

Alcoholic gastritis

127

395

3.86

35.56

3.7

2.0

0.19

0.21

g/l

2.37

110

361

Drug-induced adrenocortical insufficiency

149

511

3.47

35.48

3.2

2.3

0.23

0.21

g/l

1.86

138

485

Malignant neoplasm of palate

14.49

35.16

2.6

2.2

0.22

g/l

0.02

L02BA Anti-estrogens

875

5681

1.61

35.05

1.6

2.1

0.22

g/l

2.70

838

5303

Other coagulation defects

414

2198

2.02

34.91

2.5

2.2

0.22

g/l

0.07

389

2054

Other neurological diseases

3846

24584

1.25

34.62

2.3

2.2

0.21

g/l

1.52

3573

22742

Psoriatic and enteropathic arthropathies

627

3766

1.75

34.52

2.5

2.3

0.22

g/l

0.29

585

3522

Coxarthrosis [arthrosis of hip](FG)

2932

16251

1.30

34.50

2.1

2.2

0.21

g/l

0.73

2728

15066

Acquired absence of limb

260

4.72

34.33

2.6

2.2

0.20

0.21

g/l

0.67

240

Coxarthrosis

2720

14021

1.31

34.07

2.2

2.3

0.21

g/l

0.57

2532

13046

Open wound of forearm

518

2969

1.85

33.92

2.6

2.3

0.21

0.22

g/l

0.79

479

2770

Other diseases of gallbladder

273

1264

2.37

33.84

2.7

1.8

0.22

0.21

g/l

0.41

258

1161

Nephrotic syndrome

222

954

2.63

33.42

2.6

2.8

0.23

0.21

g/l

2.95

209

899

Benign neoplasm of other and unspecified endocrine glands

721

4537

1.68

33.31

2.2

0.22

0.21

g/l

2.66

680

4241

Persons with potential health hazards related to communicable diseases

1707

12496

1.39

33.28

2.7

2.5

0.22

g/l

0.08

1598

11711

Diseases of salivary glands

1626

11953

1.40

33.27

2.4

2.2

0.22

0.21

g/l

2.15

1525

11128

Other and unspecified psoriasis

398

2127

2.02

33.24

2.7

2.2

0.21

g/l

0.58

372

1989

Ovarian cyst

1706

7178

1.40

33.17

2.2

2.1

0.22

g/l

3.77

1614

6662

Cerebral cysts

322

1596

2.17

33.13

3.6

2.4

0.20

0.22

g/l

3.07

299

1484

Sleep disorders

4509

26991

1.23

33.10

2.1

2.3

0.23

0.22

g/l

17.64

4182

25196

Sicca syndrome [Sjögren]

486

2764

1.88

33.08

2.4

2.1

0.21

g/l

0.13

453

2598

Other blood glucose lowering drugs, excl. Insulins

866

5690

1.59

32.92

2.4

2.2

0.20

g/l

0.46

800

5282

Localized swelling, mass and lump of skin and subcutaneous tissue

1622

11941

1.40

32.90

2.4

2.3

0.22

0.21

g/l

3.15

1545

11103

Malignant neoplasm of vulva, including Hilmo

102

288

4.22

32.88

2.1

1.8

0.22

0.20

g/l

1.84

269

Other and unspecified coagulation defects

286

1362

2.28

32.87

2.7

2.3

0.22

g/l

0.15

268

1278

Hypercalcemia

292

1415

2.30

32.83

3.0

2.2

0.20

0.21

g/l

1.78

270

1319

Emphysema

421

2297

1.96

32.78

2.1

2.2

0.20

g/l

0.08

385

2127

Other disorders of white blood cells

336

1707

2.15

32.75

2.4

2.2

0.21

g/l

0.88

306

1599

Pneumocystosis

156

577

3.23

32.68

2.6

2.3

0.23

0.21

g/l

1.58

142

538

Need for immunization against other single viral diseases

151

545

3.24

32.66

2.7

2.4

0.25

0.22

g/l

4.81

142

506

Diseases of the ear and mastoid process

6256

26677

1.19

32.62

2.4

2.3

0.22

g/l

3.23

5863

24780

Other dialysis

217

936

2.63

32.53

2.9

2.5

0.23

0.21

g/l

1.58

211

875

Traumatic subarachnoid haemorrhage

225

976

2.53

32.49

2.4

2.2

0.19

0.21

g/l

2.04

207

914

Other symptoms and signs involving general sensations and perceptions

255

1169

2.40

32.49

2.0

2.4

0.20

0.21

g/l

0.46

230

1093

Sulfasalazine

1375

9861

1.43

32.45

2.6

2.1

0.22

0.21

g/l

1.06

1264

9180

Personal history of other diseases and conditions

533

3102

1.79

32.10

3.1

2.5

0.22

g/l

0.11

498

2919

Malignant neoplasm of other and ill-defined sites, including Hilmo

105

306

3.94

31.87

2.6

1.9

0.19

0.20

g/l

0.97

275

Carcinoma in situ of endometrium

131

7.09

31.63

1.4

2.2

0.24

0.21

g/l

2.43

124

Lung cancer and mesothelioma

939

5379

1.55

31.62

2.1

0.20

0.21

g/l

2.32

872

4997

Malignant neoplasm of prostate

1177

4857

1.49

31.61

2.1

0.21

0.20

g/l

0.64

1080

4380

Disorders of continuity of bone

515

3011

1.81

31.49

2.4

2.3

0.22

g/l

0.35

472

2826

Other and unspecified injuries of head

397

2153

1.97

31.48

2.5

2.3

0.20

0.21

g/l

1.54

360

2005

Myocarditis

240

1077

2.38

31.41

2.1

2.3

0.22

0.23

g/l

1.03

225

1019

Shoulder lesions

4025

20042

1.24

31.34

2.2

2.3

0.22

0.21

g/l

5.94

3787

18632

Recurrent aphthous stomatitis , including avohilmo

742

4761

1.63

31.33

2.7

2.3

0.22

0.21

g/l

0.38

682

4463

Zoster [herpes zoster]

2557

19854

1.30

31.32

2.3

2.2

0.21

g/l

1.49

2395

18401

Asthma and allergy, excluding more controls

552

3226

1.75

31.21

2.4

2.5

0.24

0.23

g/l

1.84

515

3031

Drug-induced osteoporosis with pathological fracture

138

490

3.39

31.20

3.7

2.2

0.21

g/l

0.07

129

463

Injuries to the neck

1099

7635

1.49

31.18

2.2

2.3

0.22

g/l

0.50

1004

7123

Appendectomy

3208

24801

1.26

31.11

2.3

0.22

g/l

1.39

3007

23172

Other abnormal findings of blood chemistry

275

1322

2.27

31.09

2.4

2.2

0.21

g/l

0.59

254

1238

Excessive, frequent and irregular menstruation

1841

7512

1.37

31.08

2.5

2.2

0.22

g/l

1.66

1717

6969

Hypocalcemia

169

664

2.94

31.04

3.2

2.3

0.20

0.22

g/l

2.55

157

625

Drug-induced cataract

177

712

2.87

31.00

4.7

2.3

0.22

g/l

0.07

172

665

Infections with a predominantly sexual mode of transmission

1687

11702

1.37

30.84

2.5

2.4

0.23

g/l

0.09

1558

10984

Superficial injury of thorax

763

4943

1.61

30.75

2.4

2.3

0.21

g/l

1.18

696

4618

Carcinoma in situ of colon

164

644

3.04

30.74

2.5

2.2

0.22

0.21

g/l

1.91

151

603

Malignant neoplasm of vulva

197

4.95

30.55

2.2

1.9

0.22

0.20

g/l

1.87

184

Infection of intervertebral disc (pyogenic)

116

377

3.74

30.53

3.1

2.2

0.19

0.20

g/l

0.46

104

349

Maltreatment syndromes

268

1275

2.25

30.52

2.3

2.4

0.21

0.23

g/l

2.77

233

1197

Chronic sinusitis

2135

16494

1.32

30.51

2.4

2.3

0.22

0.21

g/l

7.33

1989

15391

Malignant neoplasm of other and unspecified female genital organs

109

338

3.80

30.49

1.7

1.9

0.19

0.20

g/l

0.56

100

318

Viral pneumonia (unknown virus, not influenza)

382

2067

1.98

30.47

2.6

2.3

0.22

g/l

0.20

355

1933

Sub-endpoint used in defining T1D endpoints

1433

10283

1.41

30.45

2.4

0.19

0.21

g/l

25.50

1299

9532

Folate deficiency anaemia

255

4.49

30.29

2.6

2.3

0.19

0.21

g/l

1.99

236

Malignant melanoma of skin, including Hilmo

590

3598

1.70

30.24

2.0

0.22

0.21

g/l

2.63

555

3262

Pericarditis

223

996

2.46

30.23

2.5

2.3

0.21

0.22

g/l

0.54

209

942

Tubulo-interstitial nephritis, not specified as acute or chronic

367

1961

1.99

30.23

2.4

2.1

0.20

0.21

g/l

1.80

333

1813

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

113

358

3.63

30.20

2.2

1.8

0.17

0.20

g/l

2.64

105

321

Wide developmental disorders, excluding more controls

155

568

2.89

30.16

2.7

4.1

0.23

g/l

0.20

140

544

Gingival hyperplasia

240

1115

2.40

30.03

4.2

2.8

0.22

0.21

g/l

1.93

228

1054

Malignant neoplasm of prostate, including Hilmo

1210

5035

1.47

30.01

2.2

2.1

0.21

0.20

g/l

1.02

1114

4538

Hidradenitis suppurativa

205

883

2.53

29.97

2.4

2.3

0.22

0.23

g/l

0.41

198

831

Dissocial personality disorder

117

382

3.54

29.91

2.1

2.6

0.21

0.23

g/l

1.15

100

354

Acute gastritis

408

2268

1.91

29.77

2.6

2.0

0.20

0.21

g/l

2.61

377

2104

Dissociative [conversion] disorders

197

833

2.55

29.75

2.4

2.2

0.23

0.22

g/l

0.59

177

789

Acquired haemolytic anaemia

172

695

2.82

29.67

3.6

2.2

0.21

g/l

0.13

162

647

Mixed connective tissue disease

361

1941

2.00

29.60

2.9

2.2

0.21

0.22

g/l

0.08

332

1820

Benign neoplasm: Adrenal gland

455

2632

1.86

29.54

2.1

2.2

0.22

0.21

g/l

2.70

427

2472

Other specified/unspecified systemic involvement of connective tissue

331

1731

2.06

29.51

2.8

2.2

0.21

0.22

g/l

0.09

307

1624

Malignant neoplasm of endocrine gland

313

1597

2.08

29.37

2.0

2.2

0.23

0.21

g/l

4.20

300

1455

Malignant neoplasm of mesothelium and soft tissue

199

853

2.53

29.35

2.2

2.0

0.20

g/l

0.13

188

768

Dermatitis due to substances taken internally

312

1602

2.10

29.22

3.1

2.4

0.21

g/l

0.25

283

1507

Hyperparathyroidism

964

6561

1.51

29.08

2.5

2.0

0.22

0.21

g/l

7.09

898

6056

Hypopituitarism

392

2174

1.92

28.93

2.8

2.7

0.23

0.22

g/l

0.75

371

2049

Asthma and allergy

552

3293

1.71

28.93

2.4

2.5

0.24

0.23

g/l

2.18

515

3091

Diseases of external ear

1701

12862

1.36

28.92

2.5

2.3

0.22

0.21

g/l

1.97

1568

11968

Pneumonia due to other infectious organisms, not elsewhere classified

206

910

2.50

28.77

2.8

2.3

0.22

0.21

g/l

0.18

191

856

Myocardial infarction, strict

2412

13530

1.30

28.72

2.1

2.3

0.20

0.21

g/l

3.97

2191

12534

Other follicular disorders

372

2032

1.94

28.64

2.5

2.2

0.22

g/l

0.22

357

1911

Thiazolidinediones

609

3820

1.68

28.64

2.7

2.2

0.20

0.21

g/l

0.13

570

3552

Non-follicular lymphoma

532

3235

1.75

28.52

2.2

0.19

0.21

g/l

4.50

493

3014

Varicose veins

3136

19236

1.25

28.51

2.2

2.1

0.20

0.21

g/l

14.21

2900

17882

Myelodysplastic syndrome, including Hilmo

162

644

2.77

28.27

2.1

1.9

0.18

0.19

g/l

1.19

139

570

Idiopathic thrombocytopenic purpura

195

850

2.56

28.26

3.9

2.3

0.20

0.21

g/l

1.32

189

798

Haemorrhoids and perianal venous thrombosis

1525

11364

1.37

27.97

2.2

2.1

0.21

g/l

1.82

1410

10520

Ulcer of oesophagus

375

2075

1.93

27.95

2.7

2.0

0.20

0.21

g/l

0.94

348

1928

Iron deficiency

139

512

2.96

27.94

2.9

2.6

0.22

0.23

g/l

0.50

131

480

Amiodarone users

556

3440

1.72

27.90

2.2

0.20

g/l

0.15

515

3197

Periapical abscess

2261

17830

1.30

27.86

2.3

2.4

0.22

g/l

0.10

2095

16673

Focal brain injury

346

1863

1.97

27.78

2.5

2.4

0.20

0.21

g/l

0.71

318

1730

Secondary thrombocytopenia

106

346

3.70

27.67

3.7

2.3

0.18

0.22

g/l

4.35

325

Other and unspecified urticaria

952

6599

1.49

27.51

2.5

2.3

0.22

g/l

0.63

889

6190

Fracture of foot, except ankle

1160

8326

1.43

27.46

2.5

2.4

0.22

g/l

0.09

1047

7788

Arterial embolism and thrombosis

318

1678

2.03

27.38

2.2

2.1

0.19

0.20

g/l

1.49

289

1545

Bronchiectasis

449

2640

1.82

27.37

2.6

2.2

0.20

0.21

g/l

0.67

424

2456

Burns and corrosions

688

4474

1.60

27.32

2.6

2.5

0.22

g/l

0.27

638

4188

Pyogenic arthritis

368

2037

1.92

27.29

2.3

0.20

0.21

g/l

0.88

336

1912

Congenital malformations of the circulatory system

739

4736

1.58

27.27

3.1

2.8

0.21

0.22

g/l

1.96

709

4454

Deforming dorsopathies

1408

10442

1.39

27.26

2.2

2.3

0.22

0.21

g/l

1.68

1307

9755

Other and unspecified aplastic anaemias

287

3.92

27.16

2.7

2.5

0.21

g/l

0.19

264

Diabetic nephropathy

926

6361

1.51

27.13

2.3

2.4

0.21

g/l

0.07

850

5860

Morphin

135

503

3.02

27.11

2.1

1.8

0.19

0.21

g/l

1.10

129

466

Acute suppurative otitis media

1111

7373

1.44

27.09

2.9

2.6

0.22

0.23

g/l

0.54

1043

6892

Disorders of breast

2291

16454

1.29

26.98

2.0

2.1

0.23

0.22

g/l

8.13

2150

15369

Fall on same level involving ice and snow

2887

23502

1.25

26.76

2.4

2.3

0.21

g/l

1.86

2652

21888

Status epilepticus

231

1103

2.29

26.69

2.8

2.4

0.20

0.21

g/l

0.66

217

1032

Malignant neoplasm of gallbladder

7.07

26.51

3.9

2.0

0.19

0.21

g/l

1.03

Polyarthrosis

1069

7072

1.45

26.47

2.1

0.21

g/l

0.05

979

6605

Infective dermatitis

577

3635

1.66

26.44

2.4

2.2

0.20

0.21

g/l

1.49

530

3388

Other aneurysm

307

1626

2.03

26.38

2.9

2.1

0.20

0.21

g/l

0.50

284

1506

Alcohol induced polyneuropathy

296

3.94

26.29

3.2

2.2

0.19

0.21

g/l

1.52

277

Unspecified urinary incontinence

485

2939

1.75

26.27

2.6

2.1

0.20

0.21

g/l

2.72

440

2746

Scar conditions and fibrosis of skin

229

1094

2.27

26.23

2.7

2.2

0.23

0.22

g/l

1.31

217

1031

Other specified/unspecified bacterial intestinal infections

370

2083

1.90

26.20

2.9

2.2

0.21

g/l

0.14

349

1949

Later onset COPD

1433

8516

1.38

26.19

2.0

2.1

0.19

0.20

g/l

2.82

1289

7812

Open wound of abdomen, lower back and pelvis

190

845

2.47

26.09

2.9

2.4

0.21

0.22

g/l

0.78

173

791

Hypoparathyroidism

229

1105

2.29

25.99

3.1

2.0

0.20

0.21

g/l

0.90

215

1035

therapeutic use

202

929

2.42

25.95

3.1

2.0

0.21

g/l

0.25

190

864

D07AA Corticosteroids, weak (group I)

739

4921

1.55

25.93

2.8

2.6

0.22

g/l

0.29

689

4613

Sulfonylureas

1744

10662

1.34

25.78

2.3

2.1

0.19

0.20

g/l

2.50

1602

9788

Vitamin D deficiency

121

438

3.12

25.68

3.3

2.3

0.20

0.22

g/l

3.47

113

406

Mixed disorders of conduct and emotions, excluding more controls

309

3.40

25.63

2.5

3.7

0.23

g/l

0.22

297

Diabetic neuropathy

672

4423

1.61

25.59

2.7

2.4

0.19

0.21

g/l

6.40

617

4080

Malignant neoplasm of parotid gland, including Hilmo

204

4.38

25.58

1.8

1.9

0.24

0.20

g/l

4.62

181

Insomnia

4342

26753

1.20

25.56

2.1

2.3

0.23

0.22

g/l

16.98

4037

24955

Coeliac disease

601

3852

1.63

25.54

3.1

2.2

0.21

0.22

g/l

1.77

554

3616

Mental retardation, excluding more controls

202

898

2.36

25.51

3.0

3.2

0.21

0.22

g/l

0.27

192

854

Postmenopausal bleeding

1445

5728

1.39

25.37

2.0

2.1

0.22

0.21

g/l

1.57

1355

5301

Tobacco use

293

1548

2.03

25.37

2.3

2.2

0.22

g/l

0.40

261

1450

Childhood asthma (age<16), excluding more controls

474

2220

1.72

25.34

2.9

2.7

0.23

0.24

g/l

0.63

449

2066

Injury of unspecified body region

418

2458

1.80

25.33

2.3

0.21

g/l

0.17

384

2295

Congenital malformations of the urinary system

321

1750

1.97

25.23

3.4

2.6

0.23

0.22

g/l

1.44

306

1647

Acute myeloid leukaemia and myelodysplastic syndromes

115

407

3.14

25.21

1.9

0.20

g/l

0.13

101

365

Acetic acid derivatives and related substances

1409

5397

1.38

25.04

2.2

2.4

0.21

0.20

g/l

5.14

1301

4979

Other mental disorders due to brain damage and dysfunction and to physical disease

606

3918

1.62

25.04

2.2

2.1

0.20

g/l

0.10

545

3648

Protozoal diseases

197

912

2.42

25.03

2.5

2.3

0.22

0.21

g/l

0.89

179

862

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

277

1407

2.05

25.02

3.5

3.7

0.22

g/l

0.54

259

1337

Congenital malformations of the urinary system

338

1877

1.92

25.01

3.3

2.6

0.22

g/l

1.29

321

1767

Chronic rhinitis, nasopharyngitis and pharyngitis

1552

11820

1.34

25.00

2.3

0.23

0.21

g/l

15.23

1436

11034

Malignant neoplasm of thyroid gland, including Hilmo

316

1710

1.94

24.90

1.9

2.2

0.23

0.21

g/l

3.86

305

1555

Childhood asthma (age<16)

475

2239

1.71

24.86

2.9

2.7

0.23

0.24

g/l

0.59

450

2084

Eosinophilic disease (BM)

106

364

3.33

24.86

2.1

2.2

0.21

0.22

g/l

0.45

341

Benign neoplasm: Descending colon

403

2369

1.82

24.81

2.8

2.2

0.21

g/l

0.97

385

2197

Burns and corrosions of external body surface, specified by site

543

3424

1.66

24.78

2.6

2.5

0.21

0.22

g/l

0.49

505

3204

Injury of intra-abdominal organs

160

677

2.62

24.75

2.9

2.4

0.21

0.22

g/l

0.38

153

639

Pneumonia derived septicemia

215

1030

2.29

24.73

3.2

2.5

0.20

0.21

g/l

1.69

192

954

Migraine

2277

14711

1.28

24.68

2.5

2.4

0.23

0.22

g/l

7.67

2135

13781

Personal history of certain other diseases

104

351

3.26

24.65

2.7

2.2

0.21

0.23

g/l

2.03

324

Fracture of forearm

2776

20776

1.25

24.56

2.3

0.21

0.22

g/l

6.28

2547

19351

Use of pramipexole

1125

8210

1.42

24.55

2.2

0.21

g/l

1.45

1030

7615

Lumbar disc prolapse

3213

20379

1.23

24.52

2.2

2.3

0.22

0.21

g/l

9.90

2965

19034

Other condition

707

4738

1.55

24.48

2.8

2.3

0.21

0.22

g/l

3.62

663

4433

Striking against or struck by other objects

1562

11932

1.34

24.43

2.5

0.22

g/l

0.72

1443

11130

Malignant neoplasm of bronchus and lung

715

3952

1.55

24.37

2.0

0.20

g/l

0.12

660

3541

Sequelae of injuries of head

289

1541

2.01

24.33

2.6

2.3

0.21

0.22

g/l

0.79

265

1435

Psoriasis (vulgaris), strict definition

199

930

2.34

24.32

3.2

2.3

0.22

g/l

0.33

188

875

Dermatophytosis

662

4389

1.58

24.31

2.3

0.21

g/l

0.78

605

4092

Atopic dermatitis, strict definition with reimbursement

1298

9329

1.37

24.11

2.8

2.5

0.22

g/l

0.21

1211

8755

Cystic fibrosis, other manifestations/unspecified

14.62

24.10

7.4

1.7

0.20

0.23

g/l

1.49

Other misadventures during surgical and medical care

160

690

2.61

24.04

2.7

2.3

0.20

0.21

g/l

1.68

149

649

Speech disturbances, not elsewhere classified

476

2937

1.71

24.03

2.4

2.1

0.21

g/l

0.08

429

2729

Carrier of infectious disease

153

644

2.64

23.97

2.5

2.3

0.20

0.22

g/l

1.35

142

613

Congenital malformations of heart and great arteries

649

4159

1.58

23.94

2.9

2.8

0.21

0.22

g/l

3.01

625

3912

Small fibre neuropathy

193

903

2.39

23.93

3.0

2.3

0.22

0.21

g/l

1.35

183

842

Carcinoma in situ of breast, intraductal

454

2776

1.74

23.92

1.9

2.2

0.23

0.21

g/l

9.17

435

2615

Pneumothorax

367

2116

1.84

23.82

2.3

2.2

0.21

g/l

0.15

340

1967

Erosion of teeth , including avohilmo

1118

8170

1.41

23.77

2.8

2.4

0.23

0.22

g/l

1.93

1042

7655

Shock, not elsewhere classified

215

4.12

23.72

4.1

2.1

0.18

0.21

g/l

1.92

203

Complications following infusion, transfusion and therapeutic injection

109

393

3.19

23.59

3.7

2.2

0.22

0.21

g/l

0.67

101

365

Rheumatoid arthritis

1596

11015

1.33

23.57

2.2

0.21

g/l

2.06

1472

10293

Urolithiasis

1590

12267

1.33

23.52

2.5

2.3

0.21

g/l

2.93

1469

11362

Blood alcohol or alcohol intoxication level

147

612

2.65

23.48

2.3

2.5

0.21

0.22

g/l

0.65

131

578

Monoamine oxidase A inhibitors

568

3668

1.61

23.35

2.2

2.3

0.22

0.21

g/l

0.77

522

3455

Disorders of porphyrin and bilirubin metabolism

288

3.63

23.35

3.4

2.6

0.24

0.22

g/l

1.19

271

Convalescence

271

1436

2.01

23.10

2.8

2.2

0.22

g/l

0.19

245

1356

Malignant neoplasm of retroperitoneum and peritoneum

155

4.80

23.03

2.0

0.20

0.21

g/l

0.45

138

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1660

12826

1.31

23.01

2.5

0.23

0.22

g/l

3.14

1545

12020

Cystic kidney disease

195

928

2.31

22.90

3.7

2.5

0.23

0.21

g/l

2.25

187

867

Cystic kidney disease

207

1009

2.25

22.81

3.6

2.4

0.23

0.21

g/l

2.21

198

944

Benign neoplasm of mouth and pharynx

562

3650

1.61

22.81

2.6

2.3

0.22

0.21

g/l

2.30

529

3404

Dermatophytosis

3005

24949

1.22

22.63

2.2

2.3

0.22

g/l

1.79

2772

23252

Diabetic retinopathy, excluding more controls

1443

6136

1.36

22.62

2.5

2.3

0.20

0.22

g/l

18.47

1326

5664

Systemic sclerosis (FG)

151

650

2.59

22.61

2.8

2.1

0.20

0.21

g/l

1.76

139

617

Generalized skin eruption due to drugs and medicaments

227

1149

2.14

22.47

3.3

2.3

0.21

g/l

0.65

205

1070

Disorders of tooth development and eruption

733

4038

1.51

22.41

2.7

2.2

0.22

g/l

2.44

691

3779

Malignant melanoma of skin

439

2688

1.70

22.38

2.0

0.22

0.21

g/l

2.71

410

2444

Event of undetermined intent

325

1841

1.87

22.38

2.5

2.4

0.21

0.22

g/l

1.56

295

1721

Thiamine deficiency

152

5.05

22.34

3.2

2.5

0.17

0.22

g/l

5.05

137

Non-small cell lung cancer

395

2333

1.74

22.28

1.9

0.20

g/l

0.14

365

2080

SLE (Finngen)

191

908

2.28

22.23

2.4

2.0

0.20

0.22

g/l

3.06

176

863

Other obstructive and reflux uropathy

222

1114

2.13

22.15

2.4

2.2

0.21

0.22

g/l

0.83

210

1037

Other diseases of blood and blood-forming organs

370

2191

1.79

22.02

2.5

2.2

0.22

0.21

g/l

0.25

337

2054

Acute generalized exanthematous pustulosis

252

1332

2.04

21.96

3.2

2.3

0.21

g/l

0.33

228

1242

Mental disorders, not otherwise specified

379

2248

1.76

21.95

2.2

2.3

0.23

0.22

g/l

1.99

352

2125

Other disorders of ear

4819

27225

1.17

21.94

2.3

0.21

g/l

0.51

4474

25294

Rash and other nonspecific skin eruption

497

3166

1.65

21.94

2.5

2.3

0.22

0.21

g/l

1.77

462

2960

Pain and other conditions associated with female genital organs and menstrual cycle

844

5463

1.46

21.89

2.4

2.2

0.23

0.22

g/l

3.40

786

5097

Symptoms and signs involving speech and voice

1616

12614

1.31

21.89

2.3

2.2

0.22

0.21

g/l

2.30

1490

11747

Methotrexate

671

4551

1.53

21.84

2.5

2.1

0.22

0.21

g/l

0.48

630

4233

Senility

204

3.89

21.82

1.7

1.9

0.18

0.19

g/l

0.31

188

Thyroiditis, ILD-related definition

538

3485

1.61

21.82

2.6

2.1

0.22

g/l

0.07

509

3267

Focal epilepsy

1029

7533

1.41

21.82

2.5

2.4

0.21

g/l

0.11

955

7010

Other disorders starting during childhood or adolescence

260

1370

1.99

21.77

3.6

3.9

0.22

g/l

0.01

244

1301

Pain associated with micturition

569

3738

1.59

21.76

2.3

2.2

0.22

0.21

g/l

0.95

518

3493

Thoracic aortic aneurysm

696

4772

1.52

21.75

2.1

2.3

0.21

g/l

0.11

642

4457

Malignant neoplasm of thyroid gland

274

1481

1.95

21.75

1.9

2.2

0.23

0.21

g/l

3.40

266

1349

Calculus of kidney and ureter

1464

11299

1.33

21.68

2.5

2.3

0.22

0.21

g/l

3.29

1356

10482

Menorrhagia

1606

6870

1.32

21.65

2.3

2.1

0.22

0.21

g/l

1.10

1506

6374

Subjective visual disturbances

1219

9175

1.37

21.62

2.2

0.22

0.21

g/l

1.72

1129

8544

Abnormal findings on examination of urine, without diagnosis

249

1319

2.04

21.59

2.3

2.5

0.22

0.21

g/l

1.32

232

1234

Other female pelvic inflammatory diseases

752

5231

1.49

21.57

2.3

2.1

0.21

0.22

g/l

0.29

699

4911

Late syphilis

118

466

2.91

21.57

2.5

2.1

0.20

0.22

g/l

1.40

104

433

Coxibs

1383

5490

1.35

21.48

2.1

2.4

0.22

0.21

g/l

6.30

1275

5064

Disorders of muscles

507

3255

1.63

21.48

2.4

2.3

0.22

0.21

g/l

0.38

471

3041

Diffuse brain injury

186

884

2.24

21.40

2.5

0.22

g/l

0.18

171

834

Abnormal findings in nipple discharge synovial fluid wound secretions

107

403

3.04

21.37

3.4

2.2

0.22

g/l

0.03

377

Other abnormal uterine and vaginal bleeding

1108

5857

1.39

21.26

2.1

0.21

g/l

0.52

1016

5418

Pneumococcal septicemia

201

997

2.20

21.16

3.2

2.6

0.20

0.21

g/l

1.93

180

928

Soft tissue disorders related to use, overuse and pressure

1344

10288

1.34

21.12

2.1

2.2

0.22

0.21

g/l

6.32

1252

9595

Other ill-defined and unspecified causes of mortality

406

2489

1.72

21.11

2.3

2.1

0.18

0.20

g/l

5.40

369

2290

Other surgical follow-up care

175

819

2.30

21.09

2.6

2.2

0.21

0.22

g/l

0.48

168

763

Other disorders involving the immune mechanism, not elsewhere classified

191

932

2.25

21.08

2.7

0.22

g/l

0.04

183

874

Discitis, unspecified

118

471

2.86

21.06

2.3

2.1

0.18

0.21

g/l

2.07

108

441

Internal derangement of knee

1809

14295

1.28

21.03

2.4

2.3

0.22

0.21

g/l

2.11

1660

13338

Heart failure and hypertrophic cardiomyopathy

131

552

2.72

21.00

2.5

2.3

0.19

0.21

g/l

1.78

121

515

Adverse effects, not elsewhere classified

910

6574

1.43

20.94

2.4

0.22

g/l

0.79

855

6163

Autism spe, excluding more controls

105

388

2.89

20.88

2.9

3.5

0.24

g/l

0.30

371

Paraplegia, diplegia of upper limbs

147

651

2.53

20.81

2.6

2.3

0.19

0.21

g/l

1.84

133

606

Nail disorders

415

2565

1.70

20.77

2.2

2.4

0.23

0.22

g/l

1.57

392

2400

Left ventricular outflow tract obstruction (LVOTO), broad definition

516

3360

1.61

20.76

2.9

2.6

0.21

0.22

g/l

3.76

482

3160

Deficiency of other B group vitamins

128

531

2.67

20.74

3.0

2.1

0.19

0.21

g/l

1.88

122

489

Otitis externa

1055

7823

1.39

20.69

2.4

0.22

0.21

g/l

0.81

978

7302

Polycythaemia vera

163

749

2.35

20.58

2.0

0.20

g/l

0.19

152

670

Laparoscopic left hemicolectomy

126

527

2.75

20.58

2.6

2.3

0.22

0.21

g/l

0.67

119

492

Hypertrophy of breast in women and men

895

6476

1.42

20.42

2.3

2.2

0.23

0.22

g/l

4.20

833

6082

Lesion of lateral popliteal nerve

268

1480

1.94

20.34

2.6

2.2

0.21

g/l

0.44

247

1378

Late syphilis

102

387

3.07

20.31

2.4

2.2

0.20

0.21

g/l

0.90

357

Arthropathy in ulcerative colitis

346

3.16

20.28

2.7

2.5

0.23

g/l

0.16

330

Fistulae involving female genital tract

113

449

2.85

20.27

2.6

2.2

0.21

g/l

0.21

102

423

Rare circulating lymphoid malignancy, including Hilmo

156

712

2.38

20.13

2.5

2.7

0.20

g/l

0.08

143

649

Somnolence, stupor and coma

232

1226

2.02

20.10

2.7

2.3

0.20

0.21

g/l

1.60

202

1132

Bullous disorders

316

1841

1.83

20.07

2.4

2.2

0.21

g/l

0.28

294

1723

Corns and callosities

348

2078

1.77

20.06

2.2

2.1

0.20

0.21

g/l

2.36

331

1949

Degeneration of macula and posterior pole

2405

15733

1.24

20.03

2.2

2.1

0.20

g/l

0.96

2181

14502

Other necrotizing vasculopathies (FG)

317

1848

1.82

19.98

2.4

2.2

0.23

0.21

g/l

2.81

294

1728

Other and unspecified abdominal hernia

229

1212

2.04

19.95

2.8

2.1

0.21

g/l

0.04

219

1130

Colorectal neuroendocrine tumor and carcinoma

281

3.33

19.91

2.2

1.8

0.23

0.21

g/l

2.07

258

Chronic tubulo-interstitial nephritis

204

1037

2.11

19.82

2.3

2.0

0.21

g/l

0.09

183

968

Metabolic disorder, other/unspecified

6.92

19.78

4.9

3.5

0.20

0.22

g/l

0.66

Polymyalgia rheumatica

672

4666

1.50

19.75

2.0

0.21

0.20

g/l

1.33

618

4311

Ill-defined and unknown causes of mortality

438

2780

1.66

19.74

2.3

2.1

0.18

0.20

g/l

5.14

397

2553

Corticotropin deficiency

208

3.93

19.74

3.0

2.7

0.22

g/l

0.07

197

Acute pharyngitis

659

4500

1.49

19.68

3.1

2.6

0.23

g/l

0.43

625

4195

Sarcoidosis

653

4510

1.51

19.66

2.6

2.2

0.22

0.21

g/l

1.33

611

4216

Abscess of lung

110

439

2.85

19.65

2.6

2.4

0.20

0.21

g/l

0.90

407

Superficial injury of wrist and hand

917

6701

1.41

19.64

2.4

2.5

0.22

g/l

0.32

848

6288

Speech and linguistic disorders

410

2449

1.67

19.59

3.8

3.2

0.22

g/l

0.87

382

2299

Suppurative and unspecified otitis media

1525

10580

1.30

19.51

2.7

2.5

0.22

g/l

0.53

1429

9880

Angina pectoris

2890

16113

1.22

19.49

2.0

2.3

0.21

g/l

0.34

2660

14955

Polycystic kidney disease

160

753

2.34

19.44

3.6

2.4

0.23

0.22

g/l

1.52

154

704

Spondylopathies (FG)

624

4269

1.51

19.44

2.4

2.3

0.22

g/l

0.58

574

4001

Disorders of conjunctiva

4096

28343

1.17

19.44

2.3

0.22

g/l

4.44

3787

26446

Manic episode

160

748

2.30

19.39

2.3

2.2

0.23

0.22

g/l

0.29

146

710

Other and unspecified disorders of white blood cells

231

1240

2.01

19.36

2.6

2.3

0.20

0.21

g/l

1.02

207

1166

Other skin changes

896

6560

1.41

19.26

2.7

2.2

0.21

g/l

2.19

830

6094

Artrosis, including avohilmo

4325

20421

1.17

19.21

2.1

2.3

0.22

0.21

g/l

0.50

4018

18994

Primary adrenocortical insufficiency

273

3.39

19.20

2.5

0.22

0.23

g/l

0.55

255

Anorexia

366

2.98

19.18

3.1

2.6

0.21

0.22

g/l

0.42

344

Systemic sclerosis

151

700

2.39

19.11

2.8

2.0

0.20

0.22

g/l

2.08

139

664

Oter anti-inflammatory and antirheumatic agents, non-steroids

1124

4631

1.37

19.08

2.2

2.3

0.21

0.20

g/l

3.76

1031

4269

Inflammatory diseases of the central nervous system

413

2606

1.66

19.04

2.6

2.3

0.22

g/l

0.02

385

2442

Schizoaffective disorder

356

2162

1.72

19.03

2.0

2.3

0.23

0.22

g/l

0.73

319

2038

Other symptoms and signs involving the nervous and musculoskeletal systems

1983

16105

1.25

18.97

2.2

2.3

0.22

0.21

g/l

1.61

1836

14993

Car occupant injured in other and unspecified transport accidents

832

6020

1.42

18.95

2.4

2.3

0.22

g/l

0.11

771

5612

Papillary adenocarcinoma of thyroid gland

214

1119

2.02

18.93

1.9

2.1

0.23

0.21

g/l

3.62

207

1018

Systemic sclerosis, icd10

150

697

2.38

18.90

2.8

2.1

0.20

0.22

g/l

2.18

138

661

Other and unspecified tonsillitis

1421

9303

1.31

18.82

2.8

2.5

0.23

g/l

0.21

1333

8698

Personal history of risk-factors, not elsewhere classified

324

3.09

18.80

2.6

2.7

0.22

g/l

0.35

303

Sequelae of injuries of neck and trunk

172

842

2.22

18.76

2.6

2.3

0.21

0.22

g/l

0.59

161

789

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

683

4784

1.47

18.69

2.4

2.2

0.23

0.22

g/l

0.93

637

4483

Arthropathy in Crohn disease

252

3.46

18.52

3.6

2.5

0.24

0.23

g/l

0.66

236

Lichen simplex chronicus and prurigo

326

1956

1.76

18.51

2.4

2.1

0.21

g/l

0.41

298

1834

Other noninflammatory disorders of vulva and perineum

427

2728

1.63

18.46

2.2

0.22

0.21

g/l

0.53

389

2535

Focal epilepsy, strict definition

940

6973

1.39

18.46

2.5

2.4

0.21

g/l

0.11

868

6480

Injury of other and unspecified intrathoracic organs

328

1972

1.76

18.44

2.5

2.2

0.20

0.21

g/l

1.65

302

1844

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

265

1492

1.85

18.37

2.3

2.1

0.22

0.23

g/l

0.81

247

1410

Other disorders of the musculoskeletal system and connective tissue

715

5087

1.46

18.33

2.0

2.2

0.22

0.21

g/l

0.84

657

4748

Conjunctivitis

3652

26198

1.18

18.28

2.3

0.22

g/l

4.34

3376

24469

Migraine without aura

812

5878

1.41

18.26

2.7

2.5

0.23

0.22

g/l

1.46

766

5553

Other epidermal thickening

238

1312

1.94

18.26

2.9

2.3

0.21

g/l

0.31

216

1226

Thyrotoxicosis, other and/or unspecified

930

6903

1.38

18.17

2.2

0.21

g/l

0.06

873

6455

Hypertrophy of breast

763

5486

1.43

18.16

2.0

2.2

0.23

0.22

g/l

4.67

708

5170

Fracture of neck

315

1887

1.77

18.07

1.9

2.2

0.20

0.21

g/l

0.64

289

1754

Abnormal involuntary movements

646

4524

1.48

18.05

2.4

2.3

0.22

0.21

g/l

4.88

603

4228

Chronic lymphocytic leukaemia

138

627

2.38

18.03

1.8

1.9

0.19

g/l

0.14

125

559

Chronic lymphocytic leukaemia, helper endpoint

138

627

2.38

18.03

1.8

1.9

0.19

g/l

0.14

125

559

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

138

627

2.38

18.03

1.8

1.9

0.19

g/l

0.14

125

559

Visual impairment including blindness (binocular or monocular)

356

2199

1.71

18.02

2.3

2.2

0.20

0.21

g/l

0.13

328

2040

Symptoms and signs involving emotional state

158

758

2.24

17.98

2.3

2.5

0.23

0.22

g/l

1.10

145

715

1440

9880

1.30

17.95

2.1

2.0

0.20

g/l

0.71

1305

9074

Congenital malformations of cardiac septa

352

2102

1.71

17.85

3.0

3.1

0.21

0.22

g/l

1.46

344

1992

Diseases of tongue

310

1851

1.76

17.82

2.3

2.1

0.22

0.21

g/l

2.15

293

1730

Migraine with aura

1026

7733

1.35

17.80

2.4

0.23

0.22

g/l

3.45

967

7267

Intracranial and intraspinal abscess and granuloma

326

3.10

17.79

2.9

2.5

0.19

0.21

g/l

1.61

304

Syphilis

152

726

2.29

17.77

2.4

2.3

0.20

0.22

g/l

1.45

136

675

Syphilis

152

726

2.29

17.77

2.4

2.3

0.20

0.22

g/l

1.45

136

675

Herpesviral [herpes simplex] infections

548

3732

1.52

17.71

2.8

2.2

0.21

0.22

g/l

0.85

506

3488

Malignant neoplasm of parotid gland

151

4.17

17.70

1.9

2.0

0.24

0.21

g/l

3.43

133

Other peripheral vascular diseases

387

2449

1.65

17.62

2.3

2.2

0.21

g/l

0.03

361

2297

Foreign body in alimentary tract

289

1703

1.80

17.62

2.7

2.4

0.21

g/l

0.43

261

1578

Disorders of sclera, cornea, iris and ciliary body

2615

21978

1.21

17.61

2.3

0.22

g/l

0.10

2456

20477

Benign neoplasm: Oesophagus

341

3.03

17.44

2.8

2.4

0.21

g/l

0.08

321

Scoliosis

403

2579

1.63

17.38

2.4

2.5

0.22

0.21

g/l

0.80

374

2414

Hyperosmolality and hypernatraemia

381

2.86

17.35

1.9

2.2

0.20

g/l

0.08

352

Moderate visual impairment, binocular

169

847

2.16

17.27

2.3

2.1

0.20

g/l

0.21

155

779

Asthma and opportunity respiratory infection

259

1494

1.86

17.25

2.7

2.1

0.21

g/l

0.18

246

1395

Noninflammatory disorders of female genital tract

1882

7618

1.26

17.20

2.4

2.2

0.22

g/l

2.48

1768

7070

Other maltreatment syndromes

159

778

2.19

17.19

2.7

2.4

0.22

0.23

g/l

1.02

144

732

Other necrotizing vasculopathies

373

2362

1.67

17.19

2.4

2.1

0.23

0.21

g/l

3.74

347

2200

Systemic lupus erythematosus

191

1002

2.05

17.12

2.4

2.2

0.20

0.22

g/l

2.62

176

944

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, including Hilmo

8.87

17.09

2.8

1.5

0.21

0.22

g/l

0.30

Systemic disorders of connective tissue in diseases classified elsewhere

5.71

17.08

5.3

2.0

0.23

0.21

g/l

0.58

Unspecified event, undetermined intent

146

698

2.28

16.98

2.8

2.5

0.22

g/l

0.18

130

651

Early complications of trauma

228

1268

1.92

16.98

2.3

0.21

0.22

g/l

0.80

201

1177

!Aliquae complicationes praecoces traumatis

228

1268

1.92

16.98

2.3

0.21

0.22

g/l

0.80

201

1177

Atrophic disorders of skin

681

4869

1.45

16.92

2.5

2.2

0.22

g/l

1.50

632

4552

Diplopia

631

4458

1.47

16.86

2.3

0.22

0.21

g/l

1.52

578

4160

Acne

394

2513

1.61

16.85

2.4

2.8

0.23

g/l

0.65

366

2350

Injuries to the wrist and hand

5061

30946

1.14

16.80

2.3

2.4

0.22

g/l

3.43

4684

28830

Malignant neoplasm of renal pelvis, including Hilmo

238

3.31

16.74

1.6

1.8

0.21

0.19

g/l

1.12

208

CR(E)ST syndrome

104

437

2.69

16.72

3.0

2.1

0.20

0.22

g/l

1.94

418

Special screening examination for other diseases and disorders

477

3185

1.54

16.70

2.2

2.0

0.22

0.21

g/l

0.27

445

2961

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

169

861

2.14

16.65

2.8

2.7

0.22

g/l

0.13

161

806

Isolated proteinuria

161

806

2.17

16.61

2.3

2.5

0.23

0.21

g/l

1.13

150

757

Mixed hyperlipidaemia

214

1177

1.94

16.56

1.9

2.2

0.22

0.21

g/l

1.49

193

1103

Migraine with aura and triptan purchases

640

4531

1.45

16.56

2.4

0.23

0.22

g/l

1.32

601

4268

Focal epilepsy, mode (most common among epilepsy diagnosis)

879

6568

1.38

16.51

2.5

2.4

0.21

g/l

0.19

820

6106

Other symptoms and signs involving the circulatory and respiratory systems

322

1980

1.70

16.49

2.4

2.3

0.21

g/l

0.00

297

1865

Allergic urticaria

380

2432

1.63

16.45

2.5

2.4

0.22

g/l

0.30

350

2283

Complications of other internal prosthetic devices, implants and grafts

208

1136

1.95

16.42

2.5

2.1

0.20

g/l

0.19

191

1054

Gonarthrosis,primary

4630

25060

1.15

16.40

2.1

2.3

0.21

g/l

0.43

4291

23248

Erythema intertrigo

139

663

2.30

16.39

2.6

2.2

0.21

g/l

0.07

125

613

Eosinophilia

107

461

2.61

16.27

2.0

2.4

0.21

g/l

0.18

100

432

Open wound of shoulder and upper arm

118

528

2.45

16.19

2.2

2.6

0.21

0.22

g/l

0.97

111

491

Seborrhoeic dermatitis

450

3003

1.56

16.17

2.9

2.3

0.22

0.21

g/l

0.47

415

2794

Congenital malformations of the musculoskeletal system, not elsewhere classified

385

2.70

16.14

4.0

2.7

0.22

0.23

g/l

0.96

366

Alzheimer’s disease (Atypical or mixed), excluding more controls

384

1952

1.62

16.11

1.6

2.0

0.19

g/l

0.00

332

1795

Atopic dermatitis, strict definition

1224

9381

1.30

16.09

2.8

2.6

0.22

g/l

0.16

1144

8799

Malignant neoplasm of adrenal gland, including Hilmo

152

4.01

16.06

2.4

2.5

0.22

0.20

g/l

0.49

140

Other disorders of eye and adnexa

646

4619

1.44

16.04

2.5

2.3

0.22

g/l

0.89

608

4326

Single spontaneous delivery

1315

8813

0.78

16.02

2.0

2.2

0.21

g/l

0.04

1234

8146

Other and unspecified types of non-Hodgkin lymphoma, hilmo

227

1288

1.89

16.00

2.3

2.2

0.20

0.21

g/l

0.56

208

1192

Other hearing loss

1340

10403

1.29

15.98

2.2

2.1

0.20

g/l

0.02

1215

9564

Non-small cell lung cancer, adenocarcinoma

243

1397

1.82

15.92

2.0

1.9

0.20

g/l

0.25

223

1258

Marginal zone B-cell lymphoma, including Hilmo

354

2.79

15.85

1.9

1.8

0.19

0.21

g/l

0.96

317

Follicular cysts of skin and subcutaneous tissue

839

6271

1.38

15.79

2.4

2.3

0.22

0.21

g/l

1.25

787

5843

Certain conditions originating in the perinatal period

377

2145

1.62

15.78

3.8

3.5

0.22

g/l

1.40

353

2011

Open wound of hip and thigh

171

888

2.06

15.74

2.4

2.6

0.20

0.22

g/l

2.96

158

833

Drug-induced osteoporosis

365

2.83

15.74

3.6

2.1

0.21

0.22

g/l

0.43

343

Arterial embolism and thrombosis of lower extremity artery

186

994

2.00

15.72

2.0

2.1

0.18

0.20

g/l

2.76

170

917

Viral pneumonia (known virus, not influenza)

156

790

2.16

15.71

3.3

2.7

0.20

0.21

g/l

0.57

145

737

Cervicalgia

969

7397

1.34

15.68

2.1

2.2

0.22

0.21

g/l

4.52

897

6899

Carcinoma in situ of oral cavity, oesophagus and stomach

152

4.15

15.64

2.8

2.5

0.21

0.20

g/l

0.06

136

147

731

2.21

15.63

2.5

2.1

0.20

g/l

0.41

137

675

Any dementia, excluding more controls

1649

9192

1.26

15.61

1.7

2.1

0.20

g/l

0.83

1439

8520

Acute and transient psychotic disorders

520

3592

1.50

15.61

2.1

2.3

0.22

g/l

0.60

473

3380

Other disorders of nervous system

342

2172

1.66

15.59

2.4

2.2

0.21

g/l

0.99

320

2033

Presence of other devices

1081

8344

1.32

15.59

2.4

2.0

0.21

0.20

g/l

0.72

1022

7678

Systemic lupus erythematosus, unspecified

158

804

2.12

15.54

2.3

2.2

0.20

0.22

g/l

3.00

144

764

Motor neuron disease (with DMD)

111

492

2.46

15.53

1.8

2.5

0.23

0.21

g/l

1.99

106

467

Redundant prepuce, phimosis and paraphimosis

926

6960

1.35

15.50

2.4

2.6

0.21

0.22

g/l

0.83

865

6455

Acute laryngitis and tracheitis

489

3277

1.51

15.49

3.0

2.6

0.22

0.23

g/l

0.35

459

3049

Insulin, fast-acting (human)

594

4204

1.45

15.47

2.2

0.19

0.22

g/l

22.33

537

3922

Multiple myeloma, including Hilmo

187

1003

1.97

15.46

2.4

2.0

0.20

g/l

0.05

176

899

Achalasia of cardia

108

476

2.50

15.44

2.2

1.9

0.20

0.21

g/l

0.97

103

445

Hypertrophic cardiomyopathy

230

1325

1.86

15.43

2.3

0.20

0.21

g/l

0.72

212

1234

Superficial injury of ankle and foot

525

3639

1.49

15.42

2.4

2.5

0.23

0.22

g/l

1.66

482

3429

Reactive arthropathies

411

2718

1.57

15.39

2.6

2.3

0.22

0.21

g/l

0.42

375

2548

Injuries involving multiple body regions

193

1052

1.95

15.34

2.3

0.21

0.22

g/l

0.52

174

979

Vitreous haemorrhage

488

3352

1.52

15.30

2.4

2.2

0.20

0.21

g/l

1.01

453

3121

Rotator cuff syndrome

3054

18813

1.18

15.29

2.2

2.3

0.22

0.21

g/l

5.01

2853

17487

Aortic valve malfunction, age under 60 years

453

3071

1.54

15.20

2.8

2.5

0.21

0.22

g/l

3.09

424

2882

Prurigo nodularis

144

718

2.19

15.15

2.4

2.1

0.20

0.21

g/l

0.90

128

677

Bacterial, viral and other infectious agents

415

2762

1.56

15.09

3.0

2.5

0.22

g/l

0.91

389

2595

Cyst of kidney

366

2383

1.62

15.05

2.2

2.1

0.22

0.21

g/l

2.00

334

2218

Gastrojejunal ulcer

317

2.87

15.03

3.3

2.1

0.19

0.21

g/l

1.82

294

SLE, ICD10

179

961

2.00

15.03

2.3

2.2

0.20

0.22

g/l

2.07

164

910

SLE, strict definition

179

961

2.00

15.03

2.3

2.2

0.20

0.22

g/l

2.07

164

910

Inflammatory disease of uterus

561

3960

1.46

14.87

2.3

2.1

0.23

0.22

g/l

1.14

525

3727

Specific development disorders of scholastic skills

198

1079

1.90

14.85

3.6

3.7

0.22

0.23

g/l

1.30

185

1022

Other or ill-defined heart diseases

250

1479

1.77

14.83

2.4

2.3

0.21

0.22

g/l

1.26

230

1392

Post-traumatic wound infection, not elsewhere classified

147

742

2.14

14.83

2.4

2.5

0.21

0.22

g/l

0.62

127

694

Cardiomyopathy, Hypertrophic obstructive

111

505

2.42

14.76

2.3

2.4

0.20

0.21

g/l

1.53

101

482

Single delivery by forceps and vacuum extractor

282

2741

0.60

14.67

2.1

2.4

0.24

0.23

g/l

1.46

266

2562

Other and unspecified diseases of blood and blood-forming organs

152

782

2.12

14.66

3.1

2.3

0.21

g/l

0.20

137

732

Bacterial, viral and other infectious agents

389

2571

1.57

14.65

3.1

2.5

0.22

g/l

1.15

364

2412

Intrahepatic Cholestasis of Pregnancy (ICP)

265

1595

1.72

14.61

2.3

2.2

0.22

0.23

g/l

0.47

247

1515

Disorders of ocular muscles, binocular movement, accommodation and refraction

2129

17720

1.21

14.54

2.5

2.4

0.22

g/l

0.11

1988

16559

1013

7395

1.32

14.47

2.1

2.0

0.19

0.20

g/l

0.91

911

6781

Other other unspecified disorders of the circulatory system

204

1157

1.89

14.46

2.9

2.3

0.21

g/l

0.02

187

1078

Lactose intolerance

152

781

2.07

14.41

2.6

2.4

0.24

0.22

g/l

2.79

138

738

Ovarian dysfunction

267

1614

1.71

14.40

2.2

2.1

0.24

0.23

g/l

1.18

251

1518

Myositis

144

730

2.13

14.38

2.7

2.2

0.22

0.21

g/l

0.43

133

676

Other diseases of spinal cord

165

878

2.02

14.30

2.3

0.20

0.21

g/l

1.48

156

820

Fall involving bed

177

965

1.98

14.28

2.2

0.18

0.20

g/l

2.27

165

895

Toxic effects of substances chiefly nonmedicinal as to source

509

3565

1.47

14.26

2.3

0.21

0.22

g/l

1.17

478

3331

Motor neuron disease

105

472

2.42

14.25

1.8

2.3

0.23

0.21

g/l

2.05

100

448

Malignant neoplasm of other and ill-defined digestive organs

169

3.59

14.23

2.1

1.9

0.17

0.20

g/l

1.76

145

Delivery

1347

8842

0.79

14.16

2.1

2.2

0.22

0.21

g/l

0.14

1266

8171

1983

15216

1.22

14.16

2.2

2.1

0.21

0.20

g/l

2.58

1836

13994

Other disorders of bone

865

6596

1.34

14.14

2.5

2.3

0.22

g/l

0.56

800

6176

Seropositive rheumatoid arthritis

1170

9240

1.29

14.14

2.2

2.1

0.21

g/l

1.86

1078

8613

Necrosis of pulp, including avohilmo

2660

22747

1.18

14.14

2.4

2.3

0.22

g/l

0.84

2488

21287

Other disorders of eyelid

2181

17530

1.20

14.12

2.1

2.2

0.21

g/l

3.92

2020

16243

Atopic dermatitis

2577

18026

1.18

14.04

2.4

0.23

0.22

g/l

4.22

2380

16896

Congenital malformations of the musculoskeletal system, not elsewhere classified

333

2.71

13.98

4.3

2.8

0.22

0.23

g/l

0.67

316

Meniscus derangement

2735

15789

1.18

13.96

2.2

2.3

0.22

0.21

g/l

2.78

2548

14734

All dysplastic lesions of the vulva

210

1211

1.84

13.93

2.6

2.0

0.22

g/l

0.08

202

1145

385

2.51

13.90

2.5

2.2

0.23

g/l

0.18

365

Olecranon bursitis

308

1961

1.65

13.89

2.3

0.22

0.21

g/l

1.10

289

1815

Hypertensive Renal Disease

177

968

1.94

13.89

1.9

2.1

0.22

0.20

g/l

3.06

160

904

Pain in thoracic spine

685

5064

1.39

13.87

2.4

2.3

0.22

0.21

g/l

3.51

643

4734

Acne vulgaris

298

1870

1.64

13.85

2.3

2.9

0.23

g/l

0.29

276

1743

Radiculopathy

762

5730

1.37

13.85

2.0

2.2

0.22

0.21

g/l

4.41

695

5307

Complications of genitourinary prosthetic devices, implants and grafts

129

636

2.18

13.83

2.2

2.0

0.21

g/l

0.30

118

595

Other autoimmune haemolytic anaemias

376

2.67

13.83

2.5

2.3

0.21

g/l

0.15

355

Dental pulpitis, including avohilmo

4393

25250

1.14

13.81

2.3

2.4

0.23

0.22

g/l

6.47

4105

23616

Other diseases of peritoneum

226

1338

1.79

13.68

2.6

2.1

0.21

g/l

0.11

210

1244

Other shoulder lesions

433

2970

1.51

13.59

2.3

2.2

0.22

g/l

1.54

417

2787

Assault by unspecified means

108

501

2.33

13.54

2.7

0.22

0.24

g/l

2.09

472

Amyloidosis

124

610

2.21

13.52

2.3

2.2

0.19

0.20

g/l

1.24

117

572

Alzheimer disease, excluding more controls

822

4096

1.35

13.49

1.7

2.2

0.20

g/l

0.71

708

3820

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

328

2124

1.60

13.46

2.3

2.1

0.22

g/l

0.33

303

2006

Maternal care for other conditions predominantly related to pregnancy

761

5616

1.35

13.44

2.3

0.23

g/l

0.10

700

5311

Myelodysplastic syndrome

212

3.15

13.42

1.9

1.8

0.18

0.19

g/l

0.52

190

Neuralgia and neuritis, unspecified

251

1534

1.72

13.38

2.3

2.1

0.22

g/l

0.09

234

1429

Pemphigoid

153

815

2.04

13.36

2.3

2.1

0.20

g/l

0.03

140

764

Superficial injury of forearm

428

2939

1.50

13.33

2.5

2.4

0.22

g/l

0.09

387

2757

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

177

981

1.91

13.32

2.1

2.2

0.21

0.24

g/l

6.21

161

928

Hyperhidrosis

134

677

2.09

13.23

2.6

2.0

0.23

g/l

0.14

125

636

Acute bronchiolitis

281

1585

1.66

13.22

4.7

3.6

0.21

0.22

g/l

0.34

271

1488

Otitis externa, unspecified

499

3534

1.46

13.22

2.2

2.3

0.22

g/l

0.04

474

3310

Contact with sharp glass

185

1042

1.87

13.21

2.2

2.5

0.22

0.23

g/l

0.16

169

977

Other fall from one level to another

1000

7851

1.30

13.11

2.5

0.21

g/l

0.57

922

7319

Psoriatic arthropathies

468

3283

1.47

13.09

2.3

0.21

0.22

g/l

0.14

438

3080

Postviral fatigue syndrome

167

3.43

13.06

2.2

2.8

0.25

0.24

g/l

0.65

162

Malignant neoplasm of accessory sinuses

7.52

13.05

2.4

2.3

0.24

0.23

g/l

0.39

Other and unspecified erythematous conditions

167

920

1.95

13.04

2.5

2.1

0.22

0.21

g/l

0.20

160

863

Arthropathic psoriasis

519

3717

1.44

12.97

2.3

0.21

0.22

g/l

0.16

485

3486

Ehlers-Danlos syndrome

250

2.90

12.94

2.9

2.6

0.22

0.23

g/l

0.53

238

Diseases of male genital organs

2501

10766

1.19

12.91

2.5

2.6

0.22

0.21

g/l

1.69

2327

9965

Postprocedural musculoskeletal disorders, not elsewhere classified

359

2409

1.56

12.90

1.9

2.2

0.21

g/l

0.01

329

2248

Conjunctivitis (acute, non atopic)

1253

10081

1.26

12.89

2.4

0.22

g/l

1.14

1160

9422

Fenamates

696

3508

1.38

12.88

2.1

2.4

0.23

0.21

g/l

9.27

616

3258

Fibroblastic disorders

1083

8612

1.28

12.84

2.3

2.2

0.21

g/l

0.43

1000

7987

Artificial joint operation, meniscal resection

4643

26920

1.13

12.83

2.1

2.3

0.21

g/l

1.01

4311

24965

Lesion of ulnar nerve

637

4723

1.39

12.80

2.4

2.3

0.21

g/l

0.09

586

4393

Otitis media, unspecified

482

3130

1.46

12.80

3.5

2.9

0.22

g/l

0.29

460

2922

Primary hyperparathyroidism

528

3809

1.44

12.78

2.6

2.1

0.22

0.21

g/l

2.64

499

3538

Disorders of synovium and tendon

2497

18791

1.18

12.78

2.2

2.3

0.22

0.21

g/l

2.19

2331

17515

Other extrapyramidal and movement disorders in other diseases

1096

8740

1.28

12.77

2.2

0.22

0.21

g/l

4.48

1023

8131

Disease of hard tissues of teeth, NOS

2690

12093

1.18

12.72

2.2

2.1

0.22

0.21

g/l

15.58

2513

11236

Thyrotoxicosis

1142

9149

1.27

12.71

2.2

0.21

g/l

0.10

1066

8529

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

288

1850

1.64

12.69

2.3

2.2

0.21

g/l

0.23

267

1749

Other enthesopathies

1367

11161

1.25

12.69

2.1

2.3

0.22

g/l

3.46

1272

10436

Malignant neoplasm of eye and adnexa, including Hilmo

343

2.57

12.63

2.7

2.0

0.20

g/l

0.27

315

Lichen ruber planus, wide definition including periferal and oral lichen planus

1016

8045

1.29

12.61

2.2

0.22

0.21

g/l

0.53

942

7497

Pneumonia due to Streptococcus pneumoniae

193

1118

1.82

12.52

2.8

2.2

0.20

0.22

g/l

1.40

171

1047

Diseases of middle ear and mastoid

2516

17702

1.18

12.52

2.6

2.4

0.22

g/l

1.05

2356

16508

Cervical disc disorders

1716

14349

1.22

12.50

2.1

2.3

0.22

0.21

g/l

3.54

1603

13394

Evidence of alcohol involvement determined by blood alcohol level

390

2.48

12.49

1.9

2.5

0.23

0.22

g/l

0.12

367

Contusion of other and unspecified parts of foot

226

1368

1.73

12.43

2.5

0.23

0.22

g/l

0.66

217

1290

Other noninflammatory disorders of uterus, except cervix

1041

5542

1.29

12.41

1.9

2.1

0.21

g/l

0.51

980

5123

Other infective otitis externa

282

1810

1.63

12.32

2.2

2.3

0.22

0.21

g/l

0.67

259

1687

Lactose intolerance, other/unspecified

134

698

2.04

12.30

2.7

2.3

0.24

0.22

g/l

2.19

122

658

Other predominantly sexually transmitted diseases, not elsewhere classified

758

5781

1.34

12.29

2.7

2.3

0.23

g/l

0.06

710

5424

Open wound of neck

202

3.15

12.25

2.4

0.19

0.23

g/l

2.17

186

Benign neoplasm of ovary

783

6027

1.33

12.20

2.2

2.1

0.22

0.21

g/l

0.75

750

5616

Chronic myeloproliferative disease

411

2.47

12.16

2.0

2.2

0.20

0.21

g/l

0.32

386

Hodgkin lymphoma, hilmo

150

817

1.97

12.16

2.7

2.4

0.19

0.22

g/l

2.91

135

758

Other erythematous conditions

179

1029

1.85

12.13

2.5

2.2

0.21

g/l

0.22

171

966

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2463

20652

1.17

12.11

2.3

0.22

g/l

4.05

2278

19341

Marginal zone B-cell lymphoma

192

3.18

12.09

2.0

1.9

0.20

0.21

g/l

0.38

169

Familial hypercholesterolemia, with ischemic heart disease

459

3266

1.46

12.08

2.1

2.2

0.20

g/l

0.16

424

3023

Bell's palsy

531

3863

1.42

12.07

2.3

0.22

0.21

g/l

1.44

495

3594

Keratitis

1605

13381

1.22

12.06

2.3

0.22

g/l

0.43

1503

12452

Salpingitis and oophoritis

774

5954

1.33

12.06

2.4

2.1

0.22

g/l

0.01

711

5588

Presbycusis

646

4798

1.37

12.05

1.9

2.0

0.19

g/l

0.59

565

4356

Perforation of oesophagus

136

3.81

12.02

3.4

2.1

0.18

0.21

g/l

2.72

127

Schizophrenia

684

5171

1.35

12.00

2.0

2.4

0.22

g/l

0.39

614

4862

Intracerebral haemorrhage

578

4267

1.39

11.97

2.4

2.1

0.20

g/l

0.22

537

3910

Ingrowing nail

248

1556

1.67

11.92

2.4

2.3

0.23

0.22

g/l

1.49

238

1457

Prolonged pregnancy

258

3520

0.63

11.92

2.0

2.3

0.23

g/l

0.33

246

3318

Other and unspecified epidermal thickening

137

730

2.01

11.87

3.5

2.4

0.22

0.21

g/l

0.15

127

682

Chronic nephritic syndrome

198

1178

1.78

11.87

1.9

2.3

0.23

0.21

g/l

2.71

185

1100

Special screening examination for neoplasms

261

1657

1.64

11.85

3.0

2.0

0.22

0.21

g/l

0.82

244

1529

Myeloproliferative diseases

399

2778

1.50

11.85

2.2

2.1

0.20

0.21

g/l

0.41

360

2579

Nummular dermatitis

380

2619

1.51

11.84

2.4

2.2

0.21

g/l

0.43

348

2428

Benign neoplasm: Other and unspecified parts of small intestine

460

2.33

11.84

2.4

2.0

0.23

0.21

g/l

1.31

432

Exposure to other and unspecified inanimate mechanical forces

334

2242

1.55

11.83

2.8

2.4

0.22

g/l

0.20

309

2100

Left bundle-branch block

331

2219

1.55

11.79

2.1

2.2

0.21

g/l

1.01

300

2077

Extrapyramidal and movement disorders

1767

14902

1.21

11.78

2.0

2.2

0.21

g/l

4.16

1635

13814

Spontaneous rupture of synovium and tendon

397

2762

1.49

11.77

2.1

2.2

0.22

0.21

g/l

0.69

367

2573

Other arterial embolism and thrombosis

141

760

1.98

11.75

2.6

2.2

0.20

0.21

g/l

0.15

126

699

Malignant neoplasm of lip, including Hilmo

211

2.97

11.70

1.7

1.8

0.21

0.19

g/l

1.36

183

Other predominantly sexually transmitted diseases, not elsewhere classified

642

4820

1.36

11.70

2.8

2.3

0.23

g/l

0.34

604

4524

Polycystic ovarian syndrome

183

1059

1.79

11.68

2.2

0.24

0.23

g/l

0.62

170

991

Benign neoplasm: Ill-defined sites within the digestive system

154

3.53

11.66

2.9

2.4

0.21

g/l

0.21

144

Malignant neoplasm of accessory sinuses, including Hilmo

4.59

11.63

2.3

2.0

0.24

0.21

g/l

1.28

Allergic colitis

110

545

2.15

11.59

3.6

3.3

0.22

g/l

0.05

104

515

Conductive and sensorineural hearing loss

4008

24111

1.13

11.55

2.2

2.3

0.21

g/l

1.65

3695

22359

Hemiplegia

237

1483

1.67

11.53

2.6

2.3

0.22

0.21

g/l

1.46

216

1383

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

328

2202

1.54

11.48

2.3

2.2

0.22

g/l

0.23

303

2088

Contact with heat and hot substances

250

1588

1.65

11.44

2.7

2.6

0.21

0.22

g/l

1.02

230

1487

Herpesviral [herpes simplex] infections

1035

8302

1.27

11.37

2.5

2.2

0.22

g/l

0.01

965

7749

Fracture at wrist and hand level

1540

12834

1.22

11.36

2.4

0.22

g/l

0.12

1422

11981

Nontraumatic intracranial haemmorrhage

899

7101

1.29

11.34

2.3

2.1

0.20

g/l

0.39

835

6538

Other disorders of breast

540

3979

1.40

11.34

2.1

2.2

0.23

0.22

g/l

5.21

507

3746

Strabismus

1159

9398

1.25

11.29

2.5

2.4

0.21

g/l

0.02

1079

8769

Acute myeloid leukaemia

210

2.95

11.29

1.9

2.1

0.21

0.20

g/l

0.30

187

Acute myeloid leukaemia, including Hilmo

210

2.95

11.29

1.9

2.1

0.21

0.20

g/l

0.30

187

Acute myeloid leukaemia, helper endpoint

210

2.95

11.29

1.9

2.1

0.21

0.20

g/l

0.30

187

Medical abortion

2835

13398

1.16

11.28

2.1

0.22

g/l

0.95

2657

12490

Drug-induced obesity

217

2.95

11.27

2.3

2.4

0.20

0.23

g/l

1.59

202

Sequelae of injuries of lower limb

416

2942

1.46

11.22

2.1

2.3

0.22

g/l

0.07

385

2751

Cramp and spasm

220

1363

1.70

11.22

3.2

2.4

0.23

0.22

g/l

1.70

212

1276

Other congenital malformations

378

2624

1.49

11.22

2.8

0.22

g/l

0.02

356

2480

Primary gonarthrosis, bilateral

2546

18974

1.17

11.21

2.1

2.2

0.21

g/l

0.04

2345

17583

Other (seronegative) rheumatoid arthritis, wide

869

6855

1.30

11.20

2.1

2.2

0.21

g/l

0.55

805

6377

Carcinoma in situ of skin of trunk

171

997

1.84

11.19

2.4

2.1

0.21

0.20

g/l

0.79

161

921

Nonsuppurative otitis media

911

6221

1.29

11.19

3.1

2.6

0.22

g/l

0.62

845

5800

386

2.34

11.18

3.7

3.1

0.22

0.23

g/l

0.38

367

Reactive arthropathies, FINNGEN

314

2107

1.55

11.14

2.6

2.3

0.22

g/l

0.07

288

1977

Seronegative rheumatoid arthritis

530

3911

1.39

11.08

2.0

2.1

0.21

g/l

0.27

499

3652

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

321

2.53

11.05

2.0

2.8

0.20

0.23

g/l

1.94

301

Other abnormal immunological findings in serum

102

503

2.18

11.04

2.3

2.7

0.22

g/l

0.03

474

Mental retardation

203

1232

1.73

11.01

3.0

3.4

0.21

0.22

g/l

0.13

193

1167

Cauda equina syndrome

342

2.49

10.98

2.5

2.3

0.21

0.22

g/l

0.24

325

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

142

3.42

10.93

2.2

1.8

0.21

0.20

g/l

0.53

121

Xerosis cutis

434

2.31

10.93

2.3

2.4

0.19

0.21

g/l

1.22

401

Impetigo

203

1240

1.71

10.88

3.4

2.8

0.22

g/l

0.24

187

1168

Evidence of alcohol involvement determined by level of intoxication

250

2.74

10.86

2.8

2.6

0.20

0.23

g/l

2.45

232

Other renal tubulo-interstitial diseases

116

603

2.05

10.79

2.4

2.0

0.20

0.22

g/l

1.62

107

564

Skin changes due to chronic exposure to nonionizing radiation

1833

14411

1.19

10.74

2.2

2.1

0.21

0.20

g/l

2.71

1699

13233

Amyloidosis, other/unspecified

101

504

2.18

10.73

2.2

0.19

0.20

g/l

0.93

471

Oligomenorrhoea

147

823

1.87

10.70

2.5

2.3

0.22

g/l

0.06

139

776

Allergic conjunctivitis

2553

21718

1.16

10.70

2.3

0.22

g/l

4.06

2358

20326

Leiomyoma of uterus

2812

13943

1.16

10.69

2.1

0.22

g/l

2.91

2635

13040

Drug-induced hypoglycaemia without coma

430

2.28

10.68

2.4

0.18

0.21

g/l

2.63

399

Left ventricular outflow tract obstruction, narrow definition

240

1541

1.64

10.61

3.0

2.9

0.20

0.22

g/l

2.84

226

1455

Wide developmental disorders

155

884

1.84

10.60

2.7

3.8

0.23

0.22

g/l

0.85

140

836

Toxic effect of ethanol

181

1081

1.76

10.60

2.7

2.4

0.21

0.22

g/l

2.06

165

1006

Excessive attrition of teeth

2522

22031

1.16

10.60

2.4

0.23

0.22

g/l

6.73

2333

20637

Right bundle-branch block

176

1045

1.77

10.59

2.6

2.2

0.21

g/l

0.18

163

985

Other disorders of penis

443

3204

1.43

10.55

2.6

0.22

0.21

g/l

1.41

406

2960

Congenital malformations and deformations of the musculoskeletal system

373

2600

1.47

10.54

2.9

3.0

0.22

g/l

0.50

357

2462

Hallux valgus (acquired)

1584

9574

1.21

10.52

2.0

2.2

0.21

g/l

0.31

1460

8977

Superficial injuries involving multiple body regions

128

694

1.96

10.50

2.4

0.21

0.22

g/l

0.41

117

651

Dislocation, sprain and strain of joints and ligaments at neck level

601

4551

1.35

10.46

2.3

0.23

0.22

g/l

2.15

550

4267

Ankylosing spondylitis

387

2736

1.46

10.46

2.4

2.3

0.22

g/l

0.59

354

2565

Ehlers-Danlos syndrome

207

2.88

10.45

3.0

2.5

0.22

0.23

g/l

0.34

198

Viral warts

425

3056

1.43

10.43

3.7

2.3

0.22

g/l

0.60

402

2869

Other benign neoplasms of skin

1710

14537

1.19

10.43

2.3

2.2

0.22

0.21

g/l

2.76

1598

13494

Endocrine disorders, other/unspecified

102

515

2.14

10.42

2.0

2.2

0.20

0.22

g/l

1.60

488

Anogenital herpesviral [herpes simplex] infection

237

1516

1.62

10.40

2.7

2.2

0.23

g/l

0.71

222

1429

Other bacterial agents as the cause of diseases classified to other chapters

282

2.63

10.38

3.5

2.2

0.20

0.21

g/l

0.60

265

Ptosis of eyelid

523

3900

1.39

10.37

2.0

2.2

0.22

0.21

g/l

4.34

483

3634

Migraine without aura and triptan purchases

616

4682

1.34

10.37

2.7

2.4

0.23

g/l

1.27

578

4411

Septal defects

305

2026

1.54

10.36

3.0

3.1

0.21

g/l

1.40

298

1920

Kyphosis

364

2.39

10.34

2.1

0.21

g/l

0.09

346

Carcinoma in situ of lip, oral cavity and pharynx

5.16

10.33

2.8

2.4

0.20

0.21

g/l

0.23

Malignant neoplasm of adrenal gland

4.07

10.30

2.2

2.9

0.23

0.21

g/l

0.73

Malignant neoplasm of eye, brain and central nervous system

164

959

1.78

10.29

2.2

0.23

0.21

g/l

2.12

156

871

Carpal tunnel syndrome

2924

22761

1.14

10.28

2.1

2.2

0.22

0.21

g/l

0.78

2729

21205

Autism

112

583

2.02

10.28

2.9

3.4

0.24

0.23

g/l

0.71

546

Anxious personality disorder

434

2.21

10.27

2.8

2.3

0.22

0.24

g/l

1.33

409

Endometriosis

1447

7063

1.22

10.26

2.3

2.1

0.22

g/l

0.43

1368

6553

Other and specified injuries of hip and thigh

116

616

2.02

10.24

2.1

2.3

0.19

0.22

g/l

2.90

109

575

Congenital malformations and deformations of the musculoskeletal system

466

3394

1.40

10.18

2.8

2.9

0.22

g/l

0.49

441

3206

Actinic keratosis

1775

14040

1.19

10.16

2.2

2.1

0.21

0.20

g/l

2.59

1646

12887

Burns and corrosions of multiple and unspecified body regions

116

618

2.01

10.13

2.5

2.6

0.22

g/l

0.06

105

573

Other hammer toe(s) (acquired)

816

5963

1.29

10.11

2.0

2.1

0.20

0.21

g/l

0.94

754

5570

Other sleep disorders

487

3601

1.39

10.06

2.2

2.3

0.22

0.21

g/l

0.74

448

3341

Propionic acid derivatives

1417

5913

1.22

10.05

2.2

2.7

0.21

g/l

3.15

1319

5472

Burn and corrosion of hip and lower limb, except ankle and foot

119

641

1.98

10.04

2.5

0.21

0.22

g/l

0.23

106

593

Benign neoplasm: Rectosigmoid junction

211

1337

1.67

10.03

2.6

2.1

0.22

0.21

g/l

0.99

198

1248

Campylobacter enteritis

133

742

1.91

10.03

2.9

2.4

0.22

g/l

0.40

124

703

Encephalitis

146

838

1.85

10.01

2.9

2.4

0.22

0.21

g/l

0.90

131

789

Bullous pemphigoid

119

645

2.00

10.01

2.0

2.1

0.20

g/l

0.19

106

600

Orthopaedic devices associated with adverse incidents

109

576

2.08

10.00

2.9

2.0

0.20

0.21

g/l

0.58

103

540

Oxicams

1076

4950

1.25

9.99

2.0

2.3

0.21

0.20

g/l

6.24

997

4562

Delivery, wide proxy

1134

7339

0.81

9.97

2.0

2.2

0.22

0.21

g/l

0.40

1061

6751

Osteonecrosis due to drugs

439

2.25

9.95

2.0

0.21

g/l

0.04

411

Sensorineural hearing loss

3799

23135

1.13

9.93

2.2

2.3

0.21

g/l

1.08

3504

21433

Pure hyperglyceridaemia

116

623

1.99

9.90

2.8

2.3

0.22

0.21

g/l

0.99

109

588

Disorders of optic nerve and visual pathways

408

2946

1.43

9.82

2.4

2.3

0.22

g/l

0.41

388

2762

Essential (haemorrhagic) thrombocythaemia

146

839

1.82

9.82

2.1

2.0

0.20

g/l

0.11

129

763

294

1990

1.51

9.82

2.0

2.2

0.23

g/l

0.20

281

1887

Mixed disorders of conduct and emotions

495

2.08

9.79

2.5

3.4

0.23

g/l

0.12

467

Rheumatoid arthritis, including avohilmo

1754

15026

1.18

9.77

2.2

0.21

g/l

1.25

1624

13977

Anogenital herpesviral [herpes simplex] infection

385

2751

1.43

9.69

2.5

2.3

0.23

g/l

1.25

357

2580

Osteosarcoma, including Hilmo

4.55

9.66

2.9

3.6

0.21

g/l

0.03

Other salmonella infections

174

1058

1.73

9.63

3.9

2.1

0.21

0.22

g/l

0.23

161

993

Perineal laceration during delivery

290

3532

0.68

9.59

2.1

2.3

0.23

g/l

0.26

275

3316

Myeloid leukaemia

137

785

1.86

9.54

2.7

2.4

0.21

g/l

0.10

123

732

Lichen planus, including avohilmo

852

6843

1.27

9.52

2.2

0.21

g/l

0.24

791

6385

Other encephalitis

138

792

1.85

9.51

2.9

2.4

0.23

0.21

g/l

0.99

123

746

Hypothermia

102

534

2.06

9.50

2.2

2.4

0.18

0.21

g/l

2.89

494

Haemangioma and lymphangioma, any site

409

2976

1.42

9.48

2.5

2.3

0.22

g/l

1.09

388

2789

Mental retardation, wide definition

207

1313

1.65

9.44

3.0

3.4

0.21

g/l

0.08

196

1242

Polyarteritis nodosa and related conditions

358

2.31

9.40

2.2

2.3

0.20

0.22

g/l

0.83

334

Unspecified/other endometriosis

322

2240

1.47

9.40

2.3

2.2

0.23

0.22

g/l

1.87

304

2104

Secondary polycythaemia

121

672

1.93

9.35

2.1

2.3

0.22

0.21

g/l

0.62

116

628

Crystal arthropathies, rheuma endpoint

103

545

2.04

9.30

2.0

2.3

0.20

g/l

0.12

508

Carcinoma in situ of skin of other and unspecified parts of face

393

2855

1.43

9.30

2.3

2.0

0.20

g/l

1.45

365

2607

Myeloproliferative diseases (CML excluded)

353

2518

1.46

9.29

2.0

2.1

0.20

0.21

g/l

0.50

318

2341

Lichen planus

583

4488

1.34

9.27

2.2

0.21

g/l

0.36

542

4190

Acute lymphadenitis

239

1576

1.57

9.27

2.6

2.5

0.22

g/l

0.55

228

1481

Impotence

257

1729

1.55

9.24

2.5

0.21

g/l

0.64

238

1590

Other and unspecified haemorrhagic conditions

435

2.17

9.22

3.1

2.4

0.21

0.22

g/l

0.05

403

Polyp of the female genital tract

1355

6512

1.21

9.22

2.0

2.1

0.22

0.21

g/l

6.19

1273

6048

Other juvenile arthritis

164

990

1.72

9.21

4.3

2.9

0.23

0.22

g/l

1.06

156

935

Injury of eye and orbit

572

4385

1.33

9.19

2.6

2.4

0.22

g/l

0.60

527

4122

Open wound of wrist and hand

1979

16786

1.17

9.16

2.3

2.4

0.22

g/l

1.36

1824

15684

Malignant neoplasm of bone and articular cartilage

216

2.71

9.16

2.4

2.6

0.19

0.21

g/l

1.03

195

Impacted cerumen

462

3451

1.38

9.11

2.5

2.3

0.21

g/l

1.39

418

3201

Pollen allergy

728

5682

1.29

9.11

2.9

2.7

0.23

0.22

g/l

1.79

679

5350

Superficial injury of shoulder and upper arm

484

3633

1.37

9.11

2.1

2.3

0.21

0.22

g/l

0.14

442

3384

Ectropion of eyelid

190

1199

1.66

9.08

2.3

2.0

0.20

0.19

g/l

0.91

165

1100

Burn and corrosion of trunk

146

863

1.79

9.07

2.5

2.6

0.22

0.21

g/l

0.20

138

812

Viral infections of the central nervous system

330

2333

1.46

9.03

2.3

0.22

g/l

0.17

306

2183

Behavioural disorders, excluding more controls

346

2.23

8.98

2.4

3.2

0.22

0.23

g/l

0.76

331

Erectile dysfunction, exclusion

3.94

8.98

2.8

0.19

0.22

g/l

1.08

Infectious mononucleosis

299

2071

1.48

8.97

2.7

2.6

0.23

g/l

0.05

278

1926

Other disorders of electrolyte and fluid balance, not elsewhere classified

231

2.64

8.97

2.5

2.3

0.21

0.20

g/l

0.21

213

Other salmonella infections

193

1225

1.64

8.96

3.9

2.1

0.22

g/l

0.10

179

1149

Sleep disorders, other/unspecified

149

885

1.76

8.95

2.6

2.4

0.23

0.22

g/l

0.73

130

830

Vasomotor and allergic rhinitis

1613

13555

1.18

8.93

2.4

0.23

0.22

g/l

6.60

1510

12658

Other bursopathies

590

4568

1.32

8.93

1.9

2.2

0.21

g/l

0.67

544

4248

Other crystal arthropathies

103

553

2.01

8.93

2.0

2.3

0.20

g/l

0.11

518

Other strabismus

920

7469

1.25

8.90

2.5

0.22

g/l

0.03

863

6990

Assault by blunt object

352

2.27

8.89

2.7

0.19

0.23

g/l

2.72

329

Raynaud syndrome

367

2653

1.43

8.85

2.4

2.3

0.22

g/l

0.83

343

2493

Anti-inflammatory and antirheumatic products, non-steroids

1401

5915

1.20

8.83

2.3

2.7

0.21

g/l

3.04

1301

5474

Voice disturbances

1173

9804

1.22

8.82

2.3

2.2

0.22

0.21

g/l

3.95

1091

9147

Hypertrophic disorders of skin

233

1547

1.56

8.79

3.1

2.3

0.22

g/l

0.11

218

1454

Mixed specific developmental disorders

117

603

1.91

8.79

3.4

4.7

0.22

g/l

0.17

110

579

Other specified disorders of kidney and ureter

162

994

1.72

8.78

2.4

2.2

0.21

g/l

0.18

150

925

Hypotension due to drugs

417

2.18

8.78

2.4

2.1

0.21

0.20

g/l

0.21

382

Trochanteric bursitis

637

4992

1.31

8.78

2.1

0.23

0.21

g/l

6.50

592

4660

Other congenital malformations

528

4032

1.34

8.77

2.6

2.7

0.22

g/l

0.32

500

3799

Viral warts

886

7204

1.25

8.76

3.0

2.4

0.23

0.22

g/l

3.86

822

6747

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

157

952

1.72

8.75

3.8

3.0

0.22

g/l

0.19

151

900

Other inflammation of eyelid

595

4627

1.32

8.73

2.3

0.22

0.21

g/l

4.13

558

4328

Metatarsalgia

413

3049

1.39

8.72

2.1

2.2

0.22

0.21

g/l

1.98

386

2859

Gonarthrosis, primary, with knee surgery

2847

20200

1.13

8.72

2.0

2.2

0.21

g/l

0.55

2624

18700

Viral infections of the central nervous system

308

2167

1.47

8.68

2.3

0.22

g/l

0.09

284

2031

Somnolence

290

2.39

8.68

1.9

2.7

0.21

0.22

g/l

0.51

270

Tongue abnormality

286

1991

1.50

8.68

2.3

2.2

0.22

0.21

g/l

0.95

269

1858

Ocular pain

356

2572

1.43

8.62

2.4

2.3

0.22

g/l

0.23

339

2409

Other overlap syndromes

495

2.04

8.62

2.9

2.1

0.22

g/l

0.02

467

Congenital iodine-deficiency syndrome/hypothyroidism

143

854

1.77

8.58

2.8

2.2

0.20

0.21

g/l

0.42

129

810

Transient ischemic attack

2480

17757

1.14

8.57

2.1

2.2

0.21

g/l

0.09

2290

16416

Supervision of normal pregnancy

531

3960

0.75

8.56

2.2

2.3

0.23

g/l

0.54

502

3721

Pyoderma

524

2.00

8.56

2.6

2.3

0.20

0.21

g/l

0.51

488

Nosocomial condition (hospital)

154

3.05

8.49

2.0

2.1

0.18

0.21

g/l

1.34

142

Other bacterial agents as the cause of diseases classified to other chapters

327

2.31

8.49

3.5

2.3

0.20

0.21

g/l

0.47

308

Spondylolisthesis/Spondylolysis

814

6589

1.26

8.48

2.1

2.2

0.22

0.21

g/l

1.10

755

6153

Enthesopathies of lower limb, excluding foot

963

7926

1.24

8.48

2.4

2.3

0.23

0.22

g/l

5.22

910

7422

Other and unspecified injuries of lower leg

311

2200

1.46

8.48

2.4

2.3

0.22

g/l

0.12

287

2073

Oral lichen planus and hypothyroidism or thyroxine medication

514

2.02

8.46

2.1

1.9

0.21

0.22

g/l

0.51

489

Other disorders of optic [2nd] nerve and visual pathways

284

1982

1.49

8.45

2.4

2.3

0.22

0.21

g/l

0.30

269

1855

Melanocytic naevi

1255

10589

1.20

8.45

2.5

2.3

0.23

0.22

g/l

5.67

1194

9852

Vascular dementia

387

2737

1.40

8.44

1.6

1.9

0.20

0.19

g/l

2.00

334

2480

Toxic effect of other and unspecified substances

300

2.34

8.43

2.1

2.8

0.22

0.23

g/l

0.91

277

Secondary parkinsonism, excluding more controls

109

603

1.90

8.42

1.8

2.2

0.21

g/l

0.40

103

570

Inguinal hernia

2721

16170

1.14

8.36

2.5

2.3

0.21

g/l

0.26

2516

14958

Localized skin eruption due to drugs and medicaments

303

2.35

8.34

2.6

2.3

0.22

g/l

0.17

286

Other enthesopathy of foot (+metatarsalgia)

441

3312

1.37

8.33

2.0

2.2

0.23

0.21

g/l

2.22

412

3108

Dissection of aorta

151

922

1.72

8.32

2.1

2.3

0.21

0.20

g/l

0.30

144

851

Other disorders of patella

706

5633

1.28

8.29

2.3

0.23

0.22

g/l

1.15

657

5300

Haemangioma, any site

377

2771

1.40

8.28

2.4

2.3

0.22

g/l

1.20

357

2599

Open wound of thorax

383

2.16

8.26

2.3

2.4

0.20

0.22

g/l

0.98

364

Childhood allergy (age < 16)

473

2939

1.35

8.24

3.7

3.2

0.23

g/l

0.20

442

2746

Other localized connective tissue disorders

518

1.98

8.16

2.7

2.1

0.22

g/l

0.51

488

Heterophoria

327

2350

1.43

8.16

2.2

2.5

0.22

g/l

0.12

302

2208

Specific development disorders of speech and language

250

1646

1.51

8.16

3.9

3.3

0.21

0.22

g/l

0.28

232

1554

Lesion of radial nerve

175

1115

1.64

8.11

2.3

2.2

0.21

g/l

0.35

163

1030

Sequelae of infectious and parasitic diseases

318

2281

1.44

8.05

2.1

0.21

0.22

g/l

0.14

297

2126

Malignant neoplasm of pyriform sinus, including Hilmo

9.32

8.00

2.7

2.5

0.19

g/l

0.04

Human immunodeficiency virus [HIV] disease

493

1.99

7.99

1.9

2.5

0.25

0.23

g/l

1.30

459

Other noninflammatory disorders of vagina

331

2396

1.42

7.93

2.6

2.2

0.22

0.21

g/l

1.28

313

2230

Mantle cell lymphoma, including Hilmo

308

2.27

7.93

1.8

1.9

0.20

g/l

0.22

274

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1252

10624

1.20

7.92

2.4

2.3

0.22

g/l

0.26

1132

9899

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

103

572

1.89

7.89

2.1

1.8

0.20

g/l

0.18

513

Multiple myeloma

103

572

1.89

7.89

2.1

1.8

0.20

g/l

0.18

513

Other/unspecified rheumatoid arthritis

550

4296

1.31

7.88

2.2

2.1

0.20

0.21

g/l

0.45

509

3990

Scabies

197

1297

1.58

7.84

2.6

2.5

0.22

g/l

0.18

184

1221

Varicella [chickenpox]

199

1313

1.57

7.83

3.3

2.8

0.22

g/l

0.18

180

1235

Artificial joint re-operation

328

2386

1.43

7.83

1.8

2.1

0.20

0.21

g/l

0.97

302

2219

Ankylosing spondylitis, ICD10

372

2752

1.39

7.83

2.4

2.3

0.22

g/l

0.11

341

2579

Other and unspecified nail disorders

108

613

1.88

7.83

2.0

2.1

0.22

g/l

0.07

582

Renal cell carcinoma of kidney

121

705

1.79

7.82

2.2

1.9

0.22

0.19

g/l

3.55

108

629

Scabies

548

4274

1.31

7.81

2.5

2.6

0.22

g/l

0.11

504

4002

Hyperplasia of prostate

1695

8323

1.17

7.80

2.2

2.5

0.21

g/l

0.99

1573

7674

Cardiac murmurs and other cardiac sounds

396

2921

1.37

7.78

2.8

2.7

0.21

g/l

0.11

378

2755

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

104

3.36

7.76

1.9

2.0

0.19

0.20

g/l

0.35

Other and unspecified injuries of shoulder and upper arm

143

877

1.71

7.76

2.4

2.3

0.22

g/l

0.57

133

812

Other mycoses, not elsewhere classified/unspecified

456

2.02

7.76

3.0

2.2

0.22

g/l

0.04

428

Unspecified lump in breast

650

5187

1.28

7.76

1.9

2.1

0.22

0.21

g/l

3.00

621

4845

Dermatographic urticaria

269

1887

1.47

7.74

2.1

2.2

0.23

0.22

g/l

1.48

249

1774

Transepidermal elimination disorders

5.78

7.72

1.9

3.6

0.20

0.21

g/l

0.30

Pediculosis, acariasis and other infestations

252

1750

1.49

7.70

2.6

2.5

0.22

g/l

0.15

238

1644

Other factor of the environment

333

2.22

7.70

2.8

2.3

0.20

0.22

g/l

0.70

315

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

405

2.05

7.69

1.6

2.2

0.23

g/l

0.01

387

Psoriatic arthropathies, ICD10

455

3479

1.34

7.67

2.4

2.3

0.21

0.22

g/l

0.28

427

3262

Autism spe

105

591

1.86

7.67

2.9

3.2

0.24

0.23

g/l

0.93

551

Other psoriatic arthropathies

443

3375

1.35

7.67

2.3

0.21

0.22

g/l

0.29

415

3166

Allergic purpura

134

811

1.73

7.64

3.1

2.3

0.20

0.22

g/l

2.32

127

760

Cluster headache, strict

151

941

1.67

7.61

2.1

2.4

0.22

g/l

0.01

141

886

Disorders of vestibular function (Vertigo)

2160

18809

1.14

7.61

2.1

2.2

0.22

0.21

g/l

5.48

2017

17456

Erythema multiforme

108

619

1.85

7.55

2.9

2.2

0.21

g/l

0.07

581

Sequelae of other and unspecified infectious and parasitic diseases

227

1551

1.52

7.55

2.2

2.3

0.22

g/l

1.03

215

1464

Sequelae of injuries of upper limb

413

3122

1.36

7.54

2.3

0.22

g/l

0.29

386

2916

Cardiomyopathies, Secondary/extrinsic

182

2.71

7.52

2.2

2.5

0.22

g/l

0.01

174

Other and unspecified intracranial injuries

138

846

1.71

7.50

2.5

2.3

0.20

0.21

g/l

0.87

123

792

Congenital malformations of aortic and mitral valves

192

1273

1.58

7.49

2.9

0.20

0.22

g/l

3.25

183

1198

Generalized epilepsy

180

1174

1.59

7.49

2.1

2.8

0.23

0.22

g/l

0.34

173

1109

Other superficial mycoses

399

3000

1.36

7.48

2.2

2.3

0.23

0.22

g/l

1.09

347

2814

Gonococcal infection

154

971

1.66

7.46

1.8

2.3

0.22

0.23

g/l

0.38

143

916

Peritonsillar abscess

829

6812

1.23

7.43

2.3

2.4

0.22

g/l

1.23

777

6357

Lifestyle-related condition

311

2.24

7.43

2.8

2.3

0.21

0.22

g/l

0.38

289

Other/unspecified reactive arthropathies

279

1990

1.45

7.39

2.6

2.3

0.22

g/l

0.02

256

1864

Antenatal screening

574

4087

0.78

7.39

2.3

0.24

0.23

g/l

2.49

546

3840

Bruxism

477

1.96

7.38

2.6

2.4

0.23

g/l

0.32

450

Other superficial mycoses

100

564

1.88

7.38

2.3

2.5

0.21

0.22

g/l

0.64

532

Acute alcohol intoxication ICD-9

150

943

1.66

7.37

2.1

2.2

0.19

0.22

g/l

3.62

138

880

Orchitis and epididymitis

396

2985

1.36

7.36

2.5

2.4

0.21

g/l

0.08

366

2744

Disorders of myoneural junction and muscle in diseases classified elsewhere

215

2.54

7.36

1.8

2.3

0.21

0.22

g/l

0.51

201

IgA nephropathy (IgA glomerulonephritis)

116

685

1.80

7.35

2.9

2.4

0.22

g/l

0.05

110

641

Gonococcal infection

146

913

1.68

7.34

1.8

2.3

0.22

0.23

g/l

0.17

137

863

Autoimmune hyperthyroidism

248

1732

1.48

7.32

2.2

2.0

0.21

0.22

g/l

0.52

232

1634

Contusion of toe(s) without damage to nail

107

616

1.82

7.31

2.3

2.5

0.23

0.22

g/l

0.16

582

Other secondary coxarthrosis

160

1027

1.64

7.27

2.0

2.2

0.20

0.21

g/l

1.06

150

969

Oral lichen planus, including avohilmo , including avohilmo

296

2143

1.43

7.27

2.2

0.22

0.21

g/l

1.27

278

2023

Adult respiratory distress syndrome

369

2.12

7.25

2.7

2.3

0.21

g/l

0.17

341

Pulmonary oedema

502

1.93

7.25

2.8

2.1

0.20

g/l

0.02

456

Memory loss

401

3043

1.36

7.22

2.0

2.1

0.21

0.20

g/l

2.49

342

2828

Alzheimer’s disease (Late onset), excluding more controls

638

3337

1.28

7.16

1.7

2.1

0.20

g/l

0.15

542

3103

Exposure to smoke, fire and flames

114

674

1.78

7.16

2.3

2.4

0.21

0.22

g/l

0.36

104

629

Polycystic ovarian syndrome, broad definition

322

2356

1.39

7.11

2.3

2.2

0.23

g/l

0.21

301

2213

Other specified/unspecified soft tissue disorders

216

1481

1.51

7.11

2.6

2.0

0.22

0.21

g/l

0.73

203

1363

Vulvovaginal ulceration/inflammation in other diseases

216

1477

1.50

7.10

2.6

2.1

0.23

0.22

g/l

0.73

201

1393

Hydrocele

497

3884

1.31

7.08

2.7

2.4

0.20

g/l

1.02

459

3559

Intermittent heterotropia

237

1651

1.48

7.07

2.6

3.0

0.21

0.22

g/l

0.11

221

1571

Varicella [chickenpox]

227

1572

1.49

7.05

3.4

3.0

0.22

g/l

0.06

207

1490

Coxarthrosis, primary

2880

22024

1.12

7.05

2.1

2.2

0.21

g/l

0.08

2680

20327

Otalgia

340

2527

1.38

7.02

2.5

0.22

g/l

1.08

313

2368

Crushed, pushed or stepped on by crowd or human stampede

284

2047

1.42

7.01

3.1

2.6

0.22

0.23

g/l

0.32

260

1914

Other orthopaedic follow-up care

217

1492

1.50

6.99

2.3

2.2

0.22

g/l

0.29

199

1399

Anankastic personality disorder

153

978

1.62

6.96

2.2

2.3

0.23

g/l

0.78

135

930

Dislocation, sprain and strain of joints and ligaments of head

167

1089

1.59

6.96

2.2

2.7

0.21

0.22

g/l

1.12

154

1023

Other bullous disorders

130

803

1.71

6.96

2.6

2.3

0.21

g/l

0.49

124

755

Ethmoidectomy

537

4249

1.29

6.95

2.4

2.3

0.22

g/l

0.09

509

3989

Gout due to impairment of renal function

307

2.22

6.94

3.0

2.5

0.23

0.20

g/l

1.82

285

Lymphoid leukaemia

257

1833

1.46

6.93

2.2

2.4

0.20

0.21

g/l

0.65

232

1705

Other specified/unspecified inflammatory spondylopathies

188

1258

1.54

6.93

2.5

2.2

0.22

g/l

0.05

173

1185

Dislocation, sprain and strain of joint and ligaments of hip

166

1087

1.60

6.90

2.1

2.2

0.21

g/l

0.14

155

1014

Monoarthritis, not elsewhere classified

183

1221

1.56

6.90

2.3

2.2

0.22

g/l

0.13

171

1152

Labour and delivery complicated by fetal stress [distress]

505

4214

0.78

6.88

2.1

2.3

0.23

g/l

0.20

480

3968

Erectile dysfunction

351

2634

1.38

6.88

2.7

2.3

0.21

0.20

g/l

1.14

324

2421

Cluster headache, wide

160

1037

1.60

6.87

2.1

2.4

0.23

0.22

g/l

0.26

150

970

Malignant neoplasm of lip

140

2.79

6.84

1.6

1.8

0.20

0.18

g/l

1.02

120

Other otitis externa (chronic)

282

2045

1.42

6.83

2.5

2.2

0.22

0.21

g/l

0.13

248

1907

Generalized epilepsy, mode (most common among epilepsy diagnosis)

132

820

1.68

6.81

1.9

2.8

0.23

0.22

g/l

0.28

127

778

Hyperfunction of pituitary gland

189

1272

1.53

6.79

2.6

2.2

0.22

g/l

0.15

169

1193

Golimumab

141

891

1.65

6.78

2.1

2.4

0.24

0.23

g/l

0.77

134

837

Granulomatous disorders of skin and subcutaneous tissue

111

662

1.76

6.74

1.9

2.2

0.22

g/l

0.20

100

619

Iridocyclitis

961

8096

1.21

6.74

2.3

0.21

g/l

0.37

904

7542

Giant cell arteritis

196

1339

1.53

6.72

2.2

2.0

0.22

0.20

g/l

2.15

176

1245

Inflammatory disorders of male genital organs, not elsewhere classified

408

2.01

6.71

2.2

2.6

0.20

0.21

g/l

0.46

374

Seborrhoeic keratosis

963

8123

1.21

6.70

2.7

2.1

0.22

0.21

g/l

4.49

897

7559

Other obstetric conditions, not elsewhere classified

990

5280

1.20

6.70

2.1

2.3

0.23

g/l

0.33

935

4978

Other nutritional anaemias

256

2.29

6.67

2.1

2.2

0.20

0.21

g/l

0.40

238

Examination and encounter for administrative purposes

193

1311

1.52

6.65

1.8

1.9

0.21

g/l

0.12

178

1199

Persistent delusional disorders

322

2395

1.38

6.64

2.1

2.2

0.22

0.21

g/l

0.35

292

2243

Restless leg syndrome

566

4535

1.28

6.63

2.1

2.2

0.22

0.21

g/l

2.59

533

4236

Asthma mixed form (mode), excluding more controls

195

1325

1.51

6.62

2.4

2.1

0.21

0.22

g/l

0.96

184

1234

Ascorbic acid deficiency

10.20

6.62

8.6

5.6

0.21

0.23

g/l

0.52

Viral encephalitis, not elsewhere classified/unspecified

562

1.83

6.62

2.3

2.5

0.22

0.21

g/l

0.44

528

Other and unspecified diseases of spleen

104

3.20

6.60

2.4

2.5

0.22

0.21

g/l

0.22

Recurrent dislocation and subluxation of joint

265

1908

1.42

6.60

2.3

0.23

0.22

g/l

0.50

252

1798

Car occupant injured in noncollision transport accident

152

985

1.61

6.58

2.6

2.3

0.21

0.22

g/l

0.63

143

915

Hypertrophic scar

205

1412

1.50

6.57

2.7

2.3

0.22

g/l

0.21

190

1327

Infective bursitis

135

854

1.66

6.57

1.9

2.1

0.22

0.21

g/l

0.63

130

797

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

199

2.44

6.53

2.7

2.6

0.20

0.21

g/l

0.50

180

Embolic stroke with flimmer

112

675

1.73

6.52

1.7

2.1

0.18

0.20

g/l

2.85

101

618

Abnormality of white blood cells, not elsewhere classified

220

2.40

6.52

2.3

2.2

0.22

g/l

0.02

206

Urethritis and urethral syndrome

102

601

1.79

6.51

2.4

2.2

0.22

0.21

g/l

0.35

569

Other and unspecified hypertrophic disorders of skin

145

2.73

6.46

5.6

2.4

0.20

0.22

g/l

1.04

138

Wet age-related macular degeneration

763

6132

1.23

6.46

2.0

0.20

g/l

0.69

696

5617

Routine general health check-up of defined subpopulation

467

1.88

6.44

2.1

1.8

0.22

0.23

g/l

0.50

438

FESS (DNB20)

513

4078

1.28

6.43

2.4

2.3

0.22

g/l

0.03

485

3827

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

310

2300

1.38

6.42

2.3

0.23

0.22

g/l

0.98

295

2166

Intussusception

559

1.81

6.40

2.6

2.0

0.22

g/l

0.01

529

Other abnormal findings in urine

458

1.92

6.39

2.3

2.2

0.21

0.20

g/l

0.41

425

Injury of urinary and pelvic organs

575

1.80

6.39

2.6

2.4

0.21

g/l

0.21

537

Personal history of medical treatment

261

2.24

6.39

4.4

2.4

0.22

0.21

g/l

0.54

244

Respiratory disorders in diseases classified elsewhere

379

2.02

6.39

2.2

2.3

0.20

0.21

g/l

0.34

356

Hypermobility syndrome

188

1281

1.51

6.35

2.5

2.2

0.23

g/l

0.06

168

1211

Postpartum haemorrhage

603

6257

0.80

6.34

2.1

2.2

0.23

g/l

0.36

575

5909

Any dementia

1743

10684

1.15

6.31

1.7

2.1

0.20

g/l

0.56

1516

9846

Human immunodeficiency virus [HIV] disease resulting in other conditions

459

1.90

6.30

1.8

2.5

0.25

0.23

g/l

1.56

426

Autonomic disorders

106

638

1.75

6.30

2.7

2.2

0.22

0.21

g/l

0.45

595

Erythema nodosum

128

808

1.66

6.26

2.6

2.1

0.22

0.21

g/l

0.56

116

758

Lichen simplex chronicus

151

991

1.59

6.25

2.3

2.1

0.22

0.21

g/l

0.24

141

933

Other and unspecified follicular disorders

165

1102

1.55

6.25

2.5

2.3

0.23

0.22

g/l

1.93

156

1034

Effects of foreign body entering through natural orifice

1019

8685

1.19

6.25

2.6

2.5

0.22

g/l

0.52

939

8113

Pediculosis, acariasis and other infestations

643

5255

1.24

6.21

2.5

2.6

0.22

g/l

0.15

595

4925

Malignant neoplasm of brain, including Hilmo

167

1116

1.54

6.21

1.8

2.2

0.24

0.21

g/l

4.91

158

1016

Embolic stroke

200

1388

1.49

6.21

1.7

2.1

0.19

0.20

g/l

0.25

178

1275

Other and unspecified rosacea

358

2734

1.34

6.19

2.5

2.2

0.22

g/l

0.07

330

2565

Other and unspecified paralytic syndromes

390

1.98

6.18

2.6

2.3

0.21

0.22

g/l

0.33

368

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

143

931

1.60

6.05

2.9

3.5

0.22

g/l

0.26

137

885

Juvenile arthritis (FINNGEN)

173

1172

1.52

6.05

4.1

2.8

0.23

0.22

g/l

0.74

165

1114

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

8.70

6.03

2.8

1.6

0.22

g/l

0.06

Other complications of labour and delivery, not elsewhere classified

184

2434

0.68

6.00

2.0

2.3

0.23

g/l

0.28

175

2283

Other symptoms and signs involving the urinary system

428

3360

1.30

6.00

2.4

2.2

0.22

0.21

g/l

1.46

394

3132

Seropositive rheumatoid arthritis, wide

1170

10121

1.17

5.99

2.2

0.21

g/l

1.58

1078

9414

Injury of nerves and spinal cord at neck level

107

656

1.72

5.99

1.9

2.3

0.21

g/l

0.29

614

Astigmatism

258

1885

1.41

5.96

2.8

0.22

g/l

0.10

245

1781

Diabetic retinopathy

1763

9753

1.14

5.95

2.4

0.20

0.21

g/l

11.76

1609

8998

Dislocation of lens

394

1.94

5.95

2.5

2.1

0.19

0.20

g/l

0.38

362

Benign paroxysmal vertigo

1285

11199

1.16

5.94

2.1

2.2

0.22

0.21

g/l

3.60

1196

10404

Respiratory tuberculosis, confirmed

512

1.82

5.94

2.4

2.2

0.19

0.20

g/l

0.54

470

Temporal arteritis

171

1168

1.53

5.93

2.0

0.22

0.20

g/l

2.12

151

1085

Carbimazole or st.post thyroidectomy, condition for graves disease

863

7292

1.20

5.92

2.2

0.22

g/l

0.34

815

6819

Melanocytic naevi of trunk

485

3871

1.28

5.91

2.7

2.3

0.23

0.22

g/l

3.80

462

3621

Simple and mucopurulent chronic bronchitis

175

1197

1.51

5.89

2.4

2.3

0.20

g/l

0.05

159

1107

Female infertility, associated with anovulation

217

1537

1.44

5.88

2.3

2.2

0.24

0.23

g/l

1.00

204

1443

Other specified/unspecified spondylopathies

118

744

1.67

5.87

2.4

2.0

0.20

0.21

g/l

0.12

107

697

Temporomandibular joint disorders, including avohilmo

1759

15413

1.13

5.86

2.3

0.23

0.22

g/l

4.57

1647

14431

Benign neoplasm: Tongue

131

848

1.62

5.86

2.9

2.2

0.23

0.21

g/l

1.71

122

791

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

149

989

1.56

5.84

2.4

0.23

0.22

g/l

0.74

142

931

Dementia in other diseases classified elsewhere

198

1392

1.47

5.83

2.1

0.21

0.20

g/l

0.59

177

1295

Mature T/NK-cell lymphomas, hilmo

392

1.95

5.81

3.0

2.4

0.20

g/l

0.44

363

Nonspecific lymphadenitis

232

1674

1.42

5.81

2.6

2.2

0.22

0.23

g/l

0.73

221

1583

Burn and corrosion of wrist and hand

158

1064

1.54

5.79

2.5

2.6

0.22

g/l

0.21

145

998

Sudden idiopathic hearing loss

435

3441

1.29

5.79

2.5

2.2

0.21

g/l

0.14

402

3204

Unstable angina pectoris

1685

11789

1.14

5.76

1.9

2.2

0.21

g/l

0.15

1561

10869

Respiratory conditions due to other external agents

101

617

1.73

5.76

2.1

0.21

g/l

0.59

578

Palmar fascial fibromatosis [Dupuytren]

656

5422

1.23

5.76

2.3

2.2

0.20

g/l

0.02

600

5002

Acute nephritic syndrome

593

1.74

5.76

2.3

2.6

0.23

0.21

g/l

1.00

553

Panniculitis affecting regions of neck and back

160

1083

1.53

5.72

2.2

0.22

0.21

g/l

0.32

145

1015

Hypogonadotropic hypogonadism

124

796

1.63

5.70

2.6

2.5

0.23

g/l

0.13

119

738

Benign neoplasm: Pituitary gland, craniopharyngeal duct

215

1540

1.44

5.69

2.4

2.3

0.22

g/l

0.03

203

1437

Rosacea

464

3704

1.28

5.67

2.6

2.2

0.22

0.21

g/l

0.94

429

3474

Haemolytic-uraemic syndrome

4.33

5.66

4.0

3.0

0.23

0.22

g/l

0.10

Other/unspecified seropositive rheumatoid arthritis

1154

10024

1.17

5.62

2.2

0.21

g/l

1.62

1063

9325

Entropion and trichiasis of eyelid

364

2827

1.32

5.62

2.1

0.20

g/l

0.47

338

2600

Abnormal findings on diagnostic imaging of central nervous system

195

1376

1.46

5.61

2.6

2.3

0.23

0.22

g/l

0.70

181

1286

Sacroiliitis, not elsewhere classified

171

1174

1.50

5.61

2.1

2.2

0.23

0.22

g/l

0.24

160

1116

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1135

9850

1.17

5.60

2.2

0.21

g/l

1.49

1044

9174

Other/unspecified enthesopathies, not elsewhere classified

360

2791

1.32

5.60

2.1

2.2

0.22

0.21

g/l

1.68

336

2599

Other and unspecified glaucoma

309

2350

1.35

5.60

2.5

2.1

0.20

g/l

0.11

286

2171

Allergic rhinitis

1213

10443

1.16

5.58

2.5

0.23

0.22

g/l

3.98

1135

9805

Benign neoplasm: Anus and anal canal

130

850

1.60

5.56

2.3

2.1

0.21

g/l

0.16

117

796

Giant cell arteritis with polymyalgia rheumatica

171

1186

1.51

5.52

2.0

0.22

0.20

g/l

2.10

151

1102

Disorders of refraction and accommodation

1085

9353

1.17

5.50

2.6

2.5

0.22

g/l

0.62

1019

8742

Phakomatoses, not elsewhere classified

305

2.04

5.49

2.7

2.8

0.21

0.23

g/l

0.85

285

Optic atrophy

518

1.78

5.49

2.6

0.21

g/l

0.35

490

Other acute skin changes due to ultraviolet radiation

151

1021

1.54

5.49

2.2

0.21

g/l

0.06

136

948

Adhesive capsulitis of shoulder

721

6043

1.21

5.48

2.2

0.22

0.21

g/l

1.59

671

5633

Other keratitis

447

3568

1.28

5.47

2.2

2.3

0.22

g/l

0.06

421

3351

Pustulosis palmaris et plantaris

182

1277

1.48

5.45

2.0

2.2

0.23

0.22

g/l

1.17

167

1208

Disorders of ornithine metabolism

23.14

5.45

3.4

3.8

0.24

0.20

g/l

—

Postpartum care and examination

299

2496

0.75

5.43

2.1

2.3

0.23

g/l

0.42

276

2332

Benign neoplasm: Appendix

307

2.04

5.43

2.3

2.2

0.22

0.21

g/l

0.31

285

Respiratory tuberculosis, bacteriologically and histologically confirmed

526

1.76

5.41

2.4

2.2

0.19

0.20

g/l

0.62

482

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

945

5113

1.18

5.41

2.2

2.3

0.23

g/l

0.41

895

4819

Disorders of vitreous body and globe

2361

20593

1.11

5.41

2.2

0.21

g/l

1.71

2190

19156

Hyperaldosteronism

129

849

1.59

5.38

2.1

2.2

0.23

0.21

g/l

1.32

115

795

Other specified and unspecified disorders of eye and adnexa

163

1123

1.51

5.38

2.6

2.2

0.23

0.21

g/l

1.64

151

1054

Asthma mixed form (mode)

195

1383

1.44

5.38

2.4

2.1

0.21

0.22

g/l

0.53

184

1285

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1151

10021

1.16

5.37

2.3

2.5

0.22

g/l

0.49

1063

9397

Benign neoplasm of breast

482

3893

1.26

5.35

2.0

2.1

0.21

g/l

0.08

450

3647

Status post-ami

1182

7849

1.16

5.35

2.0

2.2

0.19

0.20

g/l

3.76

1066

7240

Exposure to unspecified smoke, fire and flames

245

2.15

5.35

2.3

2.7

0.19

0.22

g/l

1.67

228

Benign neoplasm: Other/unspecified site

454

1.83

5.35

2.2

2.1

0.22

0.21

g/l

0.50

424

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

266

1957

1.37

5.34

3.9

3.0

0.22

g/l

0.39

255

1858

Paranoid personality disorder

475

1.79

5.34

2.3

0.22

g/l

0.25

446

Recurrent dislocation of patella

173

1202

1.47

5.32

2.1

2.3

0.23

g/l

0.37

165

1133

Other disorders of the genitourinary system

543

4448

1.25

5.32

2.1

0.22

0.21

g/l

1.55

496

4147

Polyarthritis, unspecified

156

1068

1.52

5.32

2.5

2.3

0.22

g/l

0.08

146

1007

Other/unspecified enthesopathies of lower limb, excluding foot

288

2185

1.35

5.27

2.6

2.2

0.23

0.22

g/l

2.07

268

2057

Visual field defects

357

2791

1.31

5.27

2.0

2.2

0.21

g/l

0.13

329

2601

Benign neoplasm of major salivary glands

413

3287

1.29

5.26

2.5

2.2

0.22

0.21

g/l

1.02

386

3059

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

117

755

1.61

5.25

2.4

0.22

g/l

0.02

106

716

Disorders of vitreous body

2296

20146

1.11

5.25

2.2

0.21

g/l

2.08

2129

18758

Degenerative diseases of the nervous system

1538

10023

1.14

5.24

1.8

2.0

0.19

0.20

g/l

0.84

1333

9203

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

159

1097

1.51

5.24

2.2

0.22

0.21

g/l

0.54

149

1032

All dysplastic lesions of the vagina

110

701

1.64

5.24

3.1

2.0

0.22

g/l

0.06

104

665

Viral agents as the cause of diseases classified to other chapters

112

718

1.63

5.23

3.2

2.6

0.22

g/l

0.08

106

678

Other and unspecified mononeuropathies, also in other diseases

133

886

1.57

5.23

2.3

2.1

0.21

g/l

0.41

124

819

Benign neoplasm: salivary glands, exclude unknown (D119)

371

2920

1.30

5.21

2.5

2.2

0.22

0.21

g/l

1.35

346

2725

Habit and impulse disorders

374

1.88

5.19

2.3

2.7

0.24

0.23

g/l

0.44

354

HSIL lesion of the cervix uteri, vagina or vulva

656

5472

1.21

5.18

2.4

2.2

0.23

0.22

g/l

1.58

612

5177

Optic atrophy

542

1.74

5.17

2.5

0.21

g/l

0.34

512

Suggestive for eosinophilic asthma

378

2983

1.30

5.16

2.2

0.22

0.21

g/l

0.63

358

2788

Atypical facial pain

213

1552

1.41

5.14

2.1

0.23

0.22

g/l

2.97

197

1451

Personal history of allergy to drugs, medicaments and biological substances

269

2.06

5.13

2.0

2.1

0.23

0.22

g/l

0.32

253

Dislocation, sprain and strain of joints and ligaments of knee

2588

21786

1.10

5.13

2.3

2.4

0.23

0.22

g/l

4.35

2420

20403

Diseases of inner ear

2491

21990

1.10

5.13

2.1

2.2

0.22

0.21

g/l

3.69

2331

20395

Non-small cell lung cancer, squamous

142

958

1.52

5.09

1.7

1.9

0.20

0.19

g/l

0.83

132

845

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

169

2.37

5.09

2.5

1.9

0.15

0.20

g/l

2.61

149

Corneal ulcer

744

6295

1.20

5.09

2.1

2.3

0.22

g/l

0.22

705

5887

All dysplastic lesions of the cervix uteri, vagina or vulva

999

8512

1.17

5.08

2.4

2.2

0.23

0.22

g/l

1.21

938

8025

Benign neoplasm: Parotid gland

333

2596

1.32

5.06

2.5

2.2

0.22

0.21

g/l

1.32

309

2428

Long labour

595

6130

0.82

5.05

2.1

2.2

0.23

g/l

1.08

567

5783

Traumatic ischaemia of muscle

350

1.91

5.04

2.5

2.3

0.22

g/l

0.14

322

Adenocarcinomas of cervix

3.05

5.04

3.0

2.3

0.25

0.21

g/l

1.78

Coronary artery bypass grafting

1171

7630

1.16

5.04

2.0

2.3

0.19

0.20

g/l

5.80

1069

7042

Brain meningioma

160

1110

1.48

5.03

2.0

2.1

0.22

0.21

g/l

1.96

144

1007

Other sexually transmitted chlamydial diseases

192

1373

1.43

5.03

2.2

2.5

0.24

0.23

g/l

0.17

172

1279

Caries of enamel

4123

27685

1.08

5.03

2.7

2.3

0.23

0.22

g/l

13.17

3856

25875

Varicose veins of other sites

263

1986

1.36

5.02

3.6

2.1

0.20

0.22

g/l

4.27

236

1863

Pregnancy, childbirth and the puerperium

1043

6281

0.86

5.01

2.0

2.2

0.21

g/l

0.04

985

5758

Alzheimer’s disease (Early onset)

1286

0.59

5.01

1.7

1.9

0.19

0.20

g/l

0.24

1182

Brain meningioma, including Hilmo

164

1145

1.47

4.99

2.0

2.1

0.22

0.21

g/l

2.02

148

1037

Pleural plaque

389

3096

1.28

4.98

2.2

2.1

0.19

0.20

g/l

1.18

346

2838

Complications following abortion and ectopic and molar pregnancy

151

1044

1.50

4.96

2.4

2.1

0.22

g/l

0.10

143

988

Congenital malformations of the nervous system

593

1.67

4.95

2.5

3.2

0.21

0.22

g/l

0.40

563

Carcinoma in situ of other and unspecified sites

164

1154

1.48

4.95

2.0

2.3

0.21

0.20

g/l

0.86

150

1061

Other and unspecified disorders of autonomic nervous system

2.95

4.94

2.3

0.23

g/l

0.13

Alzheimer’s disease (Atypical or mixed)

408

3243

1.27

4.91

1.6

1.9

0.19

g/l

0.58

352

2946

Inflammatory disorders of breast

223

1646

1.39

4.90

2.0

2.2

0.22

g/l

0.12

210

1563

Pustular psoriasis

198

1439

1.42

4.90

2.1

2.2

0.23

0.22

g/l

1.29

183

1357

Anterior Iridocyclitis

830

7113

1.18

4.89

2.4

2.3

0.21

g/l

0.50

780

6634

Aneurysms, operations, SAH

680

5737

1.20

4.86

2.1

2.2

0.21

g/l

0.07

634

5331

Hordeolum and other deep inflammation of eyelid

236

1763

1.37

4.86

2.4

0.22

g/l

0.05

225

1661

Hyperkinetic disorders (excl. ADHD)

498

1.73

4.85

3.3

4.1

0.22

g/l

0.34

473

Oral leukoplakia, including avohilmo

127

854

1.56

4.84

2.1

2.2

0.21

g/l

0.26

119

800

Chondropathies

606

5062

1.22

4.83

2.7

2.4

0.22

g/l

1.14

552

4748

Tuberculosis, IBD comorbidity

288

2215

1.33

4.83

2.3

2.0

0.20

g/l

0.70

266

2040

Viral haemorrhagic fevers, not elsewhere classified/unspecified

658

5539

1.21

4.80

2.4

0.22

0.21

g/l

1.60

626

5178

Parkinson's disease, strict definition, excluding more controls

489

3808

1.24

4.80

2.0

2.2

0.20

g/l

0.14

445

3553

Deviated nasal septum

1433

12750

1.13

4.79

2.3

2.4

0.22

0.21

g/l

5.91

1320

11863

Universal erythroderma, KELA reimbursement

386

1.84

4.78

2.7

2.2

0.20

0.21

g/l

0.56

358

Dislocation, sprain and strain of joints and ligaments of thorax

134

911

1.52

4.76

2.5

2.2

0.22

g/l

0.06

118

860

Other lack of coordination

509

1.73

4.74

2.2

2.5

0.21

g/l

0.16

473

Superficial frostbite

168

2.32

4.73

2.4

2.2

0.22

0.23

g/l

0.58

156

Other and unspecified hereditary haemolytic anaemias

6.37

4.72

3.6

4.5

0.21

0.22

g/l

0.15

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

173

2.24

4.71

1.7

2.1

0.24

0.23

g/l

0.28

165

Other and unspecified acute skin changes due to ultraviolet radiation

115

762

1.58

4.70

2.2

0.21

g/l

0.17

102

699

Background retinopathy and retinal vascular changes

587

1.66

4.69

3.2

2.1

0.21

g/l

0.02

545

Toxic effect of corrosive substances

105

2.70

4.69

3.2

2.4

0.19

0.23

g/l

2.22

Obstructed labour due to malposition and malpresentation of fetus

540

6067

0.82

4.69

2.2

0.23

g/l

1.10

510

5738

Abnormal blood-pressure reading, without diagnosis

189

1372

1.42

4.69

2.3

0.22

0.21

g/l

1.01

172

1301

Other injuries of upper limb, level unspecified

315

1.92

4.67

2.4

0.21

0.22

g/l

0.26

292

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

110

720

1.58

4.67

2.9

2.3

0.22

g/l

0.05

103

681

Acute appendicitis

3123

27013

1.09

4.63

2.3

0.22

g/l

4.12

2913

25177

Other specified disorders of muscle

119

795

1.55

4.62

2.1

2.2

0.20

0.21

g/l

0.44

109

737

Symptoms and signs involving appearance and behaviour

203

2.16

4.61

2.1

2.3

0.20

0.22

g/l

0.81

194

Residual foreign body in soft tissue

200

1469

1.40

4.60

2.2

2.3

0.22

g/l

0.50

190

1367

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

245

1852

1.35

4.60

2.6

2.2

0.23

g/l

0.06

238

1756

Cerebral aneurysm, nonruptured

357

2842

1.28

4.60

2.1

2.2

0.22

0.21

g/l

0.19

331

2659

Parkinson's disease, excluding more controls

523

4075

1.23

4.60

2.0

2.3

0.20

g/l

0.16

478

3801

Other congenital malformations of intestine

325

1.91

4.59

5.5

2.6

0.23

0.22

g/l

0.71

304

Acute and subacute iridocyclitis

776

6652

1.18

4.59

2.3

0.21

g/l

0.47

728

6207

Glaucoma secondary to other eye disorders

172

1236

1.44

4.57

2.0

2.3

0.20

0.21

g/l

1.04

159

1149

Contact with other hot fluids

129

880

1.52

4.54

2.9

2.6

0.22

g/l

0.10

119

821

Contact with other hot metals

430

1.77

4.54

2.8

2.6

0.20

0.22

g/l

0.64

400

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

546

1.68

4.54

2.5

2.2

0.19

0.20

g/l

1.10

513

Diseases of appendix

3374

28248

1.08

4.53

2.4

2.3

0.22

g/l

5.09

3153

26315

Atrioventricular septal defect

108

2.70

4.53

3.7

4.1

0.20

0.22

g/l

0.51

103

Overexertion and strenuous or repetitive movements

391

3149

1.27

4.53

2.4

2.3

0.22

g/l

0.69

348

2942

Phantom limb syndrome

3.27

4.53

2.5

2.9

0.23

0.22

g/l

0.09

Other congenital malformations, not elsewhere classified

226

2.10

4.53

3.7

3.6

0.21

0.22

g/l

0.41

219

Mild or no visual impairment, binocular

120

2.57

4.52

2.1

2.2

0.22

g/l

0.08

115

Arthropod-borne viral fevers and viral haemorrhagic fevers

742

6345

1.19

4.52

2.5

2.4

0.22

0.21

g/l

0.95

705

5916

Vascular dementia (mixed)

491

1.71

4.52

1.4

2.0

0.21

0.19

g/l

1.37

450

Retinal vascular disorders

510

4226

1.23

4.51

2.4

2.1

0.20

g/l

0.04

472

3897

Endometriosis of ovary

645

5318

1.20

4.49

2.5

2.1

0.22

g/l

0.15

617

4967

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

1501

0.64

4.49

1.8

2.2

0.22

g/l

0.57

1419

Diabetic retinopathy, strict definition

839

6411

1.18

4.47

2.4

0.19

0.21

g/l

14.98

757

5920

Renal tubulo-interstitial disorders in diseases classified elsewhere

270

1.99

4.47

2.5

2.0

0.24

0.22

g/l

0.95

247

Vascular dementia (subcortical)

138

958

1.49

4.46

1.5

2.0

0.19

g/l

0.37

126

874

Tooth eruption problems

478

3830

1.23

4.46

3.4

2.9

0.23

g/l

0.01

450

3596

Meningitis

195

1436

1.40

4.45

2.4

2.3

0.22

g/l

0.25

185

1350

Disorders of speech understanding and production

178

1269

1.42

4.41

3.9

3.3

0.21

g/l

0.33

162

1204

Neovascular glaucoma

171

1236

1.43

4.41

2.0

2.3

0.20

0.21

g/l

1.35

158

1145

Other and unspecified injuries of ankle and foot

160

1142

1.44

4.39

3.6

2.4

0.21

0.22

g/l

1.12

148

1080

Benign neoplasm: Other and unspecified parts of mouth

143

1004

1.48

4.38

2.9

2.2

0.22

0.21

g/l

0.34

133

937

Viral agents as the cause of diseases classified to other chapters

638

1.61

4.36

3.4

2.6

0.21

0.22

g/l

0.18

605

Testicular hypofunction

132

913

1.50

4.35

2.5

0.23

0.22

g/l

0.44

125

846

Other congenital malformations of nervous system

229

2.04

4.32

2.1

3.0

0.21

0.23

g/l

0.86

222

Perforation of tympanic membrane

396

3214

1.26

4.30

2.1

2.3

0.21

g/l

0.12

365

2996

Systemic atrophies primarily affecting the central nervous system

179

1311

1.41

4.30

2.3

0.21

g/l

0.50

167

1222

L01XX Other antineoplastic agents

253

1951

1.34

4.30

1.9

2.1

0.20

0.21

g/l

1.31

230

1820

Benign neoplasm of other and unspecified sites

143

1009

1.47

4.28

2.1

2.2

0.22

0.21

g/l

0.39

134

944

Bronchitis, not specified as acute or chronic

335

2673

1.28

4.22

2.4

2.2

0.21

g/l

0.14

319

2484

Benign neoplasm: Long bones of lower limb

129

894

1.49

4.21

2.7

2.3

0.22

g/l

0.11

124

836

Tuberculosis, wide

295

2321

1.30

4.21

2.3

2.1

0.20

g/l

0.57

273

2130

Spirochaetal infections, other/unspecified

358

2885

1.27

4.20

2.7

2.3

0.22

0.21

g/l

1.80

333

2705

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

2.73

4.20

2.1

1.7

0.16

0.21

g/l

1.54

Follicular lymphoma, hilmo

188

1395

1.40

4.20

1.7

2.2

0.20

0.21

g/l

0.83

174

1293

Pilonidal cyst

295

2318

1.29

4.19

2.9

2.4

0.22

0.23

g/l

2.83

279

2161

False labour

775

5610

0.85

4.19

2.1

2.3

0.23

g/l

1.06

731

5299

Chronic conjunctivitis

125

863

1.50

4.19

2.1

2.5

0.22

0.21

g/l

0.63

113

814

Convergent concomitant strabismus

209

1570

1.36

4.18

3.1

2.6

0.22

g/l

0.49

198

1482

Trigger finger

591

4999

1.20

4.17

2.2

0.22

0.21

g/l

0.92

556

4679

Retinal vascular occlusion

500

4171

1.22

4.16

2.3

2.1

0.20

g/l

0.05

465

3850

Thyrotoxicosis with diffuse goitre

539

4522

1.21

4.15

2.1

0.22

g/l

0.17

502

4247

Optic neuritis

152

1087

1.44

4.15

2.4

2.3

0.23

0.22

g/l

0.10

146

1031

Other/unspecified synovitis and tenosynovitis

457

3777

1.23

4.15

2.4

2.2

0.21

g/l

0.20

431

3527

Single delivery by caesarean section

493

3407

0.82

4.15

2.3

2.4

0.23

g/l

0.99

463

3194

Cluster headache, strict, including avohilmo

183

1350

1.39

4.14

2.3

0.22

g/l

0.00

173

1268

Other and unspecified visual disturbances

414

3392

1.24

4.14

2.4

2.2

0.22

0.21

g/l

0.40

386

3184

Other specified and unspecified retinal disorders

150

1074

1.45

4.14

2.7

2.2

0.21

g/l

0.07

142

1004

Appendicitis, broad definition

3333

28095

1.08

4.14

2.3

0.22

g/l

4.87

3114

26172

Dementia, including avohilmo

2060

12939

1.10

4.12

1.8

2.1

0.20

g/l

0.69

1813

11959

Schizotypal disorder

565

1.62

4.12

1.9

2.4

0.23

g/l

0.16

532

Complications of labour and delivery

2218

13457

0.91

4.10

2.2

0.22

g/l

0.70

2092

12623

Panhypopituitarism

497

1.67

4.10

2.4

0.21

0.22

g/l

0.39

460

Herpesviral keratitis and keratoconjunctivitis

177

1304

1.40

4.09

2.2

2.1

0.20

0.21

g/l

0.97

163

1219

Benign neoplasm: Skin of eyelid, including canthus

650

5555

1.19

4.09

2.2

0.22

0.21

g/l

2.28

610

5163

Immunodeficiency associated with other specified major defects, or unspecified

7.96

4.09

3.9

3.3

0.20

0.24

g/l

—

Viral meningitis

133

932

1.47

4.08

2.6

2.3

0.22

0.23

g/l

0.14

122

877

Severe visual impairment, binocular

126

2.43

4.07

2.3

2.5

0.22

0.21

g/l

0.12

118

Epidural haemorrhage

227

2.01

4.07

2.5

2.9

0.20

0.22

g/l

1.10

214

Other osteochondropathies

271

2121

1.31

4.05

2.6

2.3

0.23

0.22

g/l

0.61

248

1996

Malignant neoplasm of bone and articular cartilage of limbs

2.71

4.01

3.1

3.3

0.19

0.21

g/l

0.47

Other contact dermatitis

305

2424

1.28

4.00

2.3

2.2

0.22

g/l

0.31

286

2280

Unspecified contracted kidney

154

2.27

3.98

2.8

2.3

0.24

0.22

g/l

0.63

143

Carcinoma in situ of skin of upper limb, including shoulder

115

793

1.52

3.98

2.4

2.1

0.23

0.20

g/l

3.93

107

733

Benign neoplasm of urinary organs

199

1501

1.37

3.97

2.1

2.2

0.21

g/l

0.63

182

1403

Carcinoma in situ of skin of ear and external auricular canal

401

1.74

3.96

2.0

2.2

0.21

0.19

g/l

0.62

368

Mild mental retardation

107

726

1.53

3.94

2.8

3.1

0.22

g/l

0.23

101

688

Other secondary gonarthrosis

226

1738

1.34

3.93

1.9

2.2

0.22

0.21

g/l

0.34

211

1632

Benign neoplasm: Floor of mouth

2.84

3.93

1.7

2.8

0.21

0.22

g/l

0.14

318

1.83

3.93

2.4

0.20

0.22

g/l

0.54

291

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

296

1.86

3.91

1.8

2.2

0.21

0.23

g/l

0.67

278

Frostbite

289

1.87

3.91

2.8

2.3

0.21

0.22

g/l

0.49

265

Other infective spondylopathies

3.34

3.91

3.6

1.9

0.19

0.21

g/l

0.63

Other demyelinating diseases of the central nervous system

133

940

1.45

3.90

2.3

2.4

0.22

0.23

g/l

0.09

127

883

Eustachian salpingitis and obstruction

263

2058

1.30

3.90

2.9

2.5

0.23

g/l

0.38

253

1929

Malignant immunoproliferative diseases

306

1.86

3.89

3.0

2.3

0.16

0.21

g/l

3.89

280

Pre-eclampsia

701

6045

1.17

3.88

2.2

0.22

g/l

0.66

664

5694

Pre-eclampsia or poor fetal growth

1028

9064

1.14

3.87

2.3

2.2

0.22

0.23

g/l

1.13

965

8552

Pre-eclampsia or eclampsia

766

6654

1.16

3.84

2.2

0.22

g/l

0.51

726

6269

Personality and behavioural disorders due to brain disease, damage and dysfunction

427

1.70

3.84

2.2

2.5

0.21

g/l

0.08

395

Pleural plaque with presence of asbestos

301

2408

1.28

3.83

2.3

2.2

0.19

g/l

1.17

262

2208

Dependent personality disorder

562

1.60

3.81

2.2

0.23

0.22

g/l

0.44

533

Flat foot [pes planus] (acquired)

385

3160

1.24

3.81

2.3

2.2

0.22

0.21

g/l

0.80

357

2966

Burns and corrosions confined to eye and internal organs

106

723

1.52

3.80

2.4

0.22

g/l

0.01

674

Calculus of lower urinary tract

218

1677

1.33

3.79

2.2

0.20

g/l

0.54

192

1547

Myocardial infarction, with ST-elevation

715

6192

1.17

3.79

2.2

0.20

g/l

0.37

656

5687

Hyperprolactinaemia

119

829

1.47

3.78

2.2

2.3

0.22

g/l

0.05

107

782

Generalized epilepsy, strict definition

602

1.57

3.78

2.3

2.9

0.24

0.22

g/l

1.46

571

Chronic iridocyclitis

200

1521

1.35

3.77

2.5

2.2

0.21

0.22

g/l

0.52

192

1425

Henoch-Schönlein purpura nephritis (HSPN)

2.70

3.77

2.0

2.8

0.19

0.23

g/l

1.40

Crowding of teeth, including avohilmo

323

2145

1.26

3.77

3.9

3.3

0.22

g/l

0.11

303

2014

Epiphora

645

1.55

3.76

1.8

2.1

0.20

0.21

g/l

0.73

608

Benign neoplasm: Skin of trunk

169

1256

1.38

3.73

2.6

2.3

0.22

0.21

g/l

0.13

155

1178

Enteropathogenic Escherichia coli infection

2.72

3.73

3.1

2.8

0.20

0.22

g/l

0.84

Other disorders of pigmentation

178

1334

1.37

3.73

2.3

0.20

0.21

g/l

1.53

164

1260

Hirsprung

5.13

3.72

10.9

5.2

0.22

0.20

g/l

0.59

Carcinoma in situ of skin of scalp and neck

113

787

1.50

3.72

2.4

2.2

0.20

g/l

0.56

104

719

Cluster headache, wide,, including avohilmo

192

1453

1.35

3.71

2.3

0.23

0.22

g/l

0.19

182

1363

Scissor bite

120

835

1.47

3.69

4.6

4.3

0.23

0.22

g/l

0.35

112

800

Postzoster neuralgia

464

1.66

3.69

2.2

2.1

0.20

g/l

0.05

430

Demyelinating diseases of the central nervous system

303

2432

1.27

3.68

2.4

2.3

0.22

g/l

0.14

288

2291

Burn and corrosion of shoulder and upper limb, except wrist and hand

599

1.56

3.67

2.6

2.5

0.21

0.22

g/l

0.60

559

Benign neoplasm of bone and articular cartilage

319

2578

1.26

3.67

2.6

2.2

0.23

0.22

g/l

1.10

304

2411

Guttate psoriasis

371

1.73

3.65

1.9

2.2

0.22

g/l

0.26

349

Other neurotic disorders

192

1460

1.35

3.63

2.5

2.1

0.22

0.21

g/l

0.33

176

1364

Covid-19 suspected case

809

7086

1.15

3.62

2.5

2.3

0.23

0.22

g/l

1.49

744

6618

Pedestrian injured in collision with car, pick-up truck or van

658

1.53

3.60

2.0

2.2

0.23

0.22

g/l

0.99

617

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1394

9057

0.90

3.59

2.2

2.3

0.23

g/l

1.11

1318

8520

Abscess of Bartholin gland

625

1.53

3.57

2.5

2.2

0.22

g/l

0.11

588

Allergic contact dermatitis

503

4257

1.20

3.57

2.3

2.2

0.22

g/l

1.31

468

4004

Dementia

1906

12030

1.10

3.55

1.8

2.1

0.20

g/l

0.43

1671

11126

Carcinoma in situ, bladder

146

1074

1.41

3.53

1.9

2.2

0.21

0.20

g/l

0.92

135

987

Helminthiases

477

1.62

3.51

3.2

2.3

0.19

0.22

g/l

2.96

450

Gluteal tendinitis

159

1183

1.38

3.51

2.3

2.2

0.23

0.21

g/l

3.36

150

1119

Guillain-Barre syndrome

455

1.64

3.47

1.7

2.2

0.21

g/l

0.04

432

Carcinoma in situ of cervix uteri

286

2295

1.26

3.47

2.1

2.2

0.23

0.22

g/l

0.57

263

2159

Primary coxarthrosis, bilateral

1247

11257

1.12

3.45

2.0

2.1

0.21

0.20

g/l

0.47

1163

10396

conjunctival haemorrhage

315

2565

1.25

3.45

2.5

2.2

0.21

g/l

0.54

291

2382

Postpartum hemorraghe, all women as controls

603

6882

0.86

3.45

2.1

2.2

0.23

g/l

0.30

575

6496

Monocytic leukaemia

2.55

3.45

1.4

2.6

0.20

0.21

g/l

0.13

Use of biperiden

205

1587

1.32

3.43

2.0

2.2

0.21

0.22

g/l

0.29

180

1492

Inguinal or femoral hernia, bilateral

425

3563

1.21

3.42

2.4

2.3

0.21

0.20

g/l

0.72

387

3319

Multiple delivery

207

2652

0.77

3.41

2.0

2.3

0.23

0.22

g/l

0.37

196

2482

Disorder of external ear, unspecified

130

943

1.42

3.39

2.6

2.2

0.21

0.22

g/l

0.05

118

883

Family history of certain disabilities and chronic diseases leading to disablement

153

1135

1.37

3.38

2.1

0.22

g/l

0.03

146

1069

Ankylosing spondylitis, strict definition

159

1189

1.37

3.38

2.5

2.3

0.23

g/l

0.45

149

1122

Crossbite

279

2073

1.27

3.37

4.6

3.3

0.22

g/l

0.07

260

1963

Tonsillectomy and adenotomy

2228

14341

1.09

3.36

2.5

0.23

0.22

g/l

2.14

2100

13479

Dementia due to Parkinsons disease, excluding more controls

586

1.54

3.36

1.8

2.1

0.20

g/l

0.04

540

Superficial injury of neck

473

1.60

3.35

2.3

2.6

0.22

0.23

g/l

0.23

442

Diabetic maculopathy

584

4751

1.18

3.34

2.2

2.4

0.20

0.21

g/l

5.90

532

4389

Other and unspecified injuries of abdomen, lower back and pelvis

357

1.69

3.32

2.1

2.4

0.21

0.22

g/l

0.70

336

Poisoning by medicine, drug-induced

358

1.70

3.32

1.8

2.4

0.20

0.23

g/l

1.49

335

Idiopathic peripheral autonomic neuropathy

2.53

3.31

2.5

2.4

0.20

0.21

g/l

0.07

Benign neoplasm of middle ear and respiratory system

314

2568

1.25

3.30

2.7

2.2

0.21

g/l

0.20

298

2396

Intestinal helminthiases, other/unspecified

2.69

3.30

3.3

2.5

0.22

0.20

g/l

0.24

Other deformities of toe(s)

144

1067

1.39

3.30

2.3

2.2

0.21

g/l

0.05

132

1010

Other degenerative diseases of the basal ganglia

568

1.56

3.29

2.0

2.2

0.20

0.21

g/l

0.10

530

Biomechanical lesions, not elsewhere classified

200

1554

1.32

3.29

2.3

2.2

0.23

0.21

g/l

2.74

183

1456

Corneal scars and opacities

116

831

1.45

3.29

2.6

2.4

0.21

g/l

0.30

109

786

Other protozoal intestinal diseases

532

1.55

3.28

2.7

2.3

0.23

0.22

g/l

0.81

502

Unknown and unspecified causes of morbidity

237

1876

1.28

3.27

2.5

2.0

0.21

0.22

g/l

1.54

223

1771

Anomalies of dental arch relationship, including avohilmo

745

5894

1.15

3.26

3.0

2.6

0.22

g/l

1.06

702

5538

Dysplasia of cervi uteri

853

5457

1.14

3.23

2.4

2.1

0.23

0.22

g/l

4.45

800

5091

Unspecified chronic bronchitis

137

1009

1.39

3.23

2.8

2.2

0.20

0.21

g/l

0.19

122

932

Exposure to controlled fire, not in building or structure

2.77

3.22

2.5

2.8

0.23

0.22

g/l

0.20

Injury of blood vessels at shoulder and upper arm level

3.83

3.22

2.4

2.6

0.22

0.21

g/l

0.07

Carcinoma in situ of skin

354

2941

1.23

3.22

2.7

2.0

0.21

0.20

g/l

1.65

330

2723

Retinal detachments and breaks

1549

14185

1.10

3.20

2.4

2.2

0.21

g/l

0.29

1449

13170

Conduct disorder

486

1.57

3.20

2.3

3.0

0.22

0.23

g/l

0.40

457

Benign neoplasm: Kidney

144

1075

1.38

3.18

1.8

2.2

0.21

g/l

0.39

133

1016

Other specified/unspecified dorsopathies

137

1014

1.39

3.16

2.6

2.1

0.22

0.21

g/l

0.43

120

954

Benign neoplasm: Lower jaw bone

107

2.35

3.16

2.3

2.6

0.24

0.22

g/l

0.68

102

Thyroiditis

268

2166

1.26

3.15

2.1

2.3

0.22

g/l

0.56

259

2038

Pregnancy hypertension

1501

12286

1.10

3.15

2.2

0.22

g/l

0.06

1421

11557

Adenomyosis (Endometriosis of uterus)

525

4513

1.18

3.15

2.1

0.21

g/l

0.33

497

4193

Disorders of puberty

362

1.66

3.14

3.7

3.8

0.23

g/l

0.33

345

Other specified/unspecified disorders of bone/cartilage

106

753

1.45

3.14

2.1

2.3

0.21

0.22

g/l

0.67

718

Other congenital malformations of integument

2.73

3.14

1.6

3.3

0.20

0.21

g/l

0.42

Adult-onset Still disease

2.54

3.13

2.4

2.3

0.21

0.23

g/l

0.40

Synovial cyst of popliteal space [Baker]

295

2412

1.25

3.12

1.9

2.1

0.21

g/l

0.16

274

2247

Benign neoplasm of other and unspecified intrathoracic organs

303

1.74

3.11

2.7

2.1

0.20

0.22

g/l

0.92

285

Disorder of the sleep-wake schedule

483

1.57

3.11

2.8

0.23

0.22

g/l

0.26

451

Causalgia

427

1.61

3.11

2.5

2.2

0.20

0.22

g/l

1.90

404

Inguinal hernia, bilateral

416

3516

1.20

3.10

2.4

2.3

0.21

0.20

g/l

0.55

380

3274

Mental and behavioural disorders associated with the puerperium

204

1.89

3.10

1.7

2.4

0.24

0.22

g/l

0.69

196

Chondrosarcoma, including Hilmo

2.44

3.08

1.7

2.2

0.19

0.21

g/l

0.68

Lichen sclerosus et atrophicus

398

3354

1.21

3.07

2.3

2.1

0.21

g/l

0.14

365

3135

Radial styloid tenosynovitis [de Quervain]

203

1593

1.30

3.06

2.3

2.2

0.22

g/l

0.37

190

1507

Other congenital malformations of upper alimentary tract

223

1.88

3.03

2.5

2.6

0.21

g/l

0.17

210

Spinal instabilities

115

835

1.42

3.02

3.1

2.3

0.23

0.22

g/l

1.30

106

792

Bitten or struck by other mammals

406

3430

1.20

3.02

2.3

2.4

0.23

0.22

g/l

0.91

368

3227

Carcinoma in situ of oral cavity

2.81

3.01

1.3

2.3

0.23

0.21

g/l

0.37

Testicular dysfunction

139

1041

1.37

3.00

2.5

0.23

0.22

g/l

0.45

132

968

Pedal cyclist injured in other and unspecified transport accidents

425

3609

1.19

2.99

2.4

0.21

0.22

g/l

0.34

383

3374

Hallux rigidus

578

5029

1.16

2.99

2.1

2.2

0.22

0.21

g/l

1.55

530

4727

Arnold-Chiari syndrome

200

1.89

2.99

2.2

2.9

0.22

0.23

g/l

0.43

193

Benign neoplasm of meninges

416

3532

1.20

2.98

2.1

0.21

g/l

0.80

378

3295

Contusion of ankle

141

1058

1.36

2.98

2.4

0.24

0.22

g/l

1.25

132

1007

Schizoid personality disorder

473

1.56

2.95

2.5

2.4

0.22

0.23

g/l

0.11

441

Other and unspecified vascular occlusions

382

3223

1.21

2.94

2.3

2.1

0.20

g/l

0.02

349

2969

Acute nasopharyngitis (common cold)

433

3662

1.19

2.93

2.6

2.4

0.22

g/l

0.66

402

3426

Problems related to social environment

106

762

1.43

2.93

2.7

2.2

0.21

g/l

0.18

709

Motorcycle rider injured in other and unspecified transport accidents

203

1603

1.29

2.93

2.3

2.6

0.23

g/l

0.23

194

1498

Macular pucker

645

5670

1.15

2.91

2.3

2.1

0.20

g/l

0.16

589

5261

Chronic mastoiditis

107

774

1.43

2.91

1.9

2.3

0.20

g/l

0.02

713

Other disorders originating in the perinatal period

350

1.67

2.89

3.4

5.0

0.21

0.20

g/l

0.30

337

Contact with other sharp object(s)

232

1864

1.27

2.89

2.1

2.4

0.23

g/l

0.32

218

1741

Paralytic strabismus

280

2300

1.24

2.88

2.3

2.2

0.21

g/l

0.06

254

2143

Other disorders of binocular movement

549

1.50

2.86

2.0

2.7

0.22

g/l

0.06

520

Helminthiases

139

1048

1.36

2.86

2.7

2.6

0.21

0.22

g/l

0.91

127

991

Fibrosarcoma, including Hilmo

174

1.94

2.85

2.8

2.0

0.21

0.20

g/l

0.17

156

Chondrocostal junction syndrome [Tietze]

142

1076

1.35

2.85

2.6

2.1

0.23

0.21

g/l

1.18

126

1007

Cysts of oral region, not elsewhere classified

226

1817

1.27

2.84

2.1

2.2

0.22

g/l

0.16

213

1700

Dyshidrosis [pompholyx]

381

1.61

2.82

2.3

2.2

0.22

g/l

0.20

363

Sequelae of poliomyelitis

258

1.77

2.81

1.7

2.0

0.22

0.21

g/l

0.54

236

Embedded teeth, including avohilmo

283

2327

1.23

2.81

3.2

2.6

0.22

0.23

g/l

0.57

266

2168

Sacrococcygeal disorders, not elsewhere classified

113

828

1.40

2.81

2.0

2.2

0.22

g/l

0.22

106

793

Acute appendicitis, with complications

787

7015

1.13

2.81

2.3

0.21

g/l

0.36

725

6531

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

113

2.23

2.80

1.6

2.3

0.24

0.23

g/l

0.24

102

Dronedarone medication

120

891

1.39

2.80

2.5

2.2

0.21

g/l

0.16

107

843

Mouth breathing

1730

15999

1.09

2.80

2.2

2.5

0.22

g/l

2.12

1594

14967

Congenital malformations of genital organs

312

2579

1.22

2.78

2.7

0.22

g/l

0.32

298

2445

Acute appendicitis, no complications

2336

21758

1.07

2.78

2.4

2.3

0.23

0.22

g/l

3.69

2188

20322

Coxarthrosis, primary, with hip surgery

2134

18637

1.08

2.77

2.1

2.2

0.21

g/l

0.07

1987

17201

Burn and corrosion of head and neck

596

1.47

2.76

2.5

2.6

0.21

0.22

g/l

0.21

558

Disorders of visual cortex

7.12

2.75

1.2

2.0

0.23

g/l

—

Enterobiasis

2.32

2.75

2.2

3.1

0.20

0.23

g/l

1.10

Outcome of delivery

410

2977

0.84

2.74

2.0

2.2

0.24

0.23

g/l

3.20

390

2790

Degenerative macular diseases

487

4217

1.17

2.74

2.3

2.1

0.21

0.20

g/l

0.55

443

3904

Hypermetropia

268

2201

1.24

2.74

2.7

0.21

0.22

g/l

0.15

253

2063

Chronic diseases of tonsils and adenoids

3601

21553

1.06

2.73

2.4

0.23

0.22

g/l

13.44

3397

20139

Other disorders of iris and ciliary body

107

783

1.41

2.72

2.1

2.3

0.20

0.21

g/l

1.01

728

Burns and corrosions of multiple body regions

253

1.75

2.71

2.1

2.5

0.21

0.22

g/l

0.41

232

Other sexually transmitted chlamydial diseases

273

2245

1.23

2.70

2.0

2.6

0.24

0.23

g/l

0.12

247

2093

Urethral stricture

220

1775

1.26

2.70

2.1

2.2

0.22

0.20

g/l

1.29

193

1644

Chalazion

433

3720

1.18

2.69

2.3

0.22

0.21

g/l

1.96

397

3483

Rapidly progressive nephritic syndrome

2.78

2.68

3.4

2.4

0.26

0.22

g/l

0.87

Bartonellosis

8.61

2.68

1.4

1.6

0.17

0.23

g/l

—

Calcification and ossification of muscle

2.77

2.68

1.5

1.9

0.21

0.22

g/l

0.13

Other disorders of conjunctiva

566

4965

1.15

2.66

2.6

2.2

0.21

g/l

0.82

521

4626

Other and unspecified injuries of wrist and hand

139

1061

1.34

2.65

2.5

0.22

g/l

0.21

128

991

Other congenital malformations of circulatory system

103

753

1.41

2.65

2.6

2.5

0.22

g/l

0.05

709

Behavioural disorders

508

1.50

2.65

2.4

3.2

0.22

0.23

g/l

0.37

477

Cerebral atherosclerosis

348

1.61

2.61

1.9

2.1

0.21

0.20

g/l

0.17

316

Female infertility

1046

5751

1.11

2.59

2.3

2.2

0.23

0.22

g/l

2.39

989

5376

Congenital ovarian cysts

131

994

1.34

2.59

2.0

2.1

0.24

0.23

g/l

0.90

126

941

Secondary parkinsonism+Parkinsonism in other disease

113

843

1.38

2.58

1.7

2.2

0.21

g/l

0.35

107

780

Other dermatomyositis

138

2.03

2.58

3.2

2.3

0.20

0.22

g/l

0.76

128

Drug-induced headache, not elsewhere classified

116

2.10

2.57

1.9

2.1

0.22

g/l

0.21

111

Spinal enthesopathy

710

1.40

2.57

2.3

1.7

0.19

g/l

0.25

635

Ulcer of vagina/vulva

672

1.42

2.56

2.3

2.2

0.23

0.22

g/l

0.87

630

Lumbosacral plexus disorders

2.32

2.55

2.3

2.1

0.20

0.22

g/l

0.78

Pterygium

919

0.67

2.55

2.0

2.3

0.20

0.21

g/l

0.25

857

Anomalies of pupillary function

547

1.47

2.54

2.2

2.4

0.21

0.22

g/l

0.72

521

Postprocedural disorders of nervous system

231

1885

1.24

2.53

2.3

0.23

g/l

0.86

219

1777

Other specified/unspecified deforming dorsopathies

473

1.51

2.53

2.1

0.21

0.22

g/l

0.89

454

Etanercept

237

1942

1.24

2.53

3.0

2.4

0.22

g/l

0.06

217

1824

Acute inflammation of orbit

160

1.92

2.52

2.6

2.4

0.21

0.22

g/l

0.36

151

Pregnancy with abortive outcome

2761

13566

1.07

2.52

2.1

0.22

g/l

0.02

2595

12640

Other and unspecified degenerative diseases of nervous system

105

778

1.39

2.51

2.1

2.2

0.20

g/l

0.07

721

Exposure to other and unspecified animate mechanical forces

108

802

1.38

2.51

2.3

2.6

0.23

0.22

g/l

0.05

755

Benign neoplasm: Endocrine gland, other/unspecified

2.29

2.49

1.8

2.1

0.20

0.21

g/l

0.36

Premature rupture of membranes

533

4352

0.87

2.49

2.1

2.3

0.23

g/l

0.24

508

4102

Disorders of puberty, all

451

1.51

2.47

3.9

4.1

0.24

0.22

g/l

0.98

431

Benign neoplasm: Skin of ear and external auricular canal

148

1154

1.31

2.46

1.9

2.1

0.20

0.21

g/l

0.20

139

1069

Pedestrian injured in transport accident

255

2112

1.23

2.46

2.0

2.2

0.22

g/l

0.29

235

1969

Collapsed vertebra, not elsewhere classified

222

1.76

2.46

3.2

1.8

0.21

0.20

g/l

0.29

207

Scarlet fever

183

1.83

2.46

4.5

3.4

0.22

0.23

g/l

0.18

178

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

133

2.02

2.46

3.2

2.2

0.22

0.21

g/l

0.35

124

Thyrotoxicosis with toxic multinodular goitre

241

1988

1.24

2.45

2.1

0.21

g/l

0.27

225

1855

Amoebiasis

140

1.98

2.45

2.8

2.4

0.22

g/l

0.21

131

Secondary parkinsonism

109

816

1.38

2.45

1.8

2.2

0.21

g/l

0.51

103

753

Alport

3.39

2.44

2.3

4.4

0.29

0.22

g/l

—

Benign neoplasm: Cerebral meninges

373

3200

1.18

2.43

2.1

0.22

0.21

g/l

1.32

343

2991

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1691

13671

1.08

2.43

2.1

2.2

0.22

g/l

0.23

1602

12833

Disorders of optic chiasm

4.77

2.43

2.9

0.25

0.21

g/l

—

Benign neoplasm: Penis

2.89

2.42

2.1

0.22

0.23

g/l

0.11

Other/unspecified soft tissue disorders related to use, overuse and pressure

104

773

1.38

2.42

2.2

2.1

0.22

g/l

0.46

730

Hereditary nephropathy, not elsewhere classified

2.39

2.41

3.8

2.5

0.20

0.22

g/l

0.32

Benign lipomatous neoplasm of other sites/unspecified

340

2897

1.19

2.41

2.0

2.1

0.22

0.21

g/l

1.46

316

2696

Mixed conductive and sensorineural hearing loss

492

4310

1.16

2.40

2.3

2.2

0.21

g/l

0.17

451

4003

Postpartum hemorraghe, parous women as controls

603

5791

0.88

2.40

2.1

0.23

g/l

0.24

575

5501

Endometriosis of pelvic peritoneum

555

4663

1.14

2.39

2.3

2.2

0.23

0.22

g/l

3.25

532

4370

Retinal haemorrhage

100

742

1.39

2.39

2.7

2.1

0.21

g/l

0.13

684

Burn and corrosion of other internal organs

2.35

2.38

4.4

2.3

0.21

0.23

g/l

0.39

Blepharochalasis

1263

11641

1.09

2.38

2.0

2.1

0.22

0.21

g/l

5.27

1173

10855

Foreign body entering into or through eye or natural orifice

300

2531

1.20

2.38

2.2

2.4

0.22

g/l

0.39

279

2364

Aggressive periodontitis

615

1.43

2.38

2.0

2.2

0.22

0.21

g/l

0.54

573

Open bite

176

1406

1.27

2.38

3.7

3.2

0.22

0.23

g/l

0.31

163

1332

Horner syndrome

351

1.58

2.36

2.8

2.4

0.23

0.22

g/l

0.87

327

Acné excoriée

4.39

2.35

1.4

2.0

0.25

0.22

g/l

—

Pedal cyclist injured in transport accident

853

7724

1.11

2.34

2.4

0.22

g/l

0.28

782

7213

Stenosis and insufficiency of lacrimal passages

370

3182

1.18

2.34

2.2

0.21

g/l

0.21

333

2962

Respiratory tuberculosis, confirmed and not-confirmed

202

1645

1.25

2.32

2.2

2.1

0.20

g/l

0.25

190

1516

Respiratory tuberculosis

202

1645

1.25

2.32

2.2

2.1

0.20

g/l

0.25

190

1516

Blindness, monocular

233

1.71

2.32

1.9

2.1

0.23

0.22

g/l

0.47

222

Tuberculosis of other organs

609

1.42

2.32

2.9

2.1

0.19

0.20

g/l

1.04

566

Other and unspecified disease of Bartholin gland

111

841

1.36

2.32

2.2

2.1

0.22

0.21

g/l

0.35

105

799

Normal-pressure hydrocephalus

124

1599

0.76

2.31

1.8

2.0

0.20

g/l

0.36

107

1478

Excessive vomiting in pregnancy

249

2069

1.22

2.31

2.1

2.3

0.22

g/l

0.29

227

1964

Bartonellosis

6.37

2.30

1.4

0.17

0.23

g/l

—

Injury of nerves at hip and thigh level

108

2.11

2.30

2.0

2.6

0.23

0.22

g/l

0.49

Syndrome of inappropriate secretion of antidiuretic hormone

129

1.98

2.29

4.4

2.4

0.18

0.21

g/l

0.93

120

Disorders of orbit

164

1308

1.28

2.29

2.5

2.2

0.21

g/l

0.12

150

1227

Tuberculosis

230

1901

1.23

2.29

2.2

2.0

0.20

g/l

0.11

216

1747

Retinal detachment with retinal break

517

4563

1.15

2.27

2.4

2.2

0.20

0.21

g/l

0.50

472

4232

Overjet

103

770

1.37

2.27

4.0

4.4

0.22

g/l

0.12

741

Transient retinal artery occlusion

2.63

2.26

1.9

2.1

0.21

0.20

g/l

0.26

Other and unspecified nerve root and plexus disorders, also in other diseases

775

7001

1.12

2.25

2.1

2.3

0.23

0.22

g/l

3.36

698

6544

Multiple myeloma and malignant plasma cell neoplasms

191

1555

1.26

2.25

2.4

2.1

0.19

0.20

g/l

0.93

180

1441

Deep bite

432

3301

1.16

2.24

3.4

3.0

0.23

0.22

g/l

1.09

415

3108

Alzheimer’s disease (undefined)

199

0.39

2.21

1.5

1.9

0.18

g/l

—

171

Aphakia

371

1.52

2.20

2.0

2.1

0.21

g/l

0.23

347

Other menopausal disorders

940

5811

0.90

2.20

1.9

2.1

0.23

0.21

g/l

11.85

885

5415

Abscess of external ear

332

1.56

2.18

2.5

2.3

0.22

g/l

0.11

310

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

252

2111

1.21

2.15

2.0

0.20

g/l

0.14

229

1954

Melanocytic naevi, other sites/unspecified

291

2474

1.19

2.15

2.5

2.2

0.22

g/l

0.99

279

2325

Congenital deformities of hip

550

1.42

2.13

2.3

3.2

0.22

g/l

0.06

526

Meralgia paraesthetica

129

1012

1.30

2.10

2.2

0.23

0.21

g/l

1.25

119

946

Plantar fascial fibromatosis

370

3211

1.17

2.10

2.2

0.23

0.22

g/l

2.57

344

3013

Inflammatory diseases of prostate (prostatitis)

491

4344

1.14

2.10

2.3

2.4

0.22

0.21

g/l

3.26

454

4016

Disorders of optic nerve, not elsewhere classified

630

1.39

2.10

2.4

2.3

0.22

0.21

g/l

0.51

593

Other abnormal products of conception

868

6310

0.91

2.09

2.3

2.2

0.23

g/l

0.55

820

5963

Dementia in Alzheimer disease

672

5107

1.12

2.08

1.6

2.0

0.19

g/l

0.95

560

4655

Eclampsia

2.82

2.07

1.7

2.3

0.23

0.24

g/l

—

Fibrosarcoma

148

1.84

2.07

2.6

2.0

0.21

g/l

0.02

133

Muscle strain

114

881

1.32

2.07

2.0

2.3

0.22

g/l

0.30

108

830

Contracture of joint

329

1.54

2.06

2.2

0.22

0.21

g/l

0.20

313

Other and unspecified injuries of forearm

179

1.75

2.04

2.6

2.7

0.19

0.23

g/l

1.83

170

Respiratory and cardiovascular disorders specific to the perinatal period

114

791

1.33

2.04

4.3

5.1

0.20

0.21

g/l

0.56

107

764

Mental and behavioural disorders of puerperium, not classified elsewhere

233

1.64

2.04

1.7

2.3

0.24

0.23

g/l

0.46

227

Other intracranial haemorrhages

122

956

1.31

2.02

2.8

2.1

0.20

g/l

0.04

115

889

Maternal care for known or suspected malpresentation of fetus

432

3563

0.87

2.02

2.4

2.3

0.23

g/l

0.15

408

3367

Other bursitis of hip

582

1.40

2.02

1.9

2.1

0.21

g/l

0.03

548

Tuberculosis of other organs, strict

694

1.36

2.01

2.9

2.1

0.19

0.20

g/l

0.82

640

Other acquired deformities of musculoskeletal system and connective tissue

171

1394

1.25

2.01

2.0

2.3

0.21

0.22

g/l

0.63

159

1310

Third [oculomotor] nerve palsy

541

1.41

2.00

2.6

2.2

0.22

0.21

g/l

0.31

508

Spontaneous abortion

1527

11020

0.93

2.00

2.3

2.2

0.22

g/l

0.38

1443

10346

Convergence insufficiency and excess

290

1.56

2.00

2.1

2.6

0.22

0.23

g/l

0.04

275

Maternal care for other known or suspected fetal problems

586

4145

0.89

1.98

2.4

2.3

0.23

g/l

0.44

549

3908

Pathological resorption of teeth

129

1022

1.29

1.96

3.4

2.3

0.21

0.22

g/l

0.18

122

956

Sixth [abducent] nerve palsy

129

1023

1.29

1.96

2.3

0.21

g/l

0.22

114

951

Impingement syndrome of shoulder

1000

9215

1.09

1.96

2.5

2.3

0.22

0.21

g/l

2.41

940

8611

671

1.36

1.95

2.2

2.3

0.21

0.23

g/l

1.56

634

Diphtheria

3.15

1.95

3.4

2.4

0.23

0.24

g/l

—

Flatback syndrome

3.60

1.93

1.9

1.7

0.20

0.23

g/l

—

Macular hole

234

1979

1.20

1.92

2.1

0.21

g/l

0.52

209

1841

Benign neoplasm: Skin of lower limb, including hip

105

814

1.32

1.91

2.3

0.23

0.22

g/l

1.69

770

Early syphilis

343

1.51

1.91

1.9

2.5

0.22

g/l

0.24

318

Alzheimer’s disease (Early onset), excluding more controls

973

0.74

1.91

1.7

2.1

0.19

0.20

g/l

0.38

901

Dermatitis herpetiformis

520

1.41

1.91

2.5

2.2

0.21

g/l

0.38

483

Pseudosarcomatous fibromatosis

4.81

1.91

1.2

2.1

0.26

0.23

g/l

—

Other secondary gout

2.16

1.91

1.9

2.0

0.21

0.22

g/l

0.04

Other disorders of bone density and structure

683

1.35

1.90

2.2

2.3

0.22

g/l

0.05

644

Early lumbar disc prolapse, operated

297

2555

1.17

1.90

2.3

2.4

0.24

0.23

g/l

2.38

283

2420

Non-small cell lung cancer, adenocarcinoma, helper endpoint

243

2063

1.20

1.89

2.0

2.1

0.20

g/l

0.26

223

1913

Peroneal tendinitis

444

1.44

1.89

2.8

2.1

0.25

0.22

g/l

2.80

421

Foreign body in respiratory tract

191

1588

1.22

1.87

2.6

2.4

0.22

g/l

0.88

175

1485

HSIL lesion of the cervix uteri

545

4886

1.12

1.87

2.4

2.2

0.23

g/l

2.24

506

4635

Other benign neoplasms of connective and other soft tissue

369

3236

1.15

1.86

2.1

2.2

0.22

0.21

g/l

0.28

332

3033

Alzheimer’s disease (undefined), excluding more controls

175

0.43

1.85

1.5

2.0

0.18

g/l

—

158

Congenital malformations of trachea and bronchus

273

1.57

1.85

3.0

2.6

0.22

0.21

g/l

0.09

259

Cervicobrachial syndrome

849

7791

1.10

1.84

2.1

2.3

0.23

0.21

g/l

6.04

792

7283

Trichomoniasis

249

1.59

1.83

2.9

2.0

0.20

0.22

g/l

0.78

236

Torticollis

421

1.44

1.83

2.0

2.5

0.24

0.22

g/l

0.93

398

Other inflammation of vagina/vulva

105

818

1.31

1.82

2.2

0.23

0.22

g/l

0.92

779

Cervicocranial syndrome

396

3494

1.15

1.81

2.2

2.3

0.22

0.21

g/l

2.19

374

3259

Benign neoplasm: Skin of scalp and neck

715

1.33

1.81

1.9

2.4

0.22

0.21

g/l

0.28

674

Benign neoplasm of eye and adnexa

391

3450

1.15

1.81

2.4

2.2

0.21

g/l

0.30

364

3214

Disorders of pituitary gland, other and/or unspecified

140

1.80

1.81

2.7

2.5

0.24

0.22

g/l

0.82

129

Felty syndrome

148

1.79

1.81

3.0

2.2

0.21

g/l

0.03

135

Toxic effect of alcohol

585

1.37

1.81

2.7

2.3

0.20

0.22

g/l

1.58

548

Dystonia

201

1686

1.21

1.80

2.2

2.3

0.22

g/l

0.13

183

1584

Abnormal findings in cerebrospinal fluid

2.10

1.80

2.8

2.5

0.21

0.22

g/l

0.11

Tooth agenesis EXCLUDE clefts and syndromes

128

1024

1.27

1.80

3.6

0.23

g/l

0.07

119

968

Triptan medication for migraine, min. 3 purchases

2182

15780

1.06

1.79

2.4

2.3

0.23

0.22

g/l

3.81

2055

14813

Gestational [pregnancy-induced] hypertension

818

7484

1.10

1.79

2.1

2.2

0.23

0.22

g/l

0.47

771

7042

Other congenital malformations of brain

141

1.80

1.78

3.5

4.0

0.22

0.21

g/l

0.21

133

Severe visual impairment, monocular

267

1.56

1.78

2.2

2.1

0.21

g/l

0.17

252

Iridocyclitis in diseases classified elsewhere

544

1.38

1.78

2.1

2.4

0.21

0.22

g/l

0.09

512

Other infestations

503

0.64

1.77

1.8

2.2

0.23

0.21

g/l

1.23

472

Achilles tendinitis

390

3446

1.14

1.76

2.3

0.22

0.21

g/l

0.82

371

3228

Amblyopia ex anopsia

149

1217

1.25

1.76

2.6

3.0

0.22

g/l

0.06

140

1143

Benign mammary dysplasia

535

4818

1.12

1.75

1.9

2.1

0.22

0.21

g/l

4.04

505

4488

Localized scleroderma [morphea]

375

1.46

1.75

2.1

0.23

0.22

g/l

0.97

352

Trichomoniasis

229

1.60

1.72

3.1

1.9

0.20

0.21

g/l

0.81

216

Benign neoplasm: Skin, unspecified

146

1194

1.25

1.72

2.2

0.20

0.21

g/l

1.07

141

1114

Ankle and foot

221

1.60

1.71

4.7

2.2

0.21

0.22

g/l

0.58

205

Short stature starting before birth

144

1.80

1.71

2.7

5.9

0.20

0.21

g/l

0.31

138

Benign neoplasm of thyroid gland

121

971

1.27

1.70

2.1

0.22

0.21

g/l

0.91

109

920

Other congenital malformations of skin

140

1141

1.25

1.70

2.3

2.6

0.22

g/l

0.56

131

1075

Benign neoplasm: Spinal meninges

295

1.52

1.70

2.0

0.20

0.21

g/l

0.39

278

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

2.24

1.69

1.5

2.2

0.20

0.24

g/l

0.72

Other specified disorders of external ear

143

1171

1.25

1.68

2.3

0.20

0.21

g/l

0.33

131

1091

Excessive earwax

2233

22887

0.95

1.68

2.2

2.3

0.22

0.21

g/l

5.18

2058

21208

Benign neoplasm: Larynx

120

964

1.27

1.68

2.8

2.3

0.20

0.21

g/l

0.97

115

896

Mastocytosis

136

1.78

1.68

2.5

3.1

0.21

0.23

g/l

0.40

130

Early syphilis

312

1.49

1.67

2.0

2.5

0.22

g/l

0.23

289

Motorcycle rider injured in noncollision transport accidents

101

794

1.30

1.67

2.7

2.6

0.22

0.23

g/l

0.65

740

Malignant neoplasm of penis

2.12

1.66

1.9

2.1

0.22

g/l

0.06

Bicuspidal aortic valve syndrome

135

1100

1.25

1.66

2.6

0.21

0.22

g/l

1.31

130

1031

Diphtheria

2.70

1.66

3.4

2.7

0.23

0.24

g/l

—

Other disorders of Eustachian tube

103

814

1.29

1.65

3.3

2.2

0.21

0.22

g/l

0.50

769

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

149

1228

1.24

1.65

2.4

2.3

0.23

0.21

g/l

2.04

142

1150

Injury of nerves at wrist and hand level

134

1092

1.25

1.64

2.2

2.4

0.23

0.22

g/l

0.47

129

1029

Anisometropia and aniseikonia

112

895

1.28

1.64

2.5

0.20

0.21

g/l

0.55

104

841

Disorders of eyelid in diseases classified elsewhere

115

922

1.27

1.63

2.0

2.2

0.21

g/l

0.09

109

864

Other congenital malformations of tongue, mouth and pharynx

497

1.37

1.63

3.2

3.3

0.21

g/l

0.06

473

Injury of muscle and tendon at wrist and hand level

503

4538

1.12

1.61

2.1

2.4

0.23

0.22

g/l

4.33

473

4242

All dysplastic lesions of the cervix uteri

791

7223

1.09

1.61

2.4

2.2

0.23

g/l

2.01

740

6824

Hypersomnia

365

1.44

1.60

1.6

2.6

0.22

g/l

0.07

343

LSIL lesion of the cervix uteri, vagina or vulva

440

3940

1.13

1.60

2.6

2.2

0.23

0.22

g/l

0.36

420

3717

Maternal care for known or suspected abnormality of pelvic organs

685

5096

0.91

1.59

2.3

2.2

0.23

g/l

0.26

663

4807

Left side

128

0.37

1.59

1.6

2.4

0.24

0.22

g/l

—

118

Chronic suppurative otitis media, including avohilmo

289

2526

1.16

1.58

2.1

2.4

0.22

0.21

g/l

0.48

274

2361

Chronic suppurative otitis media

239

2060

1.17

1.57

2.1

2.4

0.22

0.21

g/l

0.43

225

1921

Type 1 diabetes, definitions combined

300

2619

1.15

1.57

2.8

2.9

0.19

0.23

g/l

15.85

272

2473

Other/unspecified disorders of vestibular function

152

1263

1.23

1.56

2.0

2.2

0.22

0.21

g/l

1.08

143

1178

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

308

1.47

1.56

2.3

2.1

0.23

0.22

g/l

0.05

296

Other and/or unspecified nontoxic goitre

307

2698

1.15

1.56

2.1

0.22

0.21

g/l

1.13

294

2536

Progressive vascular leukoencephalopathy

142

1173

1.23

1.56

2.0

1.9

0.21

0.19

g/l

1.42

125

1075

Other conjunctival vascular disorders and cysts

698

1.31

1.55

3.3

2.3

0.21

g/l

0.11

653

Mesothelioma, including Hilmo

267

1.50

1.54

1.9

2.0

0.18

0.20

g/l

0.82

237

Glaucoma

2526

20788

1.05

1.53

2.0

2.2

0.21

g/l

0.16

2302

19217

Effects of other external causes

742

1.29

1.53

1.9

2.5

0.23

g/l

0.52

698

Tick-borne viral encephalitis

117

1.80

1.52

2.0

2.7

0.23

0.22

g/l

0.43

108

Other bursitis, not elsewhere classified

252

1.52

2.1

2.2

0.21

g/l

0.03

236

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2348

17745

1.05

1.52

2.3

2.2

0.22

g/l

4.55

2200

16595

Anoxic brain damage

378

1.42

1.52

2.9

2.5

0.21

0.20

g/l

0.22

348

Lateral epicondylitis

491

4441

1.11

1.52

2.2

2.3

0.23

0.22

g/l

1.54

453

4160

Other zoonotic bacterial diseases, not elsewhere classified

110

1.83

1.51

3.1

2.7

0.18

0.20

g/l

0.72

101

Vascular dementia (other)

188

1.61

1.51

1.7

2.0

0.20

0.19

g/l

0.28

175

Benign neoplasm: Connective and other soft tissue of thorax

110

1.82

1.50

2.8

2.3

0.22

g/l

0.01

102

Exposure to excessive natural cold

312

1.46

1.49

2.9

2.2

0.17

0.22

g/l

3.60

294

Calcific tendinitis of shoulder

210

1805

1.18

1.47

2.0

2.2

0.22

g/l

0.74

203

1701

Liveborn infants according to place of birth

259

1.49

1.46

3.7

5.3

0.20

0.21

g/l

1.25

249

Benign neoplasm: Conjunctiva

118

965

1.25

1.45

2.5

2.3

0.22

0.21

g/l

0.55

112

909

Benign neoplasm: Skin of upper limb, including shoulder

564

1.33

1.44

2.8

2.2

0.22

0.21

g/l

0.45

526

Pedal cyclist injured in noncollision transport accidents

405

3641

1.12

1.43

2.6

2.4

0.21

0.22

g/l

0.99

377

3415

Burn and corrosion confined to eye and adnexa

635

1.30

1.42

1.9

2.3

0.24

0.23

g/l

0.82

593

Parapsoriasis

521

1.34

1.42

2.4

2.3

0.21

0.22

g/l

0.37

489

Amoebiasis

215

1.54

1.42

2.6

2.5

0.22

g/l

0.02

202

Other peripheral vertigo

350

3126

1.13

1.41

1.9

2.2

0.22

0.21

g/l

2.14

325

2916

Viral infections of central nervous system, not elsewhere classified/unspecified

290

1.46

1.41

1.5

2.3

0.22

g/l

0.03

273

Benign neoplasm of other and unspecified female genital organs

155

1306

1.21

1.40

1.9

2.1

0.22

0.21

g/l

0.28

142

1237

Use of donepezil

673

6976

0.92

1.38

1.6

1.9

0.20

0.19

g/l

0.50

588

6337

Yaws

1.90

1.37

3.5

2.2

0.21

0.22

g/l

0.24

Sequelae of inflammatory diseases of the central nervous system

1.96

1.37

2.9

2.5

0.20

0.23

g/l

0.49

Other disorders affecting eyelid function

257

0.56

1.37

1.5

2.0

0.21

g/l

0.01

242

Birth injury to scalp

3.28

1.36

5.6

5.8

0.21

0.19

g/l

—

Infections of genitourinary tract in pregnancy

295

2612

1.14

1.36

1.9

2.2

0.21

0.22

g/l

0.94

281

2464

Myopia

417

3767

1.12

1.35

2.6

2.5

0.23

0.22

g/l

0.22

390

3537

Undescended testicle

335

1.42

1.35

4.1

3.9

0.20

0.21

g/l

0.27

316

Vascular dementia (undefined)

131

1078

1.22

1.35

1.7

1.9

0.20

0.18

g/l

1.38

104

978

Contusion of toe(s) with damage to nail

302

1.43

1.33

1.9

2.4

0.22

0.23

g/l

0.32

279

Vertigo of central origin

466

1.34

1.33

2.6

2.1

0.20

0.21

g/l

0.12

435

Bacterial meningitis

119

984

1.23

1.33

2.1

2.3

0.22

g/l

0.25

110

929

Type 1 diabetes, strict (exclude DM2)

297

2629

1.14

1.31

2.8

3.0

0.19

0.23

g/l

16.22

269

2485

Nontoxic multinodular goitre

778

7240

1.08

1.31

2.0

2.1

0.22

0.21

g/l

2.49

728

6752

Fourth [trochlear] nerve palsy

671

1.28

1.31

2.2

2.3

0.20

0.21

g/l

0.61

632

Separation of retinal layers (serosa)

146

1233

1.20

1.30

2.5

2.3

0.22

g/l

0.15

141

1151

Benign neoplasm: Vagina

355

1.39

1.30

1.5

2.1

0.22

g/l

0.29

339

Need for immunization against single bacterial diseases

101

1.83

1.30

3.9

4.5

0.22

0.21

g/l

0.15

Rheumatic fever incl heart disease

107

877

1.24

1.30

2.5

2.1

0.20

g/l

0.01

801

Gestational diabetes (for exclusion)

1109

7250

1.07

1.30

2.1

2.2

0.23

g/l

0.81

1045

6847

Membranous nephropathy

116

1.73

1.29

1.3

2.8

0.26

0.22

g/l

0.91

106

Use of selegiline

122

1460

0.82

1.29

1.8

2.1

0.20

g/l

0.48

115

1357

Disorders of synovium and tendon in diseases classified elsewhere

583

1.30

1.28

1.9

2.2

0.22

0.21

g/l

0.41

546

Ectopic testis

181

1.57

1.27

4.6

4.3

0.20

0.21

g/l

0.26

171

Endometriosis ASRM stages 3,4

809

7549

1.08

1.26

2.5

2.1

0.22

g/l

0.28

771

7064

Other vitreous opacities

146

1238

1.20

1.26

2.2

0.20

0.21

g/l

0.77

131

1165

Glucosamine medication

2139

16357

1.05

1.26

2.0

2.1

0.21

g/l

1.66

1958

15128

Graves disease, strict definition

343

3082

1.12

1.26

2.2

0.21

0.22

g/l

0.79

321

2906

Female infertility, cervical, vaginal, other or unspecified origin

925

5626

1.07

1.26

2.3

2.2

0.23

0.22

g/l

1.84

875

5262

Endometriosis diagnosis and infertility diagnosis occurring together

314

2806

1.13

1.26

2.2

0.23

0.22

g/l

0.54

303

2664

Delayed puberty

180

1.54

1.25

3.5

3.6

0.22

0.24

g/l

0.46

168

Findings of drugs and other substances, not normally found in blood

117

1.71

1.25

2.8

2.3

0.21

g/l

0.06

110

Contact with machinery

396

3590

1.11

1.24

2.5

2.4

0.21

g/l

0.09

369

3315

Medial epicondylitis

128

1074

1.21

1.24

2.1

2.2

0.23

0.22

g/l

1.03

122

1014

Secondary lactase deficiency

2.50

1.23

2.5

2.4

0.24

g/l

—

Diabetes mellitus in pregnancy

972

5834

1.07

1.23

2.1

2.3

0.23

g/l

0.74

914

5506

Contact with sharp object, undetermined intent

650

1.27

1.22

2.4

2.5

0.21

0.22

g/l

0.62

600

Melanoma in situ

165

1420

1.18

1.21

2.0

2.1

0.22

0.20

g/l

2.52

155

1319

Tinnitus

938

8817

1.07

1.20

2.1

2.2

0.23

0.21

g/l

7.92

877

8214

Caught, crushed, jammed or pinched in or between objects

176

1522

1.17

1.19

2.7

2.6

0.22

g/l

0.15

165

1425

Subarachnoid haemorrhage

381

3456

1.11

1.19

2.1

2.2

0.21

g/l

0.16

356

3198

Congenital malformations of eye, ear, face and neck

213

1869

1.15

1.17

2.4

2.8

0.22

g/l

0.52

208

1759

Other specified/unspecified disorders of ear

1.88

1.16

2.3

0.20

0.23

g/l

0.53

Other chromosome abnormalities, not elsewhere classified

169

1.57

1.16

3.1

4.4

0.21

0.20

g/l

0.54

162

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

1.86

1.13

1.6

2.5

0.21

g/l

0.07

Sequelae of other and unspecified effects of external causes

145

1.58

1.11

5.3

2.5

0.26

0.23

g/l

0.85

137

Typhoid and paratyphoid fevers

178

1.51

1.11

2.8

2.1

0.20

0.23

g/l

1.30

167

Congenital malformation of optic disc

2.12

1.10

3.2

4.4

0.21

0.20

g/l

—

Vascular syndromes of brain in cerebrovascular disorders

158

1367

1.17

1.10

2.1

0.20

g/l

0.46

149

1269

Other and unspecified syphilis

1.89

1.09

2.2

2.7

0.25

0.23

g/l

0.37

Benign neoplasm of brain and other parts of central nervous system

230

2042

1.14

1.09

2.3

2.2

0.22

0.21

g/l

0.30

215

1912

Other acute disseminated demyelination

237

1.43

1.09

3.5

2.3

0.23

g/l

0.19

225

168

1454

1.16

1.09

2.0

1.9

0.20

g/l

0.54

156

1315

Contact with other specified venomous animals

179

1.50

1.08

2.8

0.24

0.22

g/l

1.49

166

Benign neoplasm: Skin of lip

376

1.34

1.08

2.1

2.0

0.21

0.22

g/l

0.59

351

Type1 diabetes, definitions combined, early onset

153

1760

0.86

1.07

2.9

3.4

0.20

0.23

g/l

8.88

140

1671

Multiple superficial injuries of ankle and foot

2.42

1.06

2.2

2.5

0.18

0.25

g/l

—

Other inherited muscular atrophy

2.01

1.06

1.7

2.6

0.20

0.21

g/l

—

Erosion and ectropion of cervix uteri

102

855

1.21

1.05

2.4

2.1

0.22

0.21

g/l

1.43

801

Prepatellar bursitis

159

1382

1.16

1.05

2.2

2.3

0.22

0.21

g/l

0.48

146

1296

Other congenital malformations of skin

266

2389

1.12

1.04

2.3

2.4

0.23

0.22

g/l

1.22

251

2243

Benign neoplasm: Lip

611

1.25

1.03

2.1

2.3

0.22

0.21

g/l

0.34

569

Speech therapy

1061

10068

1.06

1.03

2.3

2.2

0.22

0.21

g/l

4.98

971

9374

MS-disease / Multiple Sclerosis

226

2012

1.13

1.03

2.3

0.23

0.22

g/l

0.77

216

1899

Carcinoma in situ of breast, other/unspecified

406

1.31

1.03

2.0

1.9

0.23

0.21

g/l

0.80

385

Pedestrian injured in collision with pedal cycle

106

894

1.20

1.02

1.8

2.1

0.21

0.22

g/l

0.45

101

833

Congenital malformations of ovaries, fallopian tubes and broad ligaments

157

1365

1.16

1.02

2.0

2.2

0.23

g/l

0.79

152

1295

Use of memantine

1050

8251

1.06

1.01

1.6

2.0

0.20

0.19

g/l

0.50

913

7507

Use of other anti-dementia drugs

1050

8251

1.06

1.01

1.6

2.0

0.20

0.19

g/l

0.50

913

7507

Vitreous prolapse

1.80

1.01

2.8

2.0

0.21

g/l

0.01

Nasal polyp

739

6946

1.07

1.00

2.2

2.3

0.22

0.21

g/l

1.99

702

6466

Complications of anaesthesia during pregnancy

2.03

0.99

1.9

2.4

0.22

0.24

g/l

—

Polypectomy (DHB20)

191

2156

0.88

0.99

2.2

2.3

0.22

0.21

g/l

1.05

181

2007

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

382

1.31

0.99

1.8

2.0

0.19

0.20

g/l

0.05

352

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

290

2627

1.11

0.98

2.1

2.2

0.22

g/l

0.35

276

2475

Disturbances of smell and taste

151

1317

1.16

0.97

2.2

0.23

0.22

g/l

1.70

141

1239

Unequal limb length (acquired)

166

1.48

0.97

2.6

2.8

0.23

g/l

0.15

154

Other puerperal infections

187

1652

1.14

0.97

1.9

2.2

0.24

0.23

g/l

1.36

175

1557

Congenital dislocation of hip, unilateral

201

1.44

0.96

2.2

3.6

0.23

0.22

g/l

0.47

193

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1786

12971

1.04

0.96

2.3

2.2

0.23

0.22

g/l

3.29

1684

12176

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

1.92

0.96

1.8

2.7

0.21

0.22

g/l

—

Atopic conjunctivitis

143

1244

1.16

0.95

2.3

2.4

0.22

g/l

0.05

130

1166

Other and unspecified syphilis

1.70

0.95

2.1

2.5

0.26

0.23

g/l

0.55

Vasomotor rhinitis (mode)

254

2292

1.12

0.95

2.0

2.2

0.23

0.22

g/l

1.60

237

2143

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

1.83

0.94

1.7

2.7

0.20

0.22

g/l

0.29

Benign neoplasm of male genital organs

629

1.23

0.93

3.1

2.5

0.21

g/l

0.03

576

Other endophthalmitis

127

1.55

0.92

2.1

2.0

0.21

g/l

0.06

115

Noise effects on inner ear

109

1271

0.85

0.92

2.1

2.3

0.20

0.22

g/l

1.68

104

1179

Pneumoconiosis due to asbestos and other mineral fibres

574

1.24

0.92

2.3

2.1

0.17

0.19

g/l

1.39

521

Other parasitologically confirmed or unspecified malaria

1.89

0.92

3.5

2.9

0.22

g/l

—

Noonan syndrome

2.16

0.91

2.0

3.4

0.17

0.22

g/l

—

Endometriosis ASRM stages 1,2

571

5345

1.07

0.90

2.3

2.2

0.23

0.22

g/l

2.27

548

5027

Endometriosis of rectovaginal septum and vagina

259

2347

1.11

0.90

2.2

2.1

0.22

0.21

g/l

1.29

244

2178

Benign neoplasm: Extrahepatic bile ducts

1.71

0.89

2.4

2.3

0.26

0.21

g/l

1.47

Family history of other specific disorders

290

1.33

0.89

3.0

2.6

0.23

0.22

g/l

0.14

273

Photocontact dermatitis [berloque dermatitis]

1.91

0.89

2.9

2.2

0.19

0.21

g/l

—

Injury of muscle and tendon at lower leg level

542

5070

1.08

0.88

2.3

0.23

0.21

g/l

4.07

497

4752

Hand

137

1.51

0.88

1.6

2.4

0.25

0.22

g/l

1.37

125

Nondiabetic hypoglycaemic coma

1.69

0.88

2.6

3.0

0.18

0.22

g/l

0.86

Other specified/unspecified disorders of middle ear and mastoid

1.85

0.87

1.9

2.8

0.20

0.21

g/l

—

Maternal care for known or suspected disproportion

1061

0.84

0.87

3.4

2.2

0.21

0.23

g/l

1.94

1008

Uterine polyps

346

3187

1.09

0.86

2.1

2.2

0.22

0.21

g/l

1.25

325

2973

Undescended testis, unilateral

258

1.35

0.85

4.6

3.8

0.21

g/l

0.20

240

Transient global amnesia

297

3240

0.91

0.85

2.0

2.2

0.21

g/l

0.08

268

3030

Other disorders of cornea

346

3189

1.09

0.85

2.6

2.2

0.22

0.21

g/l

0.40

324

2990

Foreign body in ear

535

1.24

0.85

2.4

2.7

0.22

g/l

0.13

496

Lipoprotein deficiency

1.78

0.84

1.9

2.5

0.18

0.21

g/l

0.62

Periodontal disease, other/unspecified

756

1.19

0.83

2.3

0.22

0.21

g/l

0.35

714

Use of galantamine

234

2579

0.90

0.83

1.7

1.9

0.20

0.19

g/l

0.44

214

2340

Enterobiasis

463

1.25

0.83

2.0

3.3

0.22

g/l

0.16

436

Rheumatic valve diseases

609

1.22

0.83

2.7

2.1

0.19

0.20

g/l

0.51

552

Use of antiglaucoma preparations and miotics

290

2658

1.10

0.82

1.8

2.0

0.20

g/l

0.01

268

2449

Hereditary corneal dystrophies

124

1084

1.16

0.82

2.3

2.1

0.21

g/l

0.13

116

1027

Cyst of Bartholin Gland

114

989

1.16

0.82

2.0

2.1

0.22

g/l

0.12

107

936

Drug-induced interstitial lung disorders, unspecified

1.75

0.82

1.0

2.6

0.24

0.22

g/l

—

Explosion of other materials

1.66

0.82

2.5

2.0

0.22

0.24

g/l

0.35

Other specified/unspecified hearing loss

304

2795

1.10

0.81

2.3

2.2

0.22

0.21

g/l

3.03

288

2599

Prominent ears

182

1.40

0.80

2.6

3.6

0.21

0.23

g/l

0.60

171

Other congenital malformations of limb(s)

174

1.41

0.79

3.1

4.7

0.22

g/l

0.00

166

Benign neoplasm: Brain, supratentorial

431

1.25

0.79

3.3

2.5

0.23

0.22

g/l

0.31

406

Dementia due to Parkinson's disease

743

1.19

0.79

1.8

2.1

0.20

g/l

0.03

677

Balanced rearrangements and structural markers, not elsewhere classified

1.66

0.77

2.2

3.0

0.24

0.23

g/l

0.37

Other benign neoplasms of uterus

196

1771

1.12

0.77

1.9

0.20

g/l

0.04

181

1641

N06DA Anticholinesterases

1281

10501

0.96

0.76

1.6

2.0

0.20

g/l

0.48

1137

9602

Use of anticholinesterases

1281

10501

0.96

0.76

1.6

2.0

0.20

g/l

0.48

1137

9602

Other noninflammatory disorders of cervix uteri

177

1591

1.12

0.76

2.2

2.1

0.22

0.21

g/l

1.44

164

1474

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

681

1.19

0.76

2.1

0.22

0.21

g/l

0.15

641

Maternal care for known or suspected fetal abnormality and damage

385

3558

0.93

0.76

2.2

0.23

g/l

0.03

365

3359

Injury of muscle and tendon at forearm level

507

1.22

0.75

2.6

2.5

0.21

0.22

g/l

0.08

477

Hypertrophy of bone

1.68

0.74

1.5

2.3

0.23

0.22

g/l

0.04

Other infective (teno)synovitis

109

1.52

0.74

1.7

1.9

0.24

0.22

g/l

0.33

103

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

1.67

0.74

3.1

2.8

0.23

0.20

g/l

0.67

Melanocytic naevi of other and unspecified parts of face

190

1717

1.12

0.74

2.1

2.2

0.22

g/l

0.64

175

1615

Other, unspecified and serous retinal detachments

109

953

1.16

0.74

2.5

2.2

0.20

0.21

g/l

0.60

103

887

Nontoxic single thyroid nodule

255

2339

1.10

0.74

2.2

0.22

0.21

g/l

1.17

242

2206

Chondrosarcoma

1.63

0.73

1.3

2.2

0.19

0.22

g/l

—

Benign neoplasm: Vulva

601

1.20

0.73

2.3

2.0

0.22

0.21

g/l

0.35

577

Medullary carcinoma of thyroid gland, including Hilmo

1.78

0.72

2.7

2.1

0.21

0.19

g/l

—

Tick-borne viral encephalitis

110

1.51

0.71

1.8

2.8

0.23

0.22

g/l

0.27

102

Early lumbar disc prolapse operation

311

2879

1.09

0.71

2.3

2.4

0.24

0.23

g/l

2.11

295

2714

Disorders of sphingolipid metabolism and other lipid storage disorders

1.61

0.71

2.0

2.5

0.21

0.20

g/l

0.17

Brain astrocytoma, including Hilmo

1.64

0.70

1.4

2.5

0.27

0.22

g/l

0.88

Brain astrocytoma

1.64

0.70

1.4

2.5

0.27

0.22

g/l

0.88

Female genital prolapse

1153

6259

1.04

0.70

2.0

2.1

0.22

0.21

g/l

2.20

1078

5812

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

287

2655

1.09

0.69

2.2

0.21

0.22

g/l

0.07

271

2490

Lichenoid drug reaction

1.61

0.69

3.0

2.2

0.20

0.21

g/l

0.24

Viral infections of central nervous system, not elsewhere classified/unspecified

384

1.24

0.69

1.7

2.2

0.23

0.22

g/l

0.13

357

Juvenile cataract

111

1.49

0.69

1.9

3.3

0.20

0.22

g/l

0.78

102

Idiopathic hypoparathyroidism

1.60

0.69

2.1

3.1

0.21

g/l

0.18

Struck by thrown, projected or falling objec

134

1501

0.89

0.68

3.0

2.4

0.23

0.22

g/l

0.36

124

1405

Viral conjunctivitis

112

988

1.14

0.67

2.3

2.2

0.22

g/l

0.04

102

927

Contraceptive management

1511

10953

0.96

0.67

2.5

2.4

0.23

g/l

3.34

1422

10244

Postmenopausal atrophic vaginitis

1082

5734

1.04

0.67

2.0

2.1

0.23

0.21

g/l

12.19

1032

5319

Other congenital malformations of ear

259

1.29

0.67

2.5

3.5

0.23

g/l

0.12

246

Contact with nonpowered hand tool

140

1254

1.13

0.67

1.9

2.4

0.22

g/l

0.11

130

1172

Other benign neoplasm of uterus: Other parts/unspecified

154

1389

1.12

0.66

1.8

0.20

g/l

0.14

142

1274

Additional codes for the location of defect, injury or illness

198

1808

1.10

0.66

2.9

2.2

0.22

0.21

g/l

0.35

190

1689

Male infertility

134

1198

1.13

0.65

2.4

2.5

0.24

g/l

0.08

126

1105

Deep endometriosis

302

2809

1.08

0.64

2.2

2.1

0.22

0.21

g/l

0.77

286

2635

Poor fetal growth

303

2817

1.08

0.64

2.5

2.2

0.23

g/l

0.50

278

2664

Brachial plexus disorders

297

2761

1.08

0.64

2.2

0.23

0.22

g/l

0.59

279

2601

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

1.68

0.64

1.9

2.5

0.15

0.19

g/l

—

Hair colour and hair shaft abnormalities

105

1.48

0.63

2.5

2.2

0.19

0.22

g/l

0.77

Other and unspecified hydrocephalus

518

1.19

0.63

2.0

2.4

0.21

g/l

0.08

486

Otosclerosis

235

2543

0.92

0.62

2.4

2.2

0.21

g/l

0.07

222

2386

Benign lipomatous neoplasm

1164

11238

1.04

0.62

2.2

0.22

0.21

g/l

1.02

1104

10456

Loose body in joint

667

1.17

0.62

1.6

2.3

0.21

0.22

g/l

0.25

626

Injury of muscle and tendon at hip and thigh level

334

3125

1.07

0.62

2.1

2.3

0.23

0.22

g/l

1.18

316

2939

Rubella [German measles]

109

968

1.14

0.61

2.6

2.5

0.21

0.23

g/l

1.17

103

909

Abnormalities of forces of labour

268

2886

0.92

0.61

2.2

0.23

g/l

0.21

263

2730

Other disorders of male genital organs

127

1140

1.12

0.60

2.4

2.5

0.23

0.22

g/l

0.41

117

1048

Mandibular prognathia AND surgery (LeFortI or BSSO)

111

0.62

0.60

2.4

2.8

0.19

0.23

g/l

—

104

Abnormal reflex

132

1.40

0.59

2.9

2.3

0.21

0.23

g/l

0.33

123

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

1.78

0.59

1.5

1.6

0.19

0.22

g/l

—

Melanocytic naevi of lip

211

1.31

0.59

1.3

2.4

0.23

0.22

g/l

0.20

196

Osteogenesis imperfecta

1.53

0.59

3.3

5.9

0.25

0.21

g/l

—

Congenital malformations of larynx

107

1.46

0.59

2.4

4.5

0.18

0.20

g/l

0.60

102

Other parasitologically confirmed or unspecified malaria

1.56

0.58

3.4

2.8

0.22

g/l

0.04

Femoral hernia

145

1314

1.11

0.58

2.2

2.0

0.21

g/l

0.00

130

1220

Major anomalies of jaw size

765

1.15

0.58

2.3

2.8

0.22

0.23

g/l

0.09

724

Glaucoma, exfoliation

352

3739

0.94

0.57

1.7

2.0

0.20

g/l

0.86

318

3439

Benign neoplasm: Vertebral column

1.55

0.56

3.1

2.7

0.19

0.22

g/l

0.60

Trigeminal neuralgia

196

1806

1.09

0.56

2.1

0.23

0.21

g/l

3.50

185

1680

Multiple gestation

220

2376

0.92

0.56

2.3

0.23

g/l

0.14

212

2257

Scleritis and episcleritis

199

1835

1.09

0.56

2.5

2.2

0.23

0.22

g/l

1.37

189

1736

Pleural plaque without asbestos

128

1157

1.12

0.56

2.2

2.1

0.19

g/l

0.09

115

1061

Persons encountering health services in circumstances related to reproduction

2427

15972

1.03

0.55

2.5

0.23

0.22

g/l

3.11

2305

14948

Divergent concomitant strabismus

249

2318

1.08

0.55

2.2

2.4

0.22

g/l

0.05

237

2178

Alzheimer’s disease, strict definition

876

7491

0.96

0.55

1.6

1.9

0.20

0.19

g/l

0.55

754

6835

Other lesions of median nerve

835

1.14

0.55

1.7

2.0

0.19

0.21

g/l

0.87

773

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.60

0.54

2.5

2.8

0.24

0.22

g/l

—

Abnormal spermatozoa

408

4302

0.94

0.53

2.1

2.4

0.21

0.20

g/l

0.74

373

3980

Injury of blood vessels at forearm level

1.51

0.53

1.7

2.8

0.20

0.23

g/l

0.57

Spasmodic torticollis

102

914

1.13

0.52

2.1

2.2

0.22

g/l

0.16

868

Benign neoplasm: Choroid

219

2036

1.08

0.52

2.4

2.2

0.21

g/l

0.08

204

1906

Chronic inflammatory disorders of orbit

1.55

0.52

2.1

2.4

0.21

0.22

g/l

—

Nontoxic goitre/thyroid nodule

1175

11399

1.03

0.51

2.0

2.1

0.22

0.21

g/l

2.89

1103

10612

Benign neoplasm: Connective and other soft tissue of abdomen

1.50

0.50

2.5

2.2

0.21

0.22

g/l

0.24

Type 1 diabetes, strict definition

185

1994

0.92

0.50

2.5

3.1

0.19

0.23

g/l

14.35

167

1887

Acute myringitis

181

1.30

0.50

3.2

2.9

0.22

g/l

0.00

171

Mandibular retrognathia

175

1884

0.92

0.48

2.6

3.0

0.23

g/l

0.52

165

1782

Thyrotoxicosis factitia

1.47

0.47

1.9

2.5

0.24

0.21

g/l

0.50

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

149

1371

1.09

0.47

1.8

2.3

0.21

0.22

g/l

0.17

125

1284

Inflammatory disease of cervix uteri

211

1969

1.08

0.47

2.5

2.0

0.22

0.21

g/l

0.29

199

1848

Haemorrhage in early pregnancy

914

8610

1.04

0.47

2.3

2.2

0.22

g/l

0.00

861

8116

Psoas tendinitis

112

1.37

0.46

2.3

1.8

0.25

0.22

g/l

0.61

104

Glaucoma-related operations

179

1926

0.92

0.46

1.8

2.1

0.21

0.20

g/l

1.09

168

1788

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

366

1.19

0.46

2.2

1.9

0.18

0.20

g/l

0.98

320

Retinal breaks without detachment

563

5863

0.96

0.46

2.2

0.21

g/l

0.33

536

5474

Galactorrhea

229

1.24

0.45

1.9

2.4

0.24

0.23

g/l

0.55

220

Conductive hearing loss, unspecified

288

2722

1.06

0.44

2.3

2.4

0.21

g/l

0.62

258

2540

Ectopic pregnancy

564

5419

1.04

0.44

2.1

2.2

0.23

0.22

g/l

0.33

519

5108

Occupational exposure to risk-factors

113

1031

1.11

0.44

2.2

2.4

0.20

0.21

g/l

0.73

107

967

Effects of air pressure and water pressure

122

1.34

0.44

4.1

2.6

0.21

0.23

g/l

0.41

115

Unattended death

249

1.22

0.43

2.0

2.3

0.19

0.21

g/l

0.51

228

Alzheimer disease

1231

8770

1.03

0.43

1.6

2.0

0.20

g/l

0.09

1063

8024

Benign neoplasm: Lymph nodes

1.44

0.43

2.0

2.5

0.23

0.22

g/l

0.17

Surgical ablation of atrial fibrillation

168

1.28

0.42

2.4

2.5

0.18

0.22

g/l

1.37

154

Inguinal of femoral hernia, unilateral

795

1.12

0.42

2.5

2.1

0.21

g/l

0.03

744

Femoral hernia, unilateral

795

1.12

0.42

2.5

2.1

0.21

g/l

0.03

744

Inguinal hernia, unilateral

795

1.12

0.42

2.5

2.1

0.21

g/l

0.03

744

Gastric ulcer - Acute with haemorrhage, drug-induced

1.56

0.42

2.6

2.2

0.25

0.21

g/l

—

Hypersensitivity angiitis

150

1.30

0.42

1.8

2.4

0.24

0.22

g/l

0.64

137

Other spirochaetal diseases

1191

11608

1.03

0.41

2.4

2.2

0.23

0.21

g/l

8.45

1103

10832

LSIL lesion of the cervix uteri

313

2973

1.06

0.41

2.5

2.1

0.23

0.22

g/l

0.35

296

2813

Unspecified maternal hypertension

227

0.78

0.41

2.2

2.3

0.23

0.24

g/l

0.12

217

Central retinal artery occlusion

664

1.13

0.41

2.0

2.2

0.19

0.20

g/l

0.27

610

Cholesteatoma of middle ear

176

1644

1.08

0.41

2.0

2.2

0.21

g/l

0.04

165

1527

Lesion of sciatic nerve

149

1384

1.08

0.40

2.3

2.1

0.21

0.20

g/l

0.64

144

1273

Supervision of high-risk pregnancy

661

3840

1.04

0.39

2.1

2.2

0.23

g/l

0.05

622

3609

Other and unspecified disorders of vitreous body

1762

17025

1.02

0.39

2.2

0.22

0.21

g/l

5.06

1631

15899

Ganglion

749

7257

1.03

0.39

2.0

2.3

0.22

g/l

1.58

695

6796

Myocardial infarction, unclassifiable

833

7213

1.03

0.39

2.0

0.19

0.20

g/l

0.36

756

6554

Eccrine sweat disorders

1.36

0.39

1.2

2.7

0.22

0.23

g/l

—

Twin gestation

215

2282

0.94

0.39

2.3

0.23

g/l

0.11

207

2166

L02BX Other hormone antagonists and related agents

192

1804

1.07

0.39

1.9

2.3

0.19

0.20

g/l

0.34

178

1655

Testicular dysfunction, other/unspecified

115

0.68

0.38

2.1

2.8

0.21

0.24

g/l

—

108

Undefined dementia

358

3452

0.95

0.38

1.8

0.18

0.19

g/l

0.86

300

3101

Graves ophthalmopathy, strict

620

1.12

0.38

2.4

2.1

0.22

g/l

0.01

583

Parkinson's disease

524

5433

0.96

0.38

2.0

2.2

0.20

g/l

0.13

479

5009

Disorders of lacrimal system and orbit in diseases classified elsewhere

687

1.12

0.37

2.4

2.0

0.21

0.22

g/l

0.13

647

Postpartum haemorrhage due to retained placenta

279

2932

0.95

0.36

2.3

2.1

0.23

g/l

0.19

264

2775

Pregnancy examination and test

436

2818

0.96

0.36

2.2

2.3

0.23

g/l

0.03

411

2636

Lens-induced iridocyclitis

1.40

0.35

2.3

2.5

0.26

0.21

g/l

—

Other spirochaetal diseases

1204

11770

1.03

0.35

2.4

2.2

0.23

0.21

g/l

8.07

1115

10987

Bicipital tendinitis

158

1481

1.07

0.35

1.9

2.2

0.22

0.21

g/l

0.05

149

1389

Benign neoplasm: Central nervous system, other parts/unspecified

109

1.32

0.35

1.9

2.6

0.22

g/l

0.02

Traumatic amputation of wrist and hand

144

1346

1.08

0.35

2.6

2.3

0.21

g/l

0.22

139

1260

Sequelae of tuberculosis

481

1.13

0.35

1.9

2.0

0.20

g/l

0.07

430

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

202

2135

0.94

0.34

2.1

2.2

0.21

g/l

0.17

190

2000

Lyme disease

1174

11480

1.02

0.34

2.4

2.2

0.23

0.21

g/l

8.70

1086

10709

Use of rasagiline

817

1.10

0.34

2.0

2.2

0.20

0.21

g/l

0.08

761

Mononeuritis multiplex

1.36

0.33

3.2

2.0

0.18

0.21

g/l

0.52

Villonodular synovitis (pigmented)

201

1.21

0.33

4.9

2.4

0.24

0.22

g/l

0.81

193

Embedded and impacted teeth

790

6341

1.03

0.33

2.9

2.6

0.23

g/l

0.23

747

5925

Respiratory tuberculosis, not confirmed

126

1175

1.08

0.33

2.1

0.20

g/l

0.09

119

1083

Dislocation, sprain and strain of joints and ligaments of elbow

199

1884

1.06

0.33

2.9

2.5

0.22

g/l

0.07

180

1765

Labour and delivery complicated by umbilical cord complications

134

1253

1.07

0.32

2.4

2.3

0.23

0.22

g/l

0.53

126

1186

Pedal cyclist injured in collision with pedestrian or animal

193

1.21

0.32

2.8

2.3

0.21

0.22

g/l

0.16

178

Vestibular neuronitis

314

3012

1.05

0.32

2.1

2.2

0.22

0.21

g/l

0.68

289

2816

Cholera

1.33

0.31

6.3

1.9

0.25

0.23

g/l

—

Non-allergic asthma

300

2874

1.05

0.31

2.4

0.22

0.21

g/l

1.40

276

2691

Unspecified abortion

148

1393

1.07

0.30

2.4

2.2

0.22

0.23

g/l

0.23

138

1317

Cicatricial alopecia [scarring hair loss]

222

1.19

0.30

1.8

2.1

0.20

0.22

g/l

0.66

208

Nontoxic diffuse goitre

101

939

1.08

0.30

2.2

2.0

0.21

g/l

0.02

894

Failed induction of labour

132

1239

1.07

0.29

2.5

2.3

0.23

g/l

0.03

123

1163

Sequelae of transport accidents

121

1.26

0.29

2.0

2.5

0.17

0.23

g/l

1.50

111

Occlusion and stenosis of arteries, not leading to stroke

374

1.13

0.29

2.2

2.0

0.21

0.20

g/l

0.36

342

Complications predominantly related to the puerperium

779

7980

0.97

0.28

2.2

0.22

g/l

0.02

720

7531

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

233

1.17

0.28

2.3

2.5

0.22

0.21

g/l

0.43

219

Other obstructed labour

225

2149

1.05

0.28

2.1

2.2

0.22

g/l

0.02

208

2040

Acromegaly and pituitary gigantism

177

1.20

0.28

2.1

2.2

0.20

0.22

g/l

0.78

163

Spirochaetal infections, other/unspecified

1180

11575

1.02

0.28

2.4

2.2

0.23

0.21

g/l

8.35

1092

10798

Contact with and exposure to communicable diseases

1000

9747

1.02

0.28

2.6

2.5

0.22

g/l

0.01

933

9165

Abrasion of teeth

1305

12815

1.02

0.28

2.3

0.23

0.22

g/l

4.24

1216

11996

Mesial bite

252

1.16

0.28

2.9

3.8

0.23

g/l

0.00

239

Cerebral arteritis

1.23

0.27

1.6

2.5

0.25

0.22

g/l

—

Primary open-angle glaucoma

1238

12184

0.98

0.27

1.8

2.1

0.20

g/l

0.25

1124

11228

Triptan medication for migraine, single purchase ok

3220

21553

1.01

0.27

2.3

2.4

0.23

0.22

g/l

10.58

3009

20185

Migraine, single triptan purchase ok & required. ICD-code if available is included

3220

21553

1.01

0.27

2.3

2.4

0.23

0.22

g/l

10.58

3009

20185

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

863

0.92

0.27

2.0

2.1

0.20

g/l

0.18

792

Other and unspecified iridocyclitis

144

1362

1.06

0.27

2.1

2.2

0.22

g/l

0.33

134

1274

Presbyopia

196

2053

0.95

0.26

2.3

0.22

g/l

0.11

187

1937

Injury of blood vessels at lower leg level

123

1.24

0.26

2.9

2.4

0.21

0.22

g/l

0.19

115

Benign neoplasm: Skin of other and unspecified parts of face

371

3590

1.04

0.26

2.4

2.1

0.21

g/l

0.42

339

3342

Certain zoonotic bacterial diseases

871

0.92

0.26

2.7

2.2

0.21

g/l

0.26

814

Accidental poisoning by and exposure to other gases and vapours

142

1.22

0.25

1.4

2.7

0.23

0.22

g/l

0.30

132

Unspecific neurodegenerative disorder

1722

11595

1.02

0.25

1.7

2.1

0.20

g/l

0.15

1504

10685

Migraine with aura, drug-induced

276

0.86

0.25

2.5

2.2

0.22

0.23

g/l

0.45

263

Meretoja disease

0.70

0.25

1.7

1.9

0.23

0.22

g/l

—

Other obstetric trauma

129

1220

1.06

0.25

2.5

2.2

0.23

g/l

0.16

123

1149

Parkinson's disease, including avohilmo

551

5647

0.97

0.24

2.0

2.1

0.20

g/l

0.00

504

5202

Acute disseminated encephalitis/encephalomyelitis

1.34

0.24

4.6

3.3

0.21

g/l

—

Other congenital infectious and parasitic diseases

0.00

0.23

0.0

6.4

—

0.24

—

Chondromalacia

805

1.07

0.23

2.5

2.3

0.22

g/l

0.10

760

Dentofacial anomalies [including malocclusion]

2834

22514

1.01

0.23

2.4

2.3

0.23

0.22

g/l

10.43

2654

21072

Seropositive rheumatoid arthritis, strict definition

541

5281

1.03

0.23

2.2

0.21

g/l

1.12

489

4936

Congenital malformation of vitreous humour

0.00

0.22

0.0

1.8

—

0.24

—

Generalized pustular psoriasis

107

1.24

0.22

3.3

2.5

0.23

0.22

g/l

0.17

100

Heredofamilial amyloidosis, unspecified

0.00

0.22

0.0

2.2

—

0.16

—

Other chorioretinal disorders in diseases classified elsewhere

0.00

0.22

0.0

2.3

—

0.21

—

Acquired stenosis of external ear canal

296

1.13

0.22

2.7

2.5

0.23

0.21

g/l

0.84

271

Maternal care for cervical incompetence

111

1051

1.06

0.22

2.7

2.1

0.22

g/l

0.18

106

989

Parkinson's disease, strict definition

489

5010

0.97

0.21

2.0

2.1

0.20

g/l

0.11

445

4618

Benign neoplasm: Respiratory system, unspecified

1.27

0.21

1.2

1.9

0.20

0.22

g/l

—

Primary open-angle glaucoma, strict

1003

10168

0.98

0.21

1.8

2.1

0.20

g/l

0.07

915

9380

Impacted teeth

533

4634

1.02

0.20

2.9

2.8

0.23

g/l

0.51

507

4319

Peripheral retinal degeneration

928

1.06

0.20

1.9

2.2

0.21

g/l

0.38

863

Infections of breast associated with childbirth

799

0.94

0.20

1.9

2.2

0.22

0.23

g/l

0.46

757

Disorders of glossopharyngeal nerve

1.19

0.20

1.2

1.7

0.20

g/l

—

Episcleritis

160

1535

1.05

0.20

2.5

2.2

0.23

0.22

g/l

1.10

152

1447

Mumps

714

1.07

0.20

1.7

2.3

0.21

0.22

g/l

0.69

671

L02BB Anti-androgens

297

3058

0.97

0.19

2.1

2.2

0.20

0.19

g/l

1.14

272

2795

Graves ophthalmopathy

695

1.07

0.19

2.4

2.0

0.21

0.22

g/l

0.27

654

Primary angle-closure glaucoma

150

1439

1.05

0.19

1.7

2.1

0.20

g/l

0.10

140

1336

Use of dimethyl fumarate

175

0.85

0.19

1.2

2.3

0.25

0.24

g/l

0.16

169

Kissing spine

1.25

0.19

2.4

2.1

0.26

0.21

g/l

—

Erythema in diseases classified elsewhere

1.18

0.18

1.9

2.2

0.26

0.22

g/l

—

Benign leiomyoma with endometriosis

563

5522

1.02

0.18

2.2

2.1

0.22

0.21

g/l

1.19

532

5145

Brain glioblastoma and astrocytoma

358

1.10

0.18

1.6

2.2

0.28

0.21

g/l

4.13

320

Exposure to ignition of highly flammable material

110

1.20

0.17

2.0

2.9

0.23

g/l

0.03

103

Abnormal findings on antenatal screening of mother

171

1648

1.04

0.17

2.4

2.3

0.22

0.23

g/l

1.08

165

1555

Multiple system atrophy (rare forms of Parkinsonism)

1.14

0.17

2.1

2.5

0.21

0.20

g/l

—

Foreign body on external eye

477

4869

0.98

0.17

2.6

2.4

0.22

g/l

0.40

446

4536

Vertical strabismus

102

973

1.05

0.17

1.8

2.4

0.21

0.22

g/l

0.03

913

Transient synovitis

196

1.13

0.17

3.2

2.8

0.23

0.22

g/l

0.32

183

Corneal pigmentations and deposits

111

1.19

0.16

2.8

2.3

0.25

0.21

g/l

0.63

102

Dissection of cerebral arteries, nonruptured

193

0.87

0.16

1.7

2.4

0.24

0.22

g/l

0.48

181

Obstructed labour due to maternal pelvic abnormality

520

5105

1.02

0.16

2.2

0.22

g/l

0.47

488

4817

Other appendicitis

277

2701

1.03

0.15

2.5

2.3

0.22

g/l

0.76

265

2526

Other specified/unspecified diseases of inner ear

129

0.84

0.15

1.5

2.2

0.21

g/l

0.09

116

Impacted maxillary molar

132

1272

1.04

0.15

3.1

2.6

0.24

0.23

g/l

0.29

126

1173

Congenital malformations of anterior segment of eye

227

1.11

0.14

2.8

2.9

0.22

g/l

0.08

213

Fall on and from ladder

257

2507

1.03

0.14

2.3

0.21

g/l

0.29

238

2326

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

1.21

0.14

3.1

2.5

0.20

0.21

g/l

—

Other disorders of amniotic fluid and membranes

344

3429

0.98

0.14

2.0

2.3

0.23

g/l

0.25

335

3247

Other disorders following mastoidectomy

0.81

0.14

1.3

2.1

0.21

g/l

—

Discontinuity and dislocation of ear ossicles

149

0.86

0.14

2.4

2.3

0.21

0.23

g/l

0.37

135

Injury of muscle and tendon at shoulder and upper arm level

1427

14142

1.01

0.13

2.2

2.3

0.21

g/l

0.57

1317

13170

Desensitization to allergens

140

1356

1.03

0.13

2.8

2.6

0.23

g/l

0.17

132

1273

Injury of muscle and tendon at ankle and foot level

668

1.05

0.13

1.8

2.2

0.23

0.22

g/l

0.40

634

Benign neoplasm: Cranial nerves

865

1.04

0.12

2.2

0.22

0.21

g/l

0.90

815

Antepartum haemorrhage, not elsewhere classified

207

2122

0.97

0.12

1.9

2.3

0.23

g/l

0.34

197

2012

Medical treatment for female infertility

544

5333

1.01

0.11

2.3

2.2

0.23

g/l

0.10

523

5045

Congenital ptosis

105

1.16

0.11

1.8

3.9

0.19

0.22

g/l

0.62

Other disorders of prostate

100

1030

0.97

0.09

1.9

2.5

0.20

g/l

0.18

939

Abnormalities of ear ossicles

1.12

0.09

4.8

2.6

0.20

0.22

g/l

—

Lesion of plantar nerve

201

1972

1.02

0.09

2.0

2.1

0.23

0.21

g/l

1.97

186

1846

Foreign body or object entering through skin

190

1863

1.02

0.09

2.3

2.4

0.22

g/l

0.06

175

1742

Glaucoma suspect

1459

14498

1.01

0.09

2.0

2.2

0.21

g/l

0.36

1326

13469

Certain zoonotic bacterial diseases

528

1.05

0.09

2.7

2.3

0.22

0.21

g/l

0.17

496

Arthropod-borne viral fevers and viral haemorrhagic fevers

313

3087

1.02

0.08

2.5

2.3

0.21

g/l

0.26

298

2889

Multiple congenital exostoses

1.06

0.08

4.9

2.8

0.29

0.22

g/l

—

Torsion of testis

490

0.96

0.08

2.4

2.9

0.21

0.24

g/l

0.90

451

Endovascular or surgical operations to intracerebral aneurysms

202

1987

1.02

0.07

2.0

2.2

0.22

0.21

g/l

0.19

192

1861

0.85

0.07

3.4

5.4

0.17

0.21

g/l

—

Other and unspecified corneal deformities and disorders

946

1.03

0.07

2.7

2.2

0.22

0.21

g/l

0.24

896

Hydrocephalus

252

2485

1.02

0.07

2.0

2.2

0.21

0.20

g/l

0.06

231

2286

Melanoma in situ of scalp and neck

1.03

0.07

1.9

2.4

0.26

0.21

g/l

—

Congenital ptosis

1.13

0.07

1.9

4.1

0.19

0.22

g/l

—

Constitutional tall stature

128

1.10

0.07

1.8

4.5

0.22

g/l

0.18

122

Distal bite

122

1187

1.02

0.07

4.8

3.9

0.23

0.22

g/l

0.29

117

1133

Other specified/unspecified disorders of tympanic membrane

103

0.86

0.06

1.9

2.7

0.19

0.22

g/l

—

Pedal cyclist injured in collision with motor vehicle

880

1.02

0.06

1.9

2.2

0.22

g/l

0.11

824

Alzheimer disease, including avohilmo

1417

10020

1.00

0.05

1.7

2.0

0.20

g/l

0.01

1234

9193

Ménière disease

325

3221

1.01

0.05

2.0

2.1

0.22

0.21

g/l

1.93

305

3002

Juvenile osteochondrosis

843

1.02

0.04

3.0

2.5

0.22

0.23

g/l

0.70

792

Mesothelioma

199

1.06

0.04

2.1

1.8

0.17

0.20

g/l

0.90

175

Carcinoma in situ of breast

140

1.08

0.04

2.3

2.0

0.21

0.22

g/l

0.34

133

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

463

4599

1.01

0.04

2.3

2.2

0.22

0.21

g/l

0.39

441

4310

Use of rivastigmine

530

5252

1.01

0.04

1.6

1.9

0.20

0.19

g/l

2.77

471

4768

Injury of blood vessels at hip and thigh level

1.11

0.04

1.7

2.5

0.23

g/l

—

Melanocytic naevi of eyelid, including canthus

251

0.95

0.04

2.0

2.1

0.22

g/l

0.09

239

Purulent endophthalmitis

170

1.06

0.04

3.0

2.0

0.18

0.20

g/l

0.83

158

Carcinoma in situ of uteri, other/unspecified

159

0.94

0.03

1.4

2.2

0.24

0.23

g/l

0.41

154

Use of levodopa decarbox-comt-inhibitor

103

1016

1.02

0.03

2.0

2.2

0.20

g/l

0.21

945

Down's syndrome

102

1.09

0.03

2.8

4.1

0.21

0.22

g/l

0.11

Preterm labour and delivery

846

8432

1.00

0.02

2.3

2.2

0.22

g/l

1.33

794

7946

Viral haemorrhagic fevers, not elsewhere classified/unspecified

249

2474

1.01

0.02

2.4

2.3

0.22

g/l

0.09

237

2316

Puerperal sepsis

417

4188

1.00

0.02

2.3

2.2

0.22

g/l

0.37

378

3958

Disorders of acoustic nerve

829

1.01

0.02

2.2

0.23

0.21

g/l

1.06

780

Type 1 diabetes, strict definition, subgroup 1

178

1789

0.99

0.02

2.5

3.0

0.19

0.23

g/l

15.79

160

1690

Non-small cell lung cancer, squamous, helper endpoint

142

1409

1.01

0.02

1.7

2.1

0.20

0.19

g/l

0.19

132

1291

Unspecified dementia

354

3172

1.00

0.01

1.8

1.9

0.18

0.19

g/l

1.13

297

2895

Benign neoplasm: Bones of skull and face

277

0.97

0.01

2.5

2.2

0.23

g/l

0.12

261

Prolapse and hernia of ovary and fallopian tube

125

1229

1.01

0.01

2.1

1.8

0.21

0.20

g/l

1.18

105

1112

Other maternal disorders predominantly related to pregnancy

2078

13036

1.00

0.01

2.2

0.22

g/l

0.70

1943

12259

Alzheimer’s disease (Late onset)

825

6948

1.00

0.01

1.6

1.9

0.20

0.19

g/l

1.24

708

6320

Use of ropinirole

117

1163

1.01

0.00

1.7

2.2

0.21

g/l

0.20

105

1086

Retained placenta and membranes, without haemorrhage

372

3727

1.00

0.00

2.3

2.2

0.21

0.22

g/l

1.20

348

3513

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

129

1284

1.00

0.00

1.9

2.2

0.23

0.22

g/l

0.33

118

1208

Postpartum haemorrhage due to anatomy

205

2052

1.00

0.00

2.3

2.0

0.23

g/l

0.59

194

1936

Use of levodopa decarboxylase inhibitor

486

4858

1.00

0.00

2.0

2.1

0.20

g/l

0.26

441

4478

Normotensive glaucoma

301

3009

1.00

0.00

1.8

2.1

0.20

g/l

0.00

269

2792

Inflammation of lacrimal passages (chronic)

447

1.01

0.00

2.2

2.0

0.23

0.20

g/l

1.49

415

Malignant neoplasm of heart, mediastinum and pleura

248

1.01

0.00

2.0

1.9

0.17

0.20

g/l

1.50

220

Lesion of medial popliteal nerve

104

0.96

0.00

1.2

2.1

0.19

0.22

g/l

—

Brain glioblastoma

278

1.01

0.00

1.6

2.1

0.28

0.21

g/l

3.51

249

Beningn neoplasm: Meninges, unspecified

442

1.00

0.00

2.2

2.0

0.22

0.21

g/l

0.06

417

Congenital lens malformations

131

0.99

0.00

2.5

3.3

0.24

0.22

g/l

0.31

122

Spermatocele

249

2488

1.00

0.00

2.3

2.4

0.21

0.20

g/l

0.25

230

2293

Migraine, unspecified, drug-induced

183

0.98

0.00

4.1

2.4

0.20

0.23

g/l

0.77

173

Use of fingolimod

175

0.97

0.00

1.8

2.6

0.25

0.24

g/l

0.32

168

Venous complications and haemorrhoids in the puerperium

285

1.02

0.00

2.6

2.1

0.22

g/l

0.06

272

Congenital malformations of posterior segment of eye

155

1.04

0.00

2.5

3.5

0.20

0.21

g/l

0.27

146

Imbalance of constituents of food intake

0.00

0.0

1.6

—

0.25

—

Nonscarring hair loss, unspecified, drug-induced

0.00

0.0

5.0

—

0.18

—

Taeniasis

0.00

0.0

2.8

—

0.21

—

Bilateral

0.00

0.0

3.0

—

0.22

—

Traumatic shock

0.00

0.0

2.0

—

0.24

—

Total (external) ophthalmoplegia

0.00

0.0

1.8

—

0.16

—

Colour vision deficiencies

0.96

-0.00

1.6

3.0

0.23

0.22

g/l

—

Congenital hydrocephalus

0.90

-0.00

2.4

2.8

0.22

0.24

g/l

—

Other and unspecified postprocedural disorders of eye and adnexa

0.97

-0.00

2.8

2.0

0.21

0.22

g/l

—

Toxic effect of soaps and detergents

0.00

-0.00

0.0

1.9

—

0.22

—

Smallpox

0.00

-0.00

0.0

2.0

—

0.23

—

Other and unspecified disorders of lacrimal system

0.96

-0.00

1.8

0.19

0.23

g/l

—

Rifle, shotgun and larger firearm discharge, undetermined intent

0.00

-0.00

0.0

1.3

—

0.26

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

0.95

-0.00

1.9

2.6

0.23

0.22

g/l

—

Macular cyst

940

1.00

-0.00

2.2

0.21

g/l

0.16

873

Visual disturbances in diseases classified elsewhere

0.00

-0.00

0.0

1.6

—

0.23

—

Typhus fever

0.00

-0.00

0.0

3.6

—

0.22

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

-0.00

0.0

2.6

—

0.22

—

Congenital cataract

120

1.00

-0.00

2.5

3.4

0.24

0.22

g/l

0.45

111

Vascular dementia (sudden onset)

0.89

-0.00

1.3

2.3

0.18

0.17

g/l

—

Radiological devices associated with adverse incidents

0.00

-0.00

0.0

3.9

—

0.21

—

Granuloma inguinale

0.00

-0.00

0.0

1.8

—

0.20

—

Maple-syrup-urine disease

0.00

-0.00

0.0

1.6

—

0.23

—

Anencephaly and similar malformations

0.00

-0.00

0.0

3.0

—

0.22

—

Labyrinthine fistula

1.00

-0.00

1.1

2.4

0.28

0.22

g/l

—

Carcinoma in situ of other and unspecified parts of intestine

0.00

-0.00

0.0

4.8

—

0.23

—

Secondary thrombocytopenia, drug-induced

0.00

-0.00

0.0

5.8

—

0.20

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Prealbumin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS